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ABSTRACT
Mucosal mast cells (MMC) play a major role in allergic disease of the gut and in the
immune response to gastrointestinal nematodes where, in the mouse, their precursors
are recruited into the jejunum and migrate intraepithelially. There, they can be
identified as the mature phenotype by their expression of the MMC-specific
chymase, mouse mast cell protease-1 (mMCP-1).
Migration of other immune cells is regulated by adhesion to extracellular matrix
(ECM) proteins via expression of adhesion molecules such as integrins, and by
interactions with chemotactic molecules such as chemokines. Previous work with
other mast cell phenotypes suggests mast cells to be no exception to this regulatory
system, therefore the aim of this project was to investigate the role of integrins and
chemokines in mast cell migration.
Initial experiments analysed, using RT-PCR, expression of potential mast cell
chemoattractants from intestinal epithelium following infection of mice with the
nematode parasite, Nippostrongylus brasiliensis. Chemokines MlP-la, RANTES,
fractalkine and TECK, and cytokines SCF and TGF-Pi were constitutively expressed
from intestinal epithelium; and MCP-1 expression was detected only on days 7 and
14 post-infection, coinciding with intraepithelial migration ofmast cells. Cultured
MMC and the CMT-93 intestinal epithelial cell line expressed some of these
molecules, suggesting epithelial cells or intraepithelial MMC as potential sources of
mast cell chemoattractants. Furthermore, expression ofmRNA for chemokine
receptors including CCR1, CCR2, CCR5, CX3CR1 and CXCR4 was detected in
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cultured MMC, possibly enabling migration towards chemokines expressed from
intestinal epithelium.
Adhesion of cultured MMC to ECM proteins was regulated by TGF-Pi, which also
regulates the mucosal phenotype, as shown by expression ofmMCP-1. MMC
cultured with TGF-Pi adhered to laminin-1 via expression of the integrin a7pl, as
demonstrated by RT-PCR, flow cytometry and use of neutralising antibodies. MMC
cultured in the absence of TGF-Pi adhered to fibronectin and vitronectin but not
laminin-1, and did not express a7pi. Expression of a7pi integrin has not previously
been shown in a haemopoeitic cell and, as epithelial basement membranes are rich in
laminin, this integrin may aid migration and retention ofMMC intraepithelially.
In conclusion, this work suggests expression of integrins and chemokine receptors by
MMC or their precursors, and of chemokines and cytokines by intestinal epithelium
as possible mechanisms regulating intraepithelial migration ofMMC.
13
CHAPTER 1
GENERAL INTRODUCTION
Mast cells are specialised granulocytic cells of the immune system, and are the major
effector cells of type I hypersensitivity reactions. They were first named
"Mastzellen", meaning "well fed cells", by the German medical student, Paul Erlich
(Foreman, 1993) because of their prominent granules. The granules were thought to
be phagocytosed material, but were later shown to contain the inflammatory
mediators central to their role in allergic disease.
1.1 MAST CELLS, ALLERGIC DISEASE AND INFLAMMATORY
MEDIATORS
Mast cells play a key role in the pathogenesis of allergic diseases such as asthma,
food allergy and ulcerative colitis (Crowe & Purdue, 1992; Page & Minshall, 1993;
Miller, 1993). In such diseases, cross-linking of surface-bound IgE by multivalent
antigen results in release of a variety of both pre-formed and newly synthesised
inflammatory mediators (reviewed in Metcalfe et al, 1997). Pre-formed mediators
include histamine, proteoglycans such as heparin and chondroitin sulphate, and a
number of proteases; those synthesised on mast cell activation include lipid
mediators such as prostaglandins and leukotrienes. In addition to these relatively
non-specific inflammatory mediators, mast cells also synthesise and release a number
of cytokines and chemokines, which may alter the course of the inflammatory
response by specific interactions with other immune cells. Studies using human and
murine cells have shown expression of cytokines including IL-1 p, TNF-a, TGF-P
and IL-13 (Moller et al, 1998; Kanbe et al, 1999; Gordon, 2000) and chemokines
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including MlP-la, MIP-1J3, MCP-1, RANTES and IL-8 (Selvan et al, 1994; Lin et
al, 2000; Oliveira & Lukacs, 2001).
1.2 MAST CELLS AND THE IMMUNE RESPONSE TO NEMATODE
PARASITES
In addition to their detrimental role in allergic reactions, mast cells are involved in
important protective functions including wound healing and, perhaps most
importantly, the immune response to gastrointestinal nematodes. Gastrointestinal
nematode infection is a major cause of disease world-wide in ruminants, and can also
cause disease in humans, in conditions of poor hygiene. In rodents (Miller & Jarret,
1971; MacDonald et al, 1980) and man (Miller, 1992), infection with gastrointestinal
nematodes results in recruitment and hyperplasia of intestinal mast cells.
Furthermore, mast cells have been shown to be functionally active during nematode
infection in the rat (Woodbury et al, 1984), and a requirement for mast cells in
primary expulsion of the nematode parasite Trichinella spiralis has been shown by
delayed expulsion in W/Wv mice, which lack intestinal mast cells (Ha et al, 1983).
In some cases however, the mast cell response to nematodes is not protective:
although infection of mice with Nippostrongylus brasiliensis results in an intestinal
mast cell response, W/Wv mice expel this parasite at the normal rate (Uber et al,
1980).
The mast cell response to nematodes includes all the hallmarks of an allergic
reaction, including IgE production and release of inflammatory mediators. The role
of the majority of these mediators in parasite expulsion is unclear, but mast cell
proteases are probably important in nematode parasite expulsion, as demonstrated by
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delayed expulsion of T. spiralis by mice deficient in the murine mucosal mast cell-
specific chymase, mouse mast cell protease-1 (Knight et al, 2000). The precise
mechanism of action ofmast cell proteases in parasite expulsion is unknown, but
may involve alterations in epithelial permeability (Scudamore et al, 1995). As a type
I hypersensitivity response, intestinal nematode infection in rodents provides us with
a useful model for study of both immunity to parasites and allergic diseases of the
gut.
1.3 MAST CELL ORIGIN AND DIFFERENTIATION
Mast cells are distributed throughout the normal connective tissue of organs which
interface the environment, such as skin, lung and intestine (Galli, 1990). However,
the origin ofmast cells and how they arise in these tissues is still a subject ofmuch
debate. Unlike basophils, which differentiate in bone marrow and circulate as
mature cells (Galli, 1990), no mature mast cells are found in the blood. Kitamura et
al (Kitamura et al, 1981) showed that, in the mouse, mast cells develop from
circulating bone marrow-derived spleen colony-forming unit (CFU-S) precursors,
which can also give rise to granulocytes. A committed murine mast cell precursor
has since been identified as a Thy-110 c-kithl cell which contains cytoplasmic granules
and expresses mRNA for mast cell proteases (Rodewald et al, 1996). Similarly, the
human mast cell precursor was first identified as a CD34+ progenitor cell
(Kirshenbaum, 1991), which could give rise to both mast cells and basophils, but has
since been further characterised as a CD34+/ c-kit"I CD13+ progenitor, from which
both mast cells and monocytes arise (Kirshenbaum et al, 1999). The factors
governing the differentiation ofmast cell progenitors into mature mast cells have
been extensively studied, and are summarised below.
16
1.3.1 Interleukins and mast cell differentiation
Mast cell dependence on T cell-derived factors was first suggested by in vivo
experiments using congenitally athymic mice (Ruitenberg & Elgersma, 1976),
thymectomised rats (Mayrhofer & Fisher, 1979), and by adoptive transfer of primed
T-cells followed by nematode challenge in rats (Nawa & Miller, 1979). Also,
several workers have cultured mast cells from haematopoietic cells in media derived
from con A-activated T-cells or WEHI-3B murine leukaemia cells (Tertian et dl,
1981; Yung et al, 1981). The major T cell-derived mast cell growth factor has been
identified as IL-3 by in vitro studies in mice (Razin et al, 1984), rats (Haig et al,
1988) and humans (Kirshenbaum et al, 1992). Evidence of a role for IL-3 in mast
cell differentiation in vivo came from repetitive administration of IL-3 to nude
athymic mice, which resulted in a large increase in intestinal mucosal mast cells
(Abe et al, 1988). Furthermore, administration of IL-3 induced a mast cell response
to the nematode parasite Strongyloides ratti (Abe & Nawa, 1988).
Other T cell-derived factors including IL-4 (Hamaguchi et al, 1987), IL-9 (Hultner et
al, 1990; Thompson-Snipes et al, 1991) and IL-10 (Thompson-Snipes et al, 1991)
synergise with IL-3 in promoting mast cell growth, but have no growth promoting
properties alone. Notably, the cytokines IL-4, IL-9 and IL-10 are those produced by
cells of the T helper 2 (TH2) subset, correlating well with the observation that
parasite infection in mice results in a predominantly TH2 type response (Grencis et
al, 1991; Else & Grencis, 1991; Else et al, 1992).
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1.3.2 Stem cell factor and mast cell differentiation
Stem cell factor (SCF) is a heavily glycosylated protein encoded for by the steel (SI)
locus. It exists in transmembrane and secreted forms (Anderson et al, 1990;
Kirshenbaum et at, 1992), and interacts with a tyrosine kinase linked receptor, c-kit,
encoded for by the W-locus. Key experiments using W/Wv and Sl/Sld mutant mice
established a role for the gene products of the SI and W loci in mast cell
differentiation before their identity was discovered. Both of these mice are deficient
in mast cells, but transplant of bone marrow cells from normal mice or Sl/Sld mice
into W/Wv mice results in differentiation into tissue mast cells (Kitamura et at,
1978), whereas the converse experiment was unsuccessful. This is now known to be
because W/Wv mice lack functional c-kit, the mast cell growth factor receptor, but
the mast cell deficiency of Sl/Sld mice is due to lack of the mast cell growth factor,
SCF.
Support ofmast cell growth by co-culture ofmast cell progenitors with fibroblasts
(Ginsburg & Lagunoff, 1967; Levi-Schaffer et al, 1986) suggested a fibroblast-
derived factor to be involved in mast cell differentiation. Furthermore, lack of
responsiveness ofmast cells derived from W/Wv mutant mice to fibroblasts
suggested this growth factor to be a ligand for the c-kit receptor. This "kit ligand"
was subsequently purified from fibroblast conditioned medium (Nocka et al, 1990),
and fibroblasts are now well recognised as a major source of SCF in vivo.
SCF also induces proliferation ofmurine (Nocka et al, 1990) rat (Kitamura et al,
1978; Haig et al, 1994) and human (Kirshenbaum et al, 1992) mast cells in vitro, and
18
synergises with IL-3 as a mast cell growth factor. Treatment ofmice with a
monoclonal antibody to c-kit or SCF, which resulted in a significantly decreased
mast cell hyperplasia in response to T. spiralis (Grencis et al, 1993) and N.
brasiliensis (Donaldson et al, 1996), showed SCF to be a key growth factor in the
mast cell response to intestinal nematode parasites.
1.3.3 Other factors involved in mast cell differentiation
Other factors which may play a role in mast cell differentiation include the
fibroblast-derived nerve growth factor, which acts synergistically with IL-3 to
stimulate growth ofmouse bone marrow-derived mast cells (mBMMC) in vitro
(Matsuda et al, 1991). Also, interferon-y (Nafziger et al, 1990) and TGF-Pi (Broide
et al, 1989) inhibit development of IL-3-dependent mBMMC, although the latter
effect is less marked when TGF-Pi is combined with IL-3 in combination with IL-9
and SCF (Miller et al, 1999).
1.4 MAST CELL HETEROGENEITY
Existence ofmorphological differences between mast cells in different locations in
the rat was first recognised 100 years ago (Galli, 1990). However, it was Enerback
in the 1960s who truly defined mast cell heterogeneity on the basis of differences in
histochemical staining. He described "mucosal" mast cells in the intestinal tract and
"connective tissue" mast cells of the skin, peritoneal cavity and other sites, in the rat
(reviewed in Enerback, 1996). Enerback and others have since shown that
connective tissue (CTMC) and mucosal type mast cells (MMC) differ in a number of
other characteristics, as detailed below.
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1.4.1 Histochemical characteristics and proteoglycan content
In the rat, Enerback reported that, following sequential staining with alcian blue and
safranin, MMC stained blue and CTMC took up safranin and stained red (Enerback,
1966b). These staining characteristics reflect differences in proteoglycan content of
the two cell types; in the rat, CTMC contain heparin (Yurt et al, 1977) whereas
MMC contain chondroitin sulphate B (Miller et al, 1999). Similarly, CTMC in the
mouse contain heparin; mucosal mast cells have not yet been purified but a non-
heparin proteoglycan content is assumed from their alcian blue+ / safranin" staining
characteristics (Miller et al, 1999). In general, similar heterogeneity of granule
proteoglycans is seen in human mast cell subsets (Metcalfe et al, 1980; Eliakim et al,
1986), but human lung mucosal mast cells appear to contain both heparin and
chondroitin sulphate E (Stevens et al, 1988).
1.4.2 Protease content
The first example of protease heterogeneity was found in the rat, where connective
tissue mast cells of the skin, tongue and intestinal serosa contain the chymase rat
mast cell protease I (RMCP I), whereas mucosal mast cells of the jejunal lamina
propria and bronchial epithelium contained RMCPII (Gibson & Miller, 1986). In the
mouse, more detailed studies revealed a complex picture, with five mast cell
chymases (mouse mast cell protease (mMCP)-l, 2, 3, 4 and 5), two tryptases
(mMCP-6 and 7) and one carboxypeptidase being reported (Reynolds et al, 1990;
Schwartz, 1994). mMCPs-3, 4, 6 and mast cell carboxypeptidase are present in
CTMC, and mMCP-1 and 2 are markers of the mucosal phenotype (Schwartz, 1994).
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Human mast cells can be classified in terms of protease content as those containing
only tryptase (MCt) and those containing both tryptase and chymase (MCtc) (Irani
et al, 1986; Schwartz, 1994). Mast cells in the lung and intestinal mucosa are
predominantly MCt, whereas in skin and intestinal submucosa, mast cells are mainly
of the MCtc type (Irani et al, 1986), however as both sites contain representatives of
each phenotype, human mast cells cannot be classified by protease content on the
basis of tissue location alone.
1.4.3 Functional characteristics
Mast cells also exhibit heterogeneity in terms of their functional characteristics. This
was first demonstrated by Enerback (Enerback, 1966a), who showed that compound
40/80, a known secretagogue for CTMC, failed to cause degranulation of intestinal
mast cells. Functional heterogeneity may be important clinically, as one
manifestation is varied responses to anti-allergic drugs: sodium chromoglycate and
theophylline inhibit IgE-mediated histamine secretion from peritoneal (CTMC) but
not isolated MMC (Pearce et al, 1982).
In humans, it is not possible to define mast cell phenotype on the basis of functional
differences since mast cells of similar phenotype, as defined by protease content,
respond differently to secretagogues depending on their anatomical location
(Lawrence et al, 1987; Liu et al, 1990).
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1.5 REGULATION OF MAST CELL PHENOTYPES
Studies described previously showed that T cell-derived cytokines, particularly IL-3,
regulate mast cell differentiation from bone marrow precursor cells; these cytokines
also play a role in control ofmast cell phenotype.
In vivo studies in athymic mice showed differential dependence ofCTMC and
mucosal mast cells on T-cells (Ruitenberg & Elgersma, 1976); intestinal mast cell
hyperplasia in response to T. spiralis was absent in these mice, whereas CTMC
numbers were comparable to those in control mice. Injection of IL-3 into athymic
mice restored the intestinal mast cell response to S. ratti, suggesting dependence of
MMC on this cytokine (Abe & Nawa, 1988), and in vitro studies have also shown the
importance of IL-3 in differentiation ofMMC in the rat (Haig et al, 1988) and mouse
(Nabel et al, 1981; Schrader et al, 1981).
In contrast, SCF appears to promote development of the connective tissue phenotype.
When IL-3-dependent mBMMC were cultured with 3T3 fibroblasts, they acquired
characteristics indicative of the connective tissue phenotype, including the ability to
stain with safranin and a 50-fold increase in histamine content (Dayton et al, 1988).
Similarly, culture of human CD34+ pluripotent progenitors with SCF in the presence
of IL-3 induced positive staining for berberine sulphate, which stains heparin-
containing but not chondroitin sulphate-containing mast cells (Kirshenbaum et al,
1992).
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The above distinctions, however, are not absolute. W/Wv and Sl/Sld mice lack both
CTMC and MMC indicating a requirement for SCF in differentiation of both mast
cell phenotypes, and administration of IL-3 to W/Wv mice increased cutaneous mast
cell numbers, suggesting its importance in differentiation ofCTMC. It is likely that
in vivo, a combination ofmast cell growth factors including SCF, IL-3 and other T
cell-derived cytokines control mast cell proliferation.
Recent in vitro studies in the mouse suggest a role for the multifunctional cytokine
TGF-Pi in regulation of the mucosal phenotype; these studies are described in more
detail in 1.6.5.
1.6 USE OF CULTURED MAST CELLS TO STUDY MAST CELL
BIOLOGY
Many aspects ofmast cell biology are investigated using mast cells cultured in vitro
from bone marrow cells, or immortalised mast cell lines. There is some confusion
with respect to the mast cell phenotype represented by these cells, and the same cells
are often used to model both immature and mature mast cells.
1.6.1 IL-3-dependent murine bone marrow-derived mast cells
IL-3-dependent murine bone marrow-derived mast cells (mBMMC) have been used
to represent immature mast cells (Sriramarao et al, 1996; Steegmaier et al, 1997),
mature differentiated mast cells (Thompson et al, 1990) and mucosal type mast cells
(Srednieta/, 1983; Meininger et al, 1992). Phenotypic analysis of these cells shows
that they exhibit some characteristics ofmucosal type mast cells, including alcian
blue staining (Katz et al, 1985) and expression of chondroitin sulphate E
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proteoglycan (Razin et al, 1984). However, these characteristics are also seen in
immature CTMC (Combs et al, 1965) and are not reliable indicators of the mucosal
phenotype. Other studies report expression ofCTMC markers carboxypeptidase A
and mMCP-5 and -6 (Gurish et al, 1992b), but low and variable expression of the
mucosal mast cell-specific chymases, mMCP-1 and -2 (Newlands et al, 1991; Gurish
et al, 1992b) by IL-3-dependent mBMMC. Work showing alteration of integrin
expression between weeks 3 and 12 ofmBMMC may indicate that the 3-4 week-old
mBMMC used in many studies are not fully differentiated, therefore these cells may
be best interpreted as immature stages of both CTMC and MMC.
In some experiments, (Papadopoulos et al, 2000) mBMMC cultured with IL-3 or IL-
4 and SCF are used to represent CTMC. These cells acquire several characteristics
ofCTMC, including presence of heparin-staining granules detected by positive
staining with safranin.
1.6.2 HMC-1 cells
HMC-1 cells are a mast cell line established from a human mast cell leukaemia
(Butterfield et al, 1988), and are said to represent several cell types including
immature mast cells (Juremalm et al, 2000; Inamura et al, 2002), immature
connective tissue mast cells (Kruger-Krasagakes et al, 1996) and mature MCt tissue
mast cells (Nilsson et al, 1998). HMC-1 cells express several known mast cell
markers including tryptase, histamine, heparin and chondroitin sulphate but no
chymase (Nilsson et al, 1994a), therefore they are in many ways similar to MCj.
However, unlike mature mast cells (Shimizu et al, 2002), they express no FcsRI and
maintain expression of CD 13 (Hamann et al, 1994). Therefore, as tryptase is thought
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to be expressed early in mast cell differentiation (Kirshenbaum et al, 1999), HMC-1
cells may also represent immature mast cells but, as neoplastic cells, HMC-1 cells
are likely to differ from normal mast cells found in vivo.
1.6.3 Human cord blood-derived mast cells
A third and most recently characterised type of cultured mast cells are those derived
from human cord blood-derived mast cells (CBMC) or BMMC cultured in the
presence of SCF, IL-6 ± IL-10 (Yuan et at, 1998). In this system, IL-6 and IL-10
synergise with SCF in their effects on mast cell differentiation and IL-10 also
minimises proliferation of granulocytes and monocytes. Ochi et al (Ochi et al, 1999)
characterised human (h) CBMC cultured for 4 weeks in SCF, IL-6 and IL-10 as
human progenitor mast cells (hPrMC) based on surface expression of c-kit and
CD 13, low level expression of FcbRIu and immunoreaetivity for chyinase (80%) and
tryptase (50%). They also used 9-week-old cells to represent mature human mast
cells (hMC), based on higher expression of c-kit, continued expression of FcsRI and
CD 13, toluidine blue staining and immunoreactivity for both tryptase and chymase.
Early chymase expression reported by hPrMC differs from other studies which
suggest tryptase as an early mast cell marker, and chymase as increasing later in mast
cell differentiation (Kirshenbaum et al, 1999; Shimizu et al, 2002), but this has been
attributed to inclusion of IL-10 in cultures. Continued expression ofCD 13 in
cultured hMC, which is not expressed in mature cells (Hamann et al, 1994), is also
inconsistent with their proposed mature phenotype. 4 week-old hCBMC cultured as
described above have similarly been used to represent hPrMC (Boyce et al, 2002),
and 6 week old cells have been used as a model for mature mast cells (Juremalm et
al, 2000).
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1.6.4 Murine mast cell lines
Numerous murine mast cell lines including PT-18, MC/9, CFTL-15 and CMC3 have
also been used to study mast cell biology and are generally thought to resemble
immature mast cells (Galli et al, 1982).
Information gained using in vitro cultured mast cells should be interpreted with care.
The phenotype of these cells may be unclear and their relevance to each individual
study should be carefully considered. In vitro cultured mast cells are utilised
extensively in the studies described below, to investigate mechanisms regulating
mucosal mast migration into jejunal mucosa.
1.6.5 mBMMC cultured with IL-3, IL-9, SCF and TGF-j3i
As detailed above, mBMMC cultured in the presence of IL-3 were initially
considered to represent MMC (Sredni et al, 1983), but it has been subsequently
shown that these cells lack the granule structure seen in vivo (Galli, 1990; Metcalfe et
al, 1997), and express little or none of the MMC-specific chymases, mMCP-1 or -2
(Newlands et al, 1991; Gurish et al, 1992b). In contrast, murine bone marrow cells
cultured with T-cell-conditioned medium (Newlands et al, 1991) or in a combination
of SCF/IL-9 or SCF/IL-10 (Eklund et al, 1993; Xia et al, 1996) expressed mMCP-1.
Therefore, experiments were set up in our laboratory to investigate the effects of
cytokines on differentiation of murine bone marrow cells into cells resembling MMC
(Miller et al, 1999). These studies showed that culture ofmBMMC with WEHI-
conditioned medium as a source of IL-3, and with SCF and IL-9 for 7 days resulted
in 95% mast cells, of which 20% were positive for expression ofmMCP-1 by
immunohistochemistry. However, when TGF-Pi was added to these cultures, the
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percentage of cells expressing mMCP-1 increased to >95% within 4 days. Cells
cultured in the presence of TGF-(3i also resembled MMC morphologically, in that
they were slightly smaller in size and possessed large, electron-dense granules. As
TGF-pi is expressed by enterocytes (Barnard et al, 1993), T-cells (Letterio &
Roberts, 1998) and other cells in the intestinal microenvironment, it was considered
that this cytokine could synergise with IL-3, IL-9 and SCF to regulate the mucosal
phenotype in vivo. Bone marrow mast cells cultured in this way bear the closest
resemblance to MMC in vivo of any cultured mast cells, and were therefore utilised
in the experiments described in chapters 2 - 6 to study potential homing mechanisms
ofMMC.
1.7 MIGRATION OF MUCOSAL MAST CELLS INTO THE JEJUNUM
Mast cells circulate as morphologically unidentifiable precursor cells (Kitamura et al,
1981; Kirshenbaum, 1991), but following infection with gastrointestinal parasites
such as N. brasiliensis (Miller & Jarret, 1971; MacDonald et al, 1980) there is an
expansion of the jejunal mucosal mast cell population, with increased numbers being
located intraepithelially. This is likely to result from both differentiation and
division ofmast cells within the intestine (Miller & Jarret, 1971), and increased
recruitment of the precursors ofmast cells from peripheral blood (Kasugai et al,
1995).
As they may represent an attractive target for development of novel anti¬
inflammatory drugs, the mechanisms governing transendothelial recruitment of other
leucocytes are relatively well defined (Springer, 1994), and the initial recruitment of
mast cell progenitors is likely to share many of these mechanisms. Once in the
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lamina propria, mast cells or their progenitors must migrate across the lamina propria
and into the epithelium; this stage may share common mechanisms with
intraepithelial migration of y8 T cells (Smith & Weis, 1996) since both of these cell
types home to the intestinal epithelium. Potential mechanisms governing leucocyte
trafficking and their application to mucosal mast cell homing are detailed below.
1.8 SELECTINS AND RECRUITMENT OF BLOOD-BORNE CELLS
ACROSS VASCULAR ENDOTHELIUM
In order to migrate into tissues, cells must attach to and traverse through vascular
endothelium. Selectins are a family of calcium-dependent lectin-type adhesion
molecules which are involved in the initial interactions of leucocytes with
endothelium (reviewed in Springer, 1994). They mediate tethering and rolling onto
vascular endothelium via interactions characterised by rapid association-dissociation
constants. There are 3 subclasses of selectins: L-selectin is expressed on most
circulating leucocytes, whereas E- and P- selectins are expressed on vascular
endothelium in response to inflammatory mediators and cytokines; P-selectin is also
expressed on platelets. Selectins recognise sialylated carbohydrate counter-
receptors; E- and P- selectins interact with carbohydrate structures closely related to
sialyl lewis-X, whereas L- and P- selectins recognise O-linked mucin-like molecules
such as GlyCAM-1 (glycosylated cell adhesion molecule-1), CD34 and PSGL-1 (P-
selectin glycoprotein ligand-1).
The first evidence of selectin involvement in recruitment ofmast cell precursors
resulted from both in vitro and in vivo studies using IL-3-dependent mBMMC. Use
of a mouse dorsal skin fold model and E- and P-selectin neutralising antibodies
28
showed rolling ofmBMMC on P-selectin (Sriramarao et al, 1996) but not E-selectin,
and in vitro studies supported this result (Steegmaier et al, 1997), and revealed
PSGL-1 as the major binding site for P-selectin on mBMMC. More recently (Boyce
et al, 2002), human cord blood cells cultured for 4 weeks in SCF, IL-6 and IL-10
were used to represent mast cell progenitors. These cells expressed PSGL-1 and, in
contrast to the above, rolled on both P-selectin and E-selectin though antibodies to
PSGL-1 did not block rolling on E-selectin, suggesting involvement of another
ligand.
On the basis of the above it is likely that, as in recruitment of other leucocytes,
selectins mediate initial interactions ofmast cell precursors with vascular
endothelium.
1.9 INTRODUCTION TO INTEGRINS
Integrins are the major receptors by which cells attach to extracellular matrix and
other cells (reviewed in Hynes, 1992; van der Flier & Sonnenberg, 2001), and are
expressed by most cells. They are a family of glycosylated, heterodimeric
transmembrane adhesion receptors that consist of non-covalently bound a and (3
subunits. a subunits vary in size between 120 and 180 kDa and P subunits are 90 -
110 kDa. Currently, 18 a and 9 P subunits are recognised and known to form 24
different heterodimers, and the combination of a and P subunits determines the
ligand specificity of the integrin.
Regulation of cell adhesion via integrins is complicated by the fact that individual
integrins can often bind more than one ligand, and the specificity and affinity of a
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given integrin receptor on a given cell is not always constant, but can be regulated by
both intracellular and extracellular signals. This "inside-out" signalling has been
studied for integrin aIIBp3 in platelets, and requires the activity ofRho-like
GTPases (van der Flier & Sonnenberg, 2001). Integrin binding is dependent on
divalent cations, the nature ofwhich can affect the affinity and specificity for
ligands.
Cell adhesion to the extracellular matrix does not simply serve the purpose of
maintaining a cell in a particular location, adhesion may also activate second
messenger pathways leading to modulation of cellular function. For example,
adhesion ofmonocytes to extracellular matrix molecules induces genes encoding
inflammatory mediators (Sporn et al, 1990), thus cell adhesion to the ECM offers a
mechanism whereby cellular function can be adapted to local microenvironmental
conditions. The roles of integrins in cell migration are detailed below.
1.9.1 Integrins and endothelial arrest
Whilst selectin-mediated rolling represents the first leucocyte-endothelial interaction,
in order to begin diapedesis between endothelial cells, a firmer adhesion must be
established. In lymphocytes, this firm adhesion is mediated by integrins including
the P2 integrins, cx4pl and a4p7 (table 1.1). Integrins also add a further regulatory
step to leucocyte homing mechanisms: the P2 integrin aLp2 interacts with
intercellular adhesion molecule-1 (ICAM-1) after induction by inflammatory
cytokines, whereas interaction with constitutively expressed ICAM2 may be
important for leucocyte trafficking in non-inflamed tissues. Furthermore, integrin
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Subunits Name Ligand
aLp2 LFA-1, CDlla/CD18 ICAM-1, ICAM-2, ICAM-3
aMp2 Mac-1, CD1 lb/CD18 ICAM-1, fibrinogen
aXp2 P150, CD1 lc/CD18 Fibrinogen
a4pl CD49d/CD29 VCAM-1, fibrinogen
a4p7 CD49d/CD" MAdCAM-1, VCAM-1,
fibronectin
Table 1.1. Integrins involved in leucocyte-endothelial interactions.
Adapted from Springer, 1994.
Subunits Ligands
(31 al Collagens, laminin
a2 Collagens, laminin
a3 Fibronectin, laminin, collagens
a4 Fibronectin
a5 Fibronectin
a6 Laminin
al Laminin
a8 Fibronectin, vitronectin, tenascin1
av Vitronectin, fibronectin
P3 av Vitronectin
allb Fibronectin
P5 av Vitronectin
(36 av Fibronectin
P7 a4 Fibronectin
Table 1.2. Integrins involved in leucocyte-extracellular matrix interactions.
Adapted from Hynes, 1992
1
Schnapp et al, 1995.
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a4p 1 is expressed on skin-homing lymphocytes, whereas gut-homing lymphocytes
express a4p7 (Kunkel & Butcher, 2002)a4p7 (Kunkel & Butcher, 2002).
Integrins are also likely to regulate seeding ofmast cell progenitors into tissues.
hCBMC cultured in SCF and IL6 constitutively express ICAM-1, VLA-4 and aMp2
(Inamura et al, 2001). Furthermore, In vitro studies using human cord blood mast
cells cultured in SCF, IL-6 and IL-10 to represent mast cell progenitors showed a4
integrin-VCAM-1 interactions to be important in attachment to TNF-a-activated
HUVEC (Boyce et al, 2002); the same study also showed expression of aLp2 and
aMp2 by cultured mast cell progenitors.
However, the most definitive demonstration of a role for integrins in recruitment of
mast cell progenitors has resulted from investigations of a4p7-MAdCAM-l
interactions in the mast cell response to intestinal nematode infection. Artis et al
(Artis et al, 2000) showed delayed recruitment ofmast cells following T. spiralis
infection in P7 integrin-deficient mice, and Issekutz (Issekutz et al, 2001)
demonstrated that blockade of either a4 or P7 integrins resulted in inhibition of the
intestinal mast cell hyperplasia following N. brasiliensis infection of rats. The key
experiment showing clearly that a4p7 integrin was required for seeding ofmast cell
precursors into the small intestine, was performed by Gurish et al (Gurish et al,
2001), using limiting dilution analysis to measure mast cell precursors in various
tissues of P7 integrin-deficient mice. In this experiment, precursors were completely
absent from the small intestine but present in lung, spleen and large intestine.
32
1.9.2 Integrins and cell adhesion to the extracellular matrix
Following nematode infection, mast cells or their precursors are thought to migrate
across the intestinal epithelium to reside intraepithelially, and it is now well
recognised that cell migration and location within tissues is regulated via adhesion to
extracellular matrix (ECM) proteins - fibrils or sheets of protein material which
contribute to the structural properties of tissues and also have important regulatory
functions (detailed in 1.9.3 and 1.9.4). The VLA (very late after activation) integrins
(table 1.2) are the major molecules mediating cell adhesion to the extracellular
matrix, and expression of these may regulate mast cell migration through tissues.
The VLA integrins are so-named because of the time at which «i (31 and OC2P2 appear
on lymphocytes (Hemler, 1990). However, since most cells in the body express one
or more Pi integrins constitutively, and some of the a subunits associate with other P
subunits, the ap nomenclature now is more widely acceptable. In addition to the Pi
integrins, the av subunit combines with P3, P4, P5 and P6 to form molecules which
also regulate adhesion to ECM proteins.
Cell adhesion to ECM proteins may be regulated by extracellular signals, for
example, the ligand binding affinity ofVLA 5 (a5pi) in mast cells was increased by
Ag cross-linking of FcsRI through a PI3 kinase-dependent mechanism (Kinashi et al,
1999). Phorbol esters such as PMA regulate adhesion to the ECM by
phosphorylation of cytoskeletal proteins (Danilov & Juliano, 1989) and are often
used for stimulation ofmaximal cell adhesion to ECM proteins. Several integrin
subunits including a3, a6 (Tamura et al, 1991) and al (Ziober et al, 1993) have
33
alternatively spliced cytoplasmic domains; some including a6 (Belkin & Stepp,
2000) and a7 (Ziober et al, 1993) can also be alternatively spliced in their
extracellular domains, which may modulate their adhesion properties (Ziober et al,
1997; von der Mark et al, 2002).
The distribution ofECM proteins varies according to tissue location, therefore mast
cell migration from the lamina propria into the epithelium may be regulated by
alterations of integrin expression corresponding to differences in ECM proteins
between the lamina propria and basement membrane. The ECM proteins rich in
these two locations and their integrin ligands are detailed in 1.9.3 and 1.9.4.
1.9.3 Integrins and adhesion to extracellularmatrix proteins of basement
membranes
Basement membranes support epithelia throughout the body and are composed of a
network of proteins including laminin and type IV collagens. Consideration of
integrins which might adhere to the BM is pertinent to study of the migration of
MMC, as adhesion ofmast cells to basement membrane proteins may aid retention
intraepithelially.
Laminin is the major non-collagenous component of basement membranes. It
consists of a cross-like structure composed of 3 subunits: 2 light chains of
approximately 200 kDa, designated p and y, and a 400 kDa a chain (Beaulieu &
Vachon, 1994). Eleven distinct laminin chains have been identified in humans and
mice, and combinations of these generate at least twelve different laminin variants
(Kikkawa et al, 2000). Expression of the different isoforms is tissue and location-
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specific and integrin binding specificities vary between isoforms (Yao et al, 1996),
though considerable overlap exists.
Due to its ready availability in significant quantities, laminin-1 isolated from the
murine Engelbreth-Holm-Swarm tumour is the most commonly studied isoform of
laminin. Several regions important in binding of laminin-1 to integrins and other
adhesion molecules have been identified using proteolytic fragments and peptides
derived from laminin. Most laminin-binding integrins, including a3(31, a6pi and
a7pi appear to bind the E8 fragment at the C-terminal of the a chain (Belkin &
Stepp, 2000), whilst the YIGSR region of the P1 chain is involved in adhesion via
the non-integrin laminin binding protein (1.9.5) (Graf et al, 1987). Other known
binding sites include IKVAV (Nomizu et al, 1995) and an RGD region (Grant et al,
1989).
Opinion on the relevance of laminin-1 to study of cell adhesion to basement
membrane laminin in vivo is divided. Whereas some authors state laminin-1 as being
a major component of the basement membranes of several tissues including small
intestine (Simon-Assmann et al, 1994; Nomizu et al, 1995; De Arcangelis et al,
1996), others suggest laminin-1 is uncommon in vivo (Falk et al, 1999; Kortesmaa et
al, 2000). Nevertheless, as the different isoforms are likely to have several integrin
binding sites in common, laminin-1 represents a convenient model for study of cell
adhesion to laminin. Other commonly studied isoforms of laminin include human
placental laminin-2/4 or merosin, in which an A-chain variant is present (Delwel et
al, 1994).
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Integrins mediating cell adhesion to laminin include pi integrins aipi, a2pi, a3pi,
a6pi, a7pi and a9pi, three members of the av subfamily (ap3, avP5 and otvp8)
and a6p4 (Belkin & Stepp, 2000).
Type IV collagen is the major collagenous component of basement membranes
(reviewed in Olson, 1993a). Molecules are heterotrimers of two al and one ot2
chain and are associated in a network structure. A major binding site has been
identified which interacts specifically with integrins aipi and a2p2 on cells.
1.9.4 Integrins and adhesion to extracellular matrix proteins found in the
lamina propria
Mast cells must migrate across the lamina propria to the epithelium; extracellular
matrix proteins which may be found in the lamina propria include fibronectin,
vitronectin and fibrillar collagens. Fibronectins are high molecular weight
glycoproteins found in many extracellular matrices and in plasma (reviewed in
(Hynes, 1993). Subunits are 235 - 270 kDa plus carbohydrate, and each subunit is
made up of repeating modules of 2 types. Alternative splicing produces variations in
structure and 2 cell binding sites are recognised: the RGD motif is recognised by
integrin a5pl, and a4pl recognises the EILDV sequence.
Vitronectin is an abundant plasma protein produced by the liver (reviewed in
(Mosher, 1993). It is also distributed ubiquitously through loose connective tissue,
particularly around vascular endothelium (Reilly & Nash, 1988). Vitronectin is
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synthesised as a single chain, which is subjected to post-translational modifications
before secretion. Its structure includes the RGD cell adhesion sequence, which is
recognised by avpl, avP3 and avP5 integrins.
The main function of fibrillar collagens, including types I - III, V and XI is provision
ofmechanical support, but they also support cell attachment and differentiation
(reviewed in Olson, 1993b). Each molecule is made up of polypeptide units (a
chains), which form triple helices. These form supramolecular aggregates in tissues
containing more than one type of collagen, and the resulting fibrils are arranged in
different patterns in different tissues. Cells adhere to collagens via integrins aipi,
a2pi and a3pi (Hynes, 1992).
1.9.5 Laminin binding protein and adhesion to the extracellular matrix
A non-integrin 67 kDa laminin binding protein (LBP) has been shown to be involved
in cell adhesion to laminin (Clement et al, 1990). It is a dimer, made up of two 37
kDa precursor proteins encoded by a single gene (Rao et al, 1989), and binds the
YIGSR sequence of laminin (Graf et al, 1987). Surface expression of LBP is
translationally regulated, therefore cells expressing high levels of LBP mRNA do not
necessarily express correspondingly high levels of LBP on their cell surface
(Landowski et al, 1995). Post-translational modifications may also occur, with
surface LBP existing in equilibrium with ribosomal-associated LBP; this is an
important consideration when measuring LBP expression, as surface expression
cannot be assumed even by detection of protein by Western blotting (Landowski et
al, 1995).
37
LBP regulates adhesion of a number of cell types to laminin, including hepatocytes
(Clement et al, 1990) and T-lymphocytes, where it is co-expressed and co-localises
with a.6 integrin (Canfleld & Khakoo, 1999). It has diverse roles in vivo: LBP is
associated with certain tumours in mice (Makrides et al, 1988) and humans (Yow et
al, 1988), and plays a role in embryo implantation in mice (Zhang et al, 2000).
1.9.6 Adhesion ofmast cells to extracellular matrix proteins
As mast cell adhesion to ECM proteins is likely to regulate their ability to migrate
through tissues and thus perform their physiological and pathological functions, it
has been extensively studied using cultured and tissue-derived mast cells from
rodents and humans (table 1.3). Much of the work on adhesion ofmurine mast cells
to ECM proteins utilised IL-3-dependent mBMMC, which are said to represent an
immature phenotype (Stevens et al, 1986). These cells adhere to laminin-1 and -2
(Thompson et al, 1989a; Thompson et al, 1990; Page & Minshall, 1993; Fehlner-
Gardiner et al, 1996a), fibronectin (Dastych et al, 1991) and vitronectin (Bianchine
et al, 1992), and integrins a6pi(Fehlner-Gardiner et al, 1996a; Vliagoftis &
Metcalfe, 1997), a4 and a5pi(Fehlner-Gardiner et al, 1996b) and avp3 (Bianchine
et al, 1992) respectively have been shown to play a role in this adhesion.
Additionally, antibodies to the non-integrin 67 kDa laminin binding protein (LBP)
block adhesion of IL-3-dependent mBMMC to laminin-1 (Thompson et al, 1989a),
indicating a role for this molecule.
As previously described, integrin-mediated adhesion may be regulated by
extracellular signals, and stimulation using PMA, FcsRI cross-linking or calcium
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ECM protein Cell type Source Adhesion Ref.
mol.
Laminin mBMMC Mouse bone a6pi Vliagoftis & Metcalfe, 1997
marrow
LBP
Fehlner-Gardiner et al, 1996a
Thompson et al, 1989a
PT-18 Mouse cell line LBP Thompson et al, 1989a
CFTL-15 Mouse cell line a6pi Fehlner-Gardiner et al, 1996a
MC/9 Mouse cell line a6pi Fehlner-Gardiner et al, 1996a
C57 Mouse cell line cc6pi Vliagoftis & Metcalfe, 1997
HMC-1 Human cell line ?' Kruger-Krasagakes et al, 1996
Human skin MC Human dermis oc3pi Columbo et al, 1995
Fibronectin mBMMC See above oc5pi,a4pi2 Fehlner-Gardiner et al, 1996b
MCP/5 Mouse cell line a5pi Dastych et al, 2001
MC/9 See above a5pi Fehlner-Gardiner et al, 1996b
CFTL-15 See above a4pi, a5pi Fehlner-Gardiner et al, 1996b
HMC-1 See above cc5pi Kruger-Krasagakes et al, 1996
Human skin MC See above a3pi, a4pi, Columbo et al, 1995
a5pi
Vitronectin mBMMC See above avP3 Bianchine et al, 1992
Human skin MC See above avp3 Columbo & Bochner, 2001
1 None of the antibodies investigated in this experiment blocked adhesion ofHMC-1 cells to laminin.
2 Both a4pi and a5pi are involved in adhesion of mBMMC during weeks 1 - 3 of culture. a5pi
mediates mBMMC adhesion to fibronectin from week 4 onwards.
Table 1.3. Summary of adhesion to ECM proteins and integrin expression by
mast cells.
mBMMC - murine bone marrow-derived mast cells.
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ionophore was necessary for adhesion of IL-3-dependent mBMMC to laminin-1
(Thompson et al, 1990) or fibronectin (Dastych et al, 1991), but cells adhered
spontaneously to vitronectin (Bianchine et al, 1992). Cytokines also stimulated
adhesion ofmBMMC to ECM proteins: IL-3 stimulated adhesion to laminin
(Thompson et al, 1989a), and SCF stimulated adhesion to both laminin (Vliagoftis &
Metcalfe, 1997) and fibronectin (Dastych & Metcalfe, 1994).
A number of murine cultured mast cell lines have also been used for study ofmast
cell adhesion to ECM proteins (table 1.3). PT-18 (Thompson et al, 1989a), C57
(Vliagoftis & Metcalfe, 1997), CFTL-15 (Fehlner-Gardiner et al, 1996a; Vliagoftis
& Metcalfe, 1997) and MC/9 (Fehlner-Gardiner et al, 1996a) mast cells adhere to
several laminin isoforms, and both LBP (Thompson et al, 1989a) and a6 integrins
(Fehlner-Gardiner et al, 1996a; Vliagoftis & Metcalfe, 1997) have been implicated in
this process. MC/9 (Fehlner-Gardiner et al, 1996b) and MCP/5L (Dastych &
Metcalfe, 1994) mast cells adhere to fibronectin via integrin a5, but both a4 and a5
regulate adhesion of CFTL-15 cells to fibronectin (Fehlner-Gardiner et al, 1996b).
Although some cultured mast cell lines (Thompson et al, 1989a; Fehlner-Gardiner et
al, 1996a) exhibited spontaneous adhesion, adhesion of other mast cell lines to ECM
proteins could be upregulated as in IL-3-dependent mBMMC. The rat basophilic
leukaemia cell line (RBL-2H3) and PMA-stimulated rat peritoneal mast cells
adhered to fibronectin and vitronectin and expression of integrins a4pl, a5pi and
avp3 was detected by immunofluorescent staining. Additionally, antibodies to a4,
a5 or P3 inhibited adhesion of these cells to fibronectin (Yasuda et al, 1995).
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Study of human mast cell migration through tissues has focussed largely on
connective tissue mast cells, due to their proposed role in allergic skin diseases.
Consequently, the human mast cell line HMC-1 which, in some studies, is said to
resemble human connective tissue mast cells (Nilsson et al, 1994a), has been widely
used for investigation of the adhesion of human mast cells to ECM proteins. In one
study, (Kruger-Krasagakes et al, 1996) these cells adhered to human laminin,
fibronectin, vitronectin and collagens type I, III and IV; but another study (Nilsson et
al, 1994c) showed them to adhere only to fibronectin. These differences are
reflected by variations in integrin expression between the two studies: Kruger-
Krasagakes et al (Kruger-Krasagakes et al, 1996) showed expression of integrins p 1,
P5, a2-6, and av by HMC-1 cells, and adhesion to fibronectin and vitronectin was
blocked by antibodies against integrins a5pi and avP5, respectively. In contrast,
Nilsson et al (Nilsson et al, 1994c) found only expression ofa4pi and a5pi by the
same cell line; the reason for these discrepancies is unclear.
Adhesion properties ofmature human skin mast cells have been investigated
following extraction of viable cells from tissues, these cells adhered spontaneously to
human laminin, fibronectin (Columbo et al, 1995) and vitronectin (Columbo &
Bochner, 2001). Expression of integrins a3pi, a4pi, a5pi and avp3 but not alpl,
a2pi or a6pi was found in these cells. a3pi, a4pl, and a5pi were shown, by use
ofmonoclonal antibodies, to be involved in adhesion to fibronectin; a3pi antibodies
also blocked adhesion to laminin and antibodies to avp3 showed a role for this
integrin in adhesion to vitronectin. Another study (Sperr et al, 1992) found that
human mast cells isolated from lung and uterus, and HMC-1 cells, expressed the
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same spectrum of integrins, with the exception of the a.3 subunit. These integrins are
suspected to be involved in location ofmast cells within tissues and the similarities
in integrin expression may reflect similarities in the areas ofECM in which mast
cells accumulate in many tissues (Metcalfe et al, 1997).
A recent study investigated integrin expression in human intestinal mast cells
(Lorentz et al, 2002). These cells expressed a similar profile of integrins to those
described above, but also expressed a2 integrin, and adhered spontaneously to
fibronectin and laminin-1. However, culture with SCF enhanced by up to 5-fold,
adhesion to fibronectin, laminin and collagens, whereas culture with IL-4 reduced
adhesion to ECM proteins. Culture of human foetal liver mast cell progenitors with
SCF also upregulated mast cell adhesion to vitronectin via expression of av(33
(Shimizu et al, 1995), therefore SCF appears to regulate adhesion of both murine and
human mast cells, perhaps reflecting its central role in mast cell function.
As described in other cell types, mast cell adhesion to ECM can modulate cellular
function. Adhesion of PMA-stimulated HMC-1 cells to fibronectin or vitronectin
enhanced cytokine gene expression and mediator secretion (Kruger-Krasagakes et al,
1999) and adhesion of IL-3-dependent mBMMC to vitronectin resulted in an
enhanced proliferative response to IL-3 (Bianchine et al, 1992), which may be due to
phosphorylation of cellular proteins (Bhattacharyya et al, 1999).
1.9.7 Integrins and adhesion to intestinal epithelial cells
In the mouse, >90% of intestinal mast cells are intraepithelial (Miller et al, 1995),
and it has been suggested that, as is thought to be the case for intraepithelial T-
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lymphocytes, expression of specific integrin chains is required for retention ofMMC
intraepithelial^ (Smith & Weis, 1996).
The integrin aEp7, which binds epithelially expressed E-cadherin (Karecla et al,
1995), is expressed in > 90% of intraepithelial lymphocytes (IEL) (Cepek et al,
1993), and is regulated by TGF-p i (Kilshaw & Murant, 1990; Parker et al, 1992). In
vitro studies showing higher expression of aEp7 on lymphocytes homed into the
epithelium (Shibahara et al, 2000) suggested a role for this integrin in intraepithelial
migration, and reduced expression of aEp7 has been shown in splenic T- cells of
Smad7 transgenic mice (Suzuki et al, 2002). These mice express Smad7, an
intracellular inhibitor of TGF-P, and reduced TGF-P-mediated expression of aEp7
resulted in a reduction in IEL in these mice, further supporting a role for aEp7 in
intraepithelial location of T cells.
Expression of aEp7 which is regulated by TGF-Pi or FcsRI-cross-linking has been
found in IL-3-dependent mBMMC (Smith et al, 1994), and TGF-Pi-regulated
expression of aE has been shown to correlate with development of the mucosal
phenotype in an in vitro model ofmast cell differentiation (Wright et al, 2002). This
strongly supports a role for TGF-Pi-regulated expression of aEp7 in intraepithelial
location ofmucosal mast cells, as mature mMCP-l+ mast cells predominate
intraepithelially (Scudamore et al, 1997). Furthermore, TGF-Pi regulates expression
of the pi integrins in other cells (Ignotz & Massague, 1987), and may therefore
upregulate expression of integrins mediating adhesion ofmast cells to epithelial
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basement membrane proteins, which could further promote intraepithelial location of
MMC.
1.10 CHEMOATTRACTANTS AND CELL MIGRATION INTO AND
THROUGH TISSUES
Whilst selectins and integrins facilitate adhesion of emigrating leucocytes to vascular
endothelium, before they migrate from the circulation into tissues, the cells must
receive chemotactic stimuli from molecules expressed by vascular endothelium or by
other cells within these tissues. Further leucocyte migration through tissues,
including migration ofmast cells into intestinal epithelium, is also likely to be
regulated by chemotactic molecules.
A number of molecules have been identified which are chemotactic for leucocytes.
Classical chemoattractants include bacterial-derived N-formyl peptides, complement
fragments C3a and C5a and lipids such as leukotriene B4 and PAF (Murdoch &
Finn, 2000). Recently, a family of chemotactic cytokines named "chemokines" have
been discovered (Taub & Oppenheim, 1993) and shown to be involved in leucocyte
recruitment into tissues.
1.10.1 Chemokines and chemokine receptors
Chemokines are low molecular weight (8-17 kDa) proteins which can be divided
into 4 groups (CXC, CX3X, CC and C) according to the positioning of two N-
terminal cysteine residues (Rottman, 1999; Murdoch & Finn, 2000). Their effects on
target cells are mediated by interaction with specific 7-transmembrane spanning G-
protein coupled receptors, which are generally classified according to their
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chemokine ligands. CXCR1 - 5 bind CXC chemokines, whereas CCR1- 9 bind a
number of CC chemokines. Additionally, receptors for fractalkine (CX3CR1) and
lymphotactin (XCR1) have been identified.
Chemokines are unique in their promiscuous interactions with their receptors
(Mantovani, 1999); one chemokine can bind to various receptors, whilst target cells
can express several different chemokine receptors. This feature is thought to render
the chemokine system more robust, so that loss of one particular chemokine or
receptor due to a gene polymorphism would be less deleterious to the system.
Although much redundancy exists in the system, chemokines do exhibit some
specificity in the cell types with which they interact. CXC chemokines generally
recruit neutrophils, whereas CC chemokines act primarily on monocytes and T-cells
(Conti et al, 1999). Furthermore, chemokine receptors are differentially expressed
on TH1 and TH2 cells, thus explaining subset-specific T-cell recruitment in diseases
characterised by a particular inflammatory response. TH1 cells express chemokine
receptors CCR5 and CXCR3 and preferentially accumulate in synovial fluid of
patients with the TH1-mediated disease rheumatoid arthritis, whereas expression of
CCR3, CCR4 and CCR8 mediates accumulation of TH2 cells in allergic-type
diseases such as asthma (Rottman, 1999; Homey & Zlotnik, 1999).
1.10.2 Chemokines and leucocyte recruitment
Chemokines are a critical part of the multi-step process whereby leucocytes are
recruited across the vascular endothelium into tissues. In addition to provision of a
chemotactic stimulus, chemokines activate p2 integrins such as CD1 lb/CD 18
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expressed by rolling leucocytes, leading to firm adhesion or "arrest" on endothelium
via interactions with counterligands such as ICAM-1, -2 and -3 (Springer, 1994;
Murdoch $ Finn, 7000) It is thought that binding of chemokines lo endothelium via
heparin binding sites may allow establishment of a concentration gradient, even in
flow conditions (Springer, 1994). Arrest chemokines or chemokine receptors have
been identified for several leucocytes: monoclonal antibodies to CCR3 blocked
eosinophil arrest on endothelium stimulated by inflammatory mediators under shear
flow conditions (Kitayama et al, 1998). Similarly, several chemokines stimulate
lymphocyte arrest under flow conditions: SDF-1, 6-C-kine andMlP-la triggered
adhesion ofmemory CD4+ T-cells (Campbell et al, 1998).
Although a specific arrest chemokine for mast cells has not been identified,
chemokine-mediated transmigration ofmast cells through endothelium has been
shown in vitro (detailed in 1.11.1), and may regulate accumulation ofmast cell
precursors into tissues.
1.10.3 Chemokine expression and inflammatory disease
Upregulation of chemokine expression has been shown in a number of inflammatory
and allergic-type diseases, and is thought to regulate the specific inflammatory
responses seen in these diseases. Some of the chemokines upregulated in these
diseases are potential mast cell chemoattractants.
In asthmatic patients, upregulation of eotaxin has been shown in lung epithelial and
endothelial cells, and mucosa-infiltrating eosinophils expressing the eotaxin receptor
CCR3 have been identified (Homey & Zlotnik, 1999). Expression of CCR3 has also
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been demonstrated in allergic dermatitis. Other chemokines associated with the
pathogenesis of asthma include RANTES, MCP-1, -3 and -5 and MlP-la (Homey &
Zlotnik, 1999; Teran, 2000).
Several chemokines are upregulated in inflammatory diseases of the gut. As mast
cells may play a role in many of these diseases (Crowe & Purdue, 1992), this
suggests a possible role for chemokines in intestinal recruitment ofmucosal mast
cells. Increased expression of the CC chemokines MCP-1 and RANTES has been
shown in inflammatory bowel disease (IBD) using RT-PCR, in .szYw-hybridisation and
immunohistochemistry. Expression ofMCP-1 was upregulated in venule
endothelial cells, spindle cells and mononuclear cells (Mazzucchelli et al, 1996), and
RANTES expression was upregulated in IEL and the subendothelial lamina propria
(Reinecker et al, 1995). In ulcerative colitis, increased immunohistochemical
staining for MlP-la was shown in colonic epithelial cells, macrophages and
neutrophils (Vainer et al, 1998); and expression of fractalkine mRNA was
upregulated in intestinal epithelial and endothelial cells during active Crohn's disease
(Muehlhoefer et al, 2000). Expression of CC chemokines may contribute towards
the chronic inflammation seen in such diseases by recruitment of inflammatory cells
such as monocytes and memory T-cells. In contrast, CXC chemokines may
contribute to the acute phase of inflammatory bowel diseases. Increased expression
of IL-8 has been identified in the mucosa of patients with active Crohn's disease and
ulcerative colitis, and this has been correlated with increased numbers of neutrophils
(Macdermott, 1999). Increased expression ofENA-78 has also been detected in
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epithelial cells of patients with lower grade disease activity, and may contribute
further towards attraction of granulocytes into IBD mucosa (Macdermott, 1999).
1.10.4 Chemokines, epithelium and the immune response to gut-dwelling
pathogens
In order to attract mast cells into epithelium, the relevant chemoattractants would be
expected to be epithelially-derived. Epithelium is well-established as a source of
chemokines, which may be expressed by both epithelial cells and intraepithelial cells
such as lymphocytes. Chemokines such as TECK, which are expressed
constitutively by intestinal epithelial cells (Wurbel et al, 2000), are suspected to be
involved in homeostatic lymphocyte trafficking into intestinal mucosa (Kunkel et al,
2000; Luster, 2001). However, several epithelial cell-derived chemokines, though
constitutively expressed, are upregulated in inflammatory diseases or in response to
cytokines, and their expression is thought to attract inflammatory cells into the
epithelium and mucosa. Stimulation of freshly-isolated human colon epithelial cells
with IL-la resulted in upregulation of expression of neutrophil chemoattractants
GRO-a, GRO-y and ENA-78 and monocyte/T-cell chemoattractants MCP-1 and
RANTES (Yang et al, 1997). Furthermore, expression of IP 10 and MIG was
upregulated in human epithelial cell lines in response to interferon-y and resulted in
chemotaxis of intraepithelial lymphocytes (Dwinell et al, 2001; Shibahara et al,
2001). IEL also migrate towards chemokines IL-8, GRO-a, MlP-la, MCP-1
(Roberts et al, 1997) and fractalkine (Muehlhoefer et al, 2000), all of which may be
expressed by intestinal epithelial cells. IEL can also express several chemokines and
cytokines themselves, including MlP-la, MIP-1(3, RANTES, IFN-y, TNF-a and
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TGF-Pi (Boismenu et al, 1996; Kearsey & Stadnyk, 1996), and may therefore
contribute to epithelially-regulated cellular recruitment.
Expression of chemokines from intestinal epithelium can be upregulated in response
to gastrointestinal infections, and intraepithelial migration ofmast cells following N.
brasiliensis could be regulated by parasite-induced expression of the relevant
chemokines by epithelium. Interaction of bacteria, viruses and nematode parasites
with intestinal epithelium can stimulate upregulation of chemokines and cytokines,
both of which may promote influx of inflammatory cells. Infection of human colon
epithelial cell lines with invasive bacteria resulted in upregulation of IL-8, MCP-1,
GM-CSF and TNF-a (Jung et al, 1995), and rotavirus infection of the human
epithelial cell line HT-29 stimulated upregulation of CC chemokines MlP-la, MCP-
1 and RANTES and of CXC chemokines IL-8, IP 10 and GRO-a (Rollo et al, 1999).
The epithelial response to the nematode parasite T. spiralis has been studied using
both cell culture (Li et al, 1998) and epithelial isolation methods (Stadnyk &
Kearsey, 1996), where upregulation of IL-1 (3, IL-8 and ENA-78 have been shown.
These chemokines are likely to initiate the neutrophil response to this parasite.
Expression of chemokines and cytokines in response to N. brasiliensis has not been
studied, but upregulation ofmast cell chemoattractants could contribute to mast cell
recruitment into the epithelium.
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1.11 MAST CELL CHEMOATTRACTANTS
As the ability to migrate into and through tissues is likely to be critical to the
function of both CTMC and MMC, several molecules have been investigated for
mast cell chemoattractant activity based on their chemoattractant activity for other
leucocytes. Mast cell types including mBMMC, hCBMC, HMC-1 cells, rat
peritoneal mast cells and human tissue mast cells have been found to undergo
directed migration towards a range ofmolecules including both classical
chemoattractants such as complement fractions, and a number of chemokines. Mast
cell migration is usually quantified using a Boyden chamber technique, where
migration through polycarbonate filters is measured. As migration ofmast cells is
dependent on adhesion to extracellular matrix proteins, filters are coated with
laminin (Taub et al, 1995; Hartmann et al, 1997), fibronectin (Nilsson et al, 1994c)
or vitronectin (Taub et al, 1995).
As reported for other cells (Haribabu et al, 1999), interaction ofmast cell
chemoattractants with their receptors activates G-protein signalling pathways, as
shown by use of specific inhibitors such as pertussis toxin, leading to cytoskeletal
rearrangements which result in cell migration.
Mast cell influx into tissues has been correlated with tissue expression of
chemoattractants, supporting an in vivo role in mast cell recruitment. A number of
mast cell chemoattractants are detailed below.
1.11.1 Chemokines and chemokine receptor expression by mast cells
The importance of chemokines in recruitment of inflammatory cells is now well
established, and a growing body of evidence suggests that mast cells, similarly,
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respond to chemokines. Expression of a number of chemokine receptors, and
chemotaxis towards their chemokine ligands has been found in mast cells (table 1.4).
Additionally, correlation of chemokine expression with increased mast cell numbers
in disease states points towards a prominent role for chemokines in mast cell
recruitment in vivo.
The first evidence ofmast cell chemoattractant activities of chemokines came from
experiments by Taub et al using IL-3-dependent mBMMC (Taub et al, 1995). These
cells migrated towards concentration gradients of MCP-1 and RANTES and,
following IgE activation, they also migrated towards PF4 and MlP-la. The
importance of several of these molecules in mast cell recruitment in vivo has also
been demonstrated. Intramuscular injection of human recombinant RANTES in mice
resulted in an influx ofmast cells within 4 h (Conti et al, 1998), and expression of
RANTES in a rat model of colitis was correlated with increased mast cell numbers
(Ajuebor et al, 2001). Similarly, injection ofMCP-1 into rat skin resulted in
recruitment of basophilic granular cells (Conti et al, 1997) and expression ofMCP-1
in human wound healing (Trautmann et al, 2000) and in chronic obstructive
pulmonary disease (COPD) (de Boer et al, 2000) correlated with increased numbers
ofmast cells.
More recently, expression of corresponding chemokine receptors to the above
chemokines and to other CC chemokine ligands was demonstrated in mBMMC
which were cultured with IL-3 and SCF. In this experiment, expression of
chemokine receptors CCR1 - 5 were shown by RT-PCR, and all except CCR4 were
Chemokine
Chemotactic
for-
Receptor
Approx.
conc.
Ref.
IL-8
HMC-1
CXCR1,
CXCR2
50
ng/ml
Nilssoneta/,
1999
hCBMC
tt
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et
al,
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It
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et
al,
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et
al,
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functional. Furthermore, expression ofCCR1, CCR2, CCR3 and CCR5 was
upregulated by IgE or SCF (Oliveira & Lukacs, 2001).
Studies ofCC-chemokine receptor expression in human mast cells have focussed on
the eotaxin receptor, CCR3, as its ligand eotaxin is associated with allergic disease
(Homey & Zlotnik, 1999), and CCR3 expression is shared by other cells central to
allergic inflammation, such as eosinophils, basophils and TH2 lymphocytes.
Tryptase-chymase double-positive mast cells of skin and intestinal submucosa
expressed CCR3, and mast cells isolated from human lung underwent chemotaxis
towards eotaxin (Romagnani et al, 1999; De Paulis et al, 2001). Ochi et al (Ochi et
al, 1999) cultured human cord blood-derived mast cells with SCF, IL-6 and IL-10 to
study chemokine receptor expression during mast cell differentiation. They reported
that CCR3 was the only chemokine receptor expressed by cells from 9 week-old
cultures, which resembled mature hMC, but in 4 week-old cells resembling mast cell
progenitors, expression of CXCR2, CXCR4, CCR3 and CCR5 was detected by RT-
PCR and flow cytometry.
In contrast to the above, Juremalm et al (Juremalm et al, 2000) reported expression
ofCXCR4 and migration towards its ligand SDF-la in both HMC-1 cells, which
were used to represent immature mast cells, and CBMC cultured for 6 weeks in SCF
and IL-6, and said to represent a more mature mast cell. This discrepancy was
explained by the authors as possibly being due to different culture protocols; IL-10
was not included in this study. Another study (Lin et al, 2000) also reported
expression ofCXCR4 in CBMC cultured with SCF and IL-6 (for 8 weeks), and
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showed transmigration of these cells through human umbilical vein endothelial
monolayers in response to SDF-la, thus demonstrating a possible functional role for
SDF-la in seeding ofmast cells into tissues.
Expression of the CXC receptors CXCR1 and CXCR2, which in humans are the
receptors for IL-8, has been reported in cultured human mast cells. One study
(Nilsson et al, 1999) reported HMC-1 cells to express CXCR2 only and migrate
towards IL-8, whereas an earlier study (Lippert et al, 1998) reported expression of
both functional CXCR1 and CXCR2 by HMC-1 cells. A recent study showed
expression of CXCR1 and CXCR2 in hCBMC cultured with SCF and IL-6, using
RT-PCR and flow cytometry; these cells also underwent chemotaxis towards IL-8
(Inamura et al, 2002).
The CX3C chemokine fractalkine is also chemotactic for "mucosal" and "connective
tissue" mast cells cultured from murine bone marrow cells in IL-3, and IL-4 and
SCF, respectively (Papadopoulos et al, 2000). Both cell types expressed mRNA for
the fractalkine receptor CX3CR1, as did mast cells isolated from human skin.
1.11.2 Cytokines as mast cell chemoattractants
A number of the cytokines which play a role in mast cell growth and differentiation
are also chemotactic for mast cells (table 1.5). SCF is chemotactic for HMC-1 cells,
human SCF-dependent CBMC (Nilsson et al, 1994b), murine mast cells cultured in
spleen cell-conditioned medium and murine peritoneal mast cells (Meininger et al,
1992). Also, expression of SCF has been correlated with mast cell accumulation in
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human arthritic synovial fluid (Ceponis et al, 1998) and in nasal lavage fluid in
pollen allergic rhinitis (Nilsson et al, 1998).
The chemotactic activity of TGF-Pi for mast cells further supports a key role in
regulation ofmast cell migration into epithelium. Studies using murine peritoneal
mast cells and the CMC3 mast cell line showed TGF-pi to be an extremely potent
mast cell chemoattractant, active at femtomolar concentrations (Gruber et al, 1994).
IL-3 is the key T-cell-derived mast cell growth factor and also exhibits chemotactic
activity towards murine peritoneal mast cells (Matsuura & Zetter, 1989).
1.11.3 Classical chemoattractants and mast cell chemotaxis
Classic neutrophil chemoattractants including complement fractions C3a and C5a,
and platelet activating factor (PAF) are also chemotactic for mast cells (table 1.5).
Investigations using HMC-1 cells showed both C3a and C5a to be active at
picomolar concentrations via distinct G protein-coupled receptors (Nilsson et al,
1996). Additionally, human CBMC cultured in SCF and IL-6 and freshly isolated
human skin mast cells were chemoattracted by complement fractions (Hartmann et
al, 1997).
More recently, PAF has also been shown to be a chemoattractant for HMC-1 cells,
active at nanomolar concentrations (Nilsson et al, 2000).
1.11.4 Other mast cell chemoattractants
Antibacterial peptides induce mast cell chemotaxis; both LL-37 and P-defensin-2
stimulated degranulation and chemotaxis of rat peritoneal mast cells
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Molecule Chemotactic for- Approx. conc. Ref.
Complement HMC-1 mast cell line Picomolar Nilsson eta/, 1996
C3a, C5a hCBMC
Skin MC
Hartmann et al, 1997
Clq C57
HMC-1
Biphasic
0.1 nM, 50 nM
Ghebrehiwet et al, 1995
PAF HMC-1
hCBMC
mBMMC
nM Nilsson et al, 2000
SCF HMC-1
hCBMC
50 ng/ml Nilsson et al, 1994b
hBMMC
Murine peritoneal MC
1 ng/ml Meininger et al, 1992
TGF-P! Murine peritoneal MC fM Gruber et al, 1994
CMC3 mast cell line
IL-3 Murine peritoneal MC 100 U/ml Matsuura & Zetter, 1989
Angiogenic
factors
C57 pM Gruber et al, 1995
sAA HMC-1 pM Olssoneta/, 1999
hCBMC
Adenine
nucleotides
Rat peritoneal MC pM McLoskey et al, 1999
Laminin mPT-18
mBMMC
250 pg/ml Thompson et al, 1989b
Specific Ag RBL 100 ng Orida et al, 1983
LL-37 Rat peritoneal MC 5 pg/ml Niyonsaba et al, 2002b
P-defensin-2 Rat peritoneal MC 3 pg/ml Niyonsaba et al, 2002a
Table 1.5. Summary of mast cell chemoattractants.
mBMMC - murine bone marrow-derived mast cells, hCBMC - human cord blood-
derived mast cells, RBL - rat basophilic leukaemia cell line. See table 1.3 for the
sources ofmast cells.
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(Niyonsaba et al, 2002a; Niyonsaba et al, 2002b). These peptides are widely
expressed in epithelial tissues, where mast cells may be present, and are upregulated
in inflammatory diseases and so may contribute towards mast cell accumulation.
Mast cells also undergo chemotaxis towards laminin, a major component of
basement membranes. Murine PT18 mast cells are attracted towards laminin and the
synthetic peptide PA22-2, which corresponds to the active site on the A-chain of
laminin (Thompson et al, 1989b). Other mast cell chemoattractants include
angiogenic factors (Gruber et al, 1995), adenine nucleotides (McLoskey et al, 1999),
serum amyloid A (Olsson et al, 1999) and specific antigen (Orida et al, 1983). The
list continues to grow as more potential mast cell chemoattractants are investigated.
1.12 AIMS OF THIS STUDY
Whilst considerable advances have been made in the field ofmast cell trafficking,
important questions remain unanswered. Previous work on mast cell trafficking into
the intestinal mucosa has focussed on seeding ofmast cell precursors across vascular
endothelium into tissues (Artis et al, 2000; Issekutz et al, 2001; Gurish et al, 2001).
Mechanisms whereby mast cells or their precursors migrate through the intestinal
lamina propria, but particularly into intestinal epithelium, are poorly understood.
Upregulation of expression ofmast cell chemoattractants from intestinal epithelium
may regulate the mast cell response to gastrointestinal nematode infection. Epithelial
expression of neutrophil chemoattractants has been shown in response to T. spiralis
(Stadnyk & Kearsey, 1996; Li et al, 1998) but epithelial expression ofmast cell
chemoattractants following gastrointestinal nematode infection has not been
investigated.
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Expression of chemokine receptors which may play a role in murine mast cell
migration has also been investigated in cultured mBMMC but, as described in 1.6.1,
these cells are likely to resemble immature mast cells, therefore their relevance to
intraepithelial migration ofMMC is questionable. Similarly, previous studies of
integrin expression in mast cells may have revealed molecules likely to regulate
migration through connective tissues of the lamina propria. However, study of the
integrins controlling intraepithelial migration or retention ofmature mucosal mast
cells intraepithelially is likely to be made more relevant by use of a cultured MMC
homologue (Miller et al, 1999).
The aims of this study therefore, were to characterise mechanisms controlling
intraepithelial migration ofmurine MMC, utilising mBMMC cultured as described
(Miller et al, 1999) (1.6.5) to represent MMC where appropriate. In order to do this,
three hypotheses have been formed and tested.
The first hypothesis was that gastrointestinal nematode infection would result in
upregulation in expression ofmast cell chemoattractants by intestinal epithelium.
Secondly, it was hypothesised that mucosal type mast cells would express the
relevant receptors to respond to such mast cell chemoattractants. The final
hypothesis was that, in regulation of the mucosal phenotype, TGF-Pi might also
regulate the expression of integrins which might support intraepithelial migration of
mucosal mast cells
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CHAPTER 2
MATERIALS AND METHODS
2.1 ANIMALS
12-week-old male BALB/c mice were obtained from Bantam and Kingman
Universal, Hull, U.K. and maintained at the Centre for Tropical Veterinary Medicine
animal house, University ofEdinburgh, on ad libitum water and standard pelleted
food.
2.2 PARASITOLOGICAL TECHNIQUES
2.2.1 Infection ofmice with Nippostrongyius brasiliensis
The mouse-adapted strain ofNippostrongyius brasiliensis was maintained as
described previously (Nawa & Miller, 1978). Briefly, 7 days after infection faeces
were collected into deionised water, washed and mixed to form a thick paste. A pre-
autoclaved 50:50 mix of washed granular charcoal (10-18 mesh, BDH, Poole,
Dorset, U.K.) and peat moss was added to the faeces and the mixture incubated at
26°C in paper-lined petri dishes placed in a humidified plastic box. After 7-28 days
of incubation, the L3 larvae were allowed to migrate for 5 min into warm saline in the
petri dish. They were then removed into a larger volume ofwarm saline and
collected using the Baermann technique, with live larvae migrating through 2 layers
of laboratory tissue held in a filter funnel into the clamped end of a drainage tube.
Suspensions of larvae were then counted under a dissecting microscope, and the
volume adjusted so that 5OOL3 larvae in a volume of 0.2 ml could be injected
subcutaneously into the flank of mice under halothane anaesthesia.
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2.2.2 Faecal egg counts
When required to confirm infection, faeces were collected overnight on day 6 of
infection. 1 g of faeces was mixed with 15 ml of saturated salt solution and the eggs
separated using a tea strainer and counted in a Me Master chamber.
2.3 COLLECTION AND PREPARATION OF SAMPLES FROM
NIPPOSTRONGYLUS BRASILIENSIS INFECTED MICE
2.3.1 Serum samples
Serum was obtained by collecting blood from the brachial artery immediately after
death but prior to perfusion (2.3.2). Blood was allowed to clot for 1 h at 37°C, then
stored overnight at 4°C to aid clot retraction. Serum was then aspirated into fresh
tubes, centrifuged at 13000g for 5 min, and the supernatant stored at -70°C before
use.
2.3.2 Collection ofmurine jejunal epithelium
Epithelium was stripped from a section of proximal jejunum using a modification of
the method previously described by Bjerknes et al (Bjerknes & Cheng, 1981). A
solution of 24 mM ethylenediaminetetraacetic acid (EDTA) in calcium-magnesium-
free Hank's balanced salt solution (CMF HBSS) (Gibco-BRL Life Technologies,
Paisley, U.K.), pH 7.4 was prepared immediately before experiments.
Anaesthetised mice were killed by careful cervical dislocation; previous experiments
showed this step to be critical in order to prevent damage to the aorta or other great
vessels, which would inhibit perfusion. The abdomen was then opened, and a 10 -
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15 cm length of proximal jejunum flushed free of intestinal contents using warm
CMF HBSS. The thorax was opened and, after sectioning the caudal vena cava at
the diaphragm, mice were perfused at a rate of approximately 10 ml/min via the left
ventricle with 90 ml of 24 mM EDTA in CMF HBSS at 37°C using a syringe driver
(Harvard Apparatus Ltd., Edenbridge, U.K.). Following perfusion, a length of
jejunum was removed and divided into 2 segments, which were tied at one end onto
a thin metal rod and everted. The epithelium was then released from the underlying
tissue by rapid manual rotation of the gut segment in ice cold CMF HBSS, and the
epithelial fragments were allowed to settle on ice. The whole procedure for each
animal was completed within 20 min.
2.3.3 Preparation of epithelial samples
Exfoliated epithelium in a minimum volume ofCMF HBSS was removed into TRI
reagent (Sigma, Poole, Dorset, U.K.) for use in RT-PCR, and vortexed for 1 min
before storage at -70°C. Epithelium for use in ELISA or Western blotting was snap-
frozen in dry ice and stored at -70°C. Samples of the exfoliated epithelium were
placed in 4% paraformaldehyde in PBS for examination by light microscopy, in
order to check the purity of the cell population collected (fig. 3.1). After 24 hours in
paraformaldehyde, samples were placed in 70% alcohol before initial embedding in
agar, followed by routine processing into paraffin wax. 4 pm thick sections were
stained using routine haematoxylin and eosin protocols. The proportion of
contaminating non-epithelial cells was assessed in haematoxylin and eosin-stained
sections when 500 epithelial cells were counted.
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2.3.4 Collection and preparation ofmurine whole jejunal samples
Whole proximal jejunum was collected from mice following perfusion, or from
unperfused mice killed by cervical dislocation. For use in RT-PCR, jejunum was
placed in RNA-/ater™ (Ambion, Austin, Texas, U.S.A.) for at least 24 h at room
temperature then stored at -70°C before homogenisation, on ice, into TRI reagent.
For use in Western blotting, jejunum was stored at -70°C in high-salt buffer (PBS /
0.5 M NaCl / 0.05% Tweenso) with protease inhibitors (Complete™ mini EDTA-free
protease inhibitor cocktail tablets, Roche, Lewes, U.K.).
2.4 CELL CULTURE
2.4.1 Murine bone marrow-derived mast cell (mBMMC) culture
Dulbecco's Modified Eagle's Medium (DMEM) was obtained from Gibco-BRL.
Foetal calf serum (FCS) was batch tested and purchased from Sigma. Basic culture
medium (BCM) was prepared from DMEM with the addition of 10% FCS, 2 mmol/1
L-glutamine, 1 mmol/1 sodium pyruvate, 100 U/ml penicillin, 100 pg/ml
streptomycin and 2.5 pg/ml of Fungizone. Complete culture medium consisted of
BCM with the addition of 5 ng/ml IL-9 (R&D systems Ltd, Abingdon, U.K.), 1
ng/ml IL-3 (R&D Systems Ltd), 50 ng/ml SCF (Peprotech, London, U.K.) ±1 ng/ml
recombinant human TGF-Pi (Sigma). mBMMC cultured with and without TGF-Pi
were termed mBMMCT+ and mBMMC1", respectively.
Mice were killed by cervical dislocation, their femurs isolated and femoral bone
marrow flushed into warm BCM. In general, 5 mice were required for a sufficient
yield of cells to stabilise a culture. Conditions were kept as clean as possible by
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regular spraying ofmice and equipment with 70% alcohol. In a sterile category 2
laminar flow hood, single cell suspensions were made by passing bone marrow three
times through a 19 gauge needle followed by filtration through sterile lens tissue.
The total volume of the cell suspension was made up to 50 ml with warm BCM and 2
x 10 pi aliquots taken for counting (2.4.5). Cells were pelleted by centrifugation for
7 min at 230g, resuspended at 5 x 105 live cells/ml in complete culture medium and
placed in a sterile tissue culture flask in a humid 5% CO2 incubator. They were fed
every 2 days, following counting, by centrifugation and resuspension at a density of
5 x 105 cells/ml in half-volume of original culture medium and half-volume of fresh
complete culture medium. Cytospin preparations (2.4.6) were taken and stained with
Leishman's (2.4.7) and toluidine blue (2.4.8) for enumeration ofmast cells; cells used
for experiments were typically 14-30 days old and consisted of >98% mast cells
(figures 2.1 and 2.2).
Cytospin preparations were also fixed in paraformaldehyde (2.4.9) and expression of
the MMC-specific chymase, mMCP-1, analysed by immunohistochemistry (2.10.3).
A small proportion ofmBMMC7" used for the studies described in chapter 4
expressed mMCP-1 (see 2.4.2). However, in experiments described in chapters 5
and 6, typically <2% mBMMC1" and >98% ofmBMMCT+ were positive for
expression ofmMCP-1, confirming differentiation ofmBMMCT+ but not mBMMC7"
into MMC homologues.
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Figure 2.1. Leishman-stained cultured mast cells.
(a) mBMMC1"
(b) mBMMCT+
(c) The murine mast cell line, MC/9.
Magnification = x 40.
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Figure 2.2. Expression of raMCP-1 by mBMMC.
Cytospin preparations of (a) mBMMCT" and (b) mBMMCT+.
Main picture - mBMMC stained by immunohistochemistry for mMCP-1, showing
expression only in mBMMCT+ cultured with TGF-(3i.
Inset - toluidine blue-stained mBMMC; both mBMMC1" and mBMMCT+ stained
with toluidine blue, which is specific for mast cells.
(magnification = x 40).
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2.4.2 Determination of anti-TGF-/3i antibody concentration for mBMMCT~
cultures
Previous work (Miller et al, 1999) showed that a proportion ofmBMMC grown in
culture without TGF-Pi (mBMMC1") may be mMCP-l+. This was suspected to be
due to low levels of TGF-|3i in the culture system from an unknown source, which
could be neutralised by addition of anti - FGF-f31 antibody. Therefore, the minimum
anti-TGF-Pi antibody concentration that would neutralise endogenous TGF-Pi in
mBMMC1" was determined by titration.
T TmBMMC " cultures were set up (2.4.1), and on day 7 of culture, mBMMC " were
5 T
resuspended at 5 x 10" cells/ml in mBMMC " culture medium containing 0, 0.1, 1,
2.5, 5, 10, 100 or 1000 ng/ml of chicken anti-human anti-TGF-Pi polyclonal
antibody (R&D Systems). Cells were seeded in triplicate 0.5 ml volumes in 48 well
tissue culture plates (Corning Costar, High Wycombe, U.K.) and cultured for 48 h
after which 100 pi of cell suspension was removed, and cytospin preparations made
(2.4.6) and fixed in 4% paraformaldehyde (2.4.9) for analysis ofmMCP-1 expression
by immunohistochemistry (2.10.3). Statistical analysis was not performed due to
insufficient numbers in each group.
After 48 h of culture, expression ofmMCP-1 was low (5.8% (5.0 - 7.7%))(median
(range)) in control wells containing no anti-TGF-Pi, but numbers ofmMCP-1+ cells
were reduced in cultures containing > 10 ng/ml of anti-TGF-Pi (2.7 (2.6 - 2.7)) at
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Figure 2.3. The effect of anti-TGF-P! antibody on spontaneous expression of
mMCP-1 by mBMMCT.
Expression ofmMCP-1 after (a) - 48 h (500 cells counted) and (b) - 96 h (1000 cells
counted) of culture of day 7 mBMMC " with chicken anti-human TGF-Pi polyclonal
antibody.
After 48 h of culture, numbers ofmMCP-1+ cells were reduced in cultures containing
>10 ng/ml of antibody, and after 96 h there were no mMCP-1+ cells in cultures
containing > 10 ng/ml antibody.
Results are expressed as median (range), n=3 for all groups except 10 ng/ml anti-
TGF-P i, 48 h culture, where n=2
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10 ng/ml TGF-Pi (figure 2.3a). Because of this small difference in expression,
cultures were continued for a further 48 h and the process repeated. After 96 h of
culture, there were no mMCP-l + cells in wells containing >10 ng/ml of anti-TGF-Pi
(figure 2.3b). On the basis of the above results, 10 ng/ml of anti-TGF-Pi antibody
• T
was included from day 10 onwards in the mBMMC " culture used for experiment
4.2.
2.4.3 MC/9 cell culture
MC/9 cells were obtained from the American Type Culture Collection (LGC-ATCC
Teddington, U.K.) and cultured as instructed. DMEM was obtained from ATCC and
supplemented with 6 pg/ml folic acid (Sigma), 0.05 mM 2-mercaptoethanol (Sigma)
and 2. mM glutamine (Gibco-BRT,). 100 TJ/ml penicillin and 100 pg/ml streptomycin
(Gibco-BRL) were also included. MC/9 culture medium consisted of the above, with
the addition of 10% Rat T-stim® (BD Pharmingen, Oxford, U.K.) and 10% FCS
(Sigma). Cells were fed every 2 days, following counting, by centrifugation and
resuspension at 2 - 5 x 105 cells/ml in half-original medium and half-fresh medium.
2.4.4 Culture of CMT-93 murine intestinal epithelial cells
The epithelial cell line CMT-93, derived from a mouse rectal carcinoma, was a gift
from Dr. P.J. Kilshaw, Babraham Institute, Cambridge, U.K. Cells were seeded at 1
- 3 x 104/ml in Dulbecco's Minimum Essential Medium (Gibco-BRL) with 2 mM
L-glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin (Sigma) and 10% foetal
calf serum (Serotec, Kidlington U.K.) and grown to confluence before harvesting
into TRI reagent (2.4.10).
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2.4.5 Cell counting
Cells were counted in an improved Neubauer haemocytometer. For total WBC
counts, a 10 pi aliquot of cell suspension was diluted 50:50 in white blood cell
counting fluid (0.01% gentian violet in 3% acetic acid in deionised water). For
live/dead cell counts, an aliquot of cell suspension was diluted 50:50 in 0.2%
nigrosin, and viability assessed based on nigrosin exclusion.
2.4.6 Cytospin preparations
100 pi of cells suspended at 5 x 105 cells/ml were centrifuged for 5 min at 40g onto a
glass slide in a Shandon Cytospin 2 cytocentrifuge (Southern Instruments, Runcorn,
U.K.). Preparations were air-dried prior to fixation and staining.
2.4.1 Leishman staining of cytospin preparations
Air-dried cytospin preparations were stained with 100% Leishman's solution (Fisher
Scientific, Loughborough, U.K.) for 2 min followed by 50% Leishman's solution for
6 min (by adding an approximately equal volume of deionised water to the slide).
Slides were then rinsed in tap water, air dried and mounted in DPX (BDH).
2.4.8 Toluidine blue staining of cytospin preparations
Air-dried cytospin preparations were first fixed for 5 min in Carnoy's fixative, then
rinsed in deionised water and stained overnight in 0.5% Toluidine Blue (Fisons,
Loughborough, U.K.) in 0.5 M HC1. Slides were then rinsed in deionised water and
counterstained briefly (1-2 sec) in 0.1% eosin in 70% ethanol.
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2.4.9 Paraformaldehyde fixation of cytospin preparations
Air-dried cytospin preparations were fixed for 10 min using 4% paraformaldehyde.
They were then rinsed with deionised water and stored in 70% ethanol at 4°C before
detection ofmMCP-1 expression by immunohistochemistry (2.10.3).
2.4.10 Collection of cultured mBMMC and CMT-93 intestinal epithelial cells
for RNA extraction
Cultured mast cells were collected into TRI reagent and RNA extracted for use in
RT-PCR. 0.5 x 106 - 1 x 107 cells were centrifuged for 7 min at 230g and the
resultant pellet vortexed for 1 min into TRI reagent and stored at -70°C before use.
Cultured CMT-93 epithelial cells were also collected into TRI reagent. Culture
medium was decanted from cells adherent to the flask and a cell scraper used to
collect cells into 2 ml of TRI reagent per 75 cm flask. RNA in TRI reagent was then
aspirated, vortexed and stored at -70°C.
2.5 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION (RT-
PCR)
2.5.1 Preparation of RNA
Total RNA was recovered from samples in TRI reagent by chloroform extraction and
precipitation according to the manufacturer's instructions. RNA quality and quantity
was then determined by measurement of absorbance at 260/280 nm in a Beckman
DU 650 spectrophotometer. Where necessary, RNA was further checked for
degradation by denaturing gel electrophoresis (2.5.2).
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Some RNA samples were found to be contaminated with genomic DNA, therefore
samples were DNase-treated using a DNA-/ree™ kit (Ambion, Austin, Texas,
U.S.A.). 50 pi RNA samples were incubated for 40 min at 37°C with 2 pi (4 U) of
DNase I and 5 pi of 10 x DNase buffer. Samples were then incubated for 2 min at
room temperature with 5 pi ofDNase inactivation reagent, flicking once during
incubation to disperse the reagent. The inactivation reagent was pelleted to remove it
from suspension, by centrifugation at 1 OOOOg for 1 min. RNA samples were then re-
quantified by spectrophotometry as before.
2.5.2 Denaturing gel electrophoresis
Under RNase free conditions, a 1 x MOPS, 1% agarose gel mixture was made and 2
ml of 37% formaldehyde added before pouring. 6 pi RNA samples were incubated
at 65°C for 10 min with 12.5 pi of deionised formamide (Sigma), 2.5 pi of 10 x
MOPS and 4 pi of 37% formaldehyde. 2.5 pi ofNorthern running dye (50%
glycerol / 0.1 mg/ml bromophenol blue in RNase-free water) and 0.5pl of ethidium
bromide (0.5 mg/ml) was then added to each sample, and 20 pi loaded onto the gel.
Samples were electrophoresed in a 1 x MOPS running buffer for 1 h at 70 V. An
image was visualised and recorded under UV light using a charge-coupled device
(CCD) camera linked to an image processor (Appligene, Watford, U.K.).
2.5.3 Preparation of cDNA
1 pg of each RNA sample was reverse-transcribed in a 20 pi volume using a
Promega Reverse Transcription (RT) kit (Promega, Southampton, U.K.). Reactions
contained 1 x RT buffer (10 mM Tris-HCl / 50 mM KC1 / 0.1% Triton X-100, pH
8.8), 1 mol/1 of each dNTP, 20 U ofRNase inhibitor, 0.5 pg of oligo dT primer, 5
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mol/1 ofMgCh and 15 U of avian myoblastoma virus (AMV) reverse transcriptase.
Incubation was for 1 h at 42°C followed by 5 min at 99°C to inactivate the enzyme.
2.5.4 Primers and probes
If available, published primer sequences were used, otherwise primers were designed
using RNA and genomic DNA sequences from Genbank (www.ncbi.nlm.nih.gov).
The internet primer design software programmes "Genefischer" (www.genefisher.de)
and "Netprimer" (www.premierbiosoft.com) were employed to aid design of suitable
primers; all primers were intron spanning where possible. Oligonucleotide probes for
use in Southern blotting were also designed as above by examination of PCR product
sequences derived from Genbank. Oligos for primers and probes were obtained from
Cruachem (Paisley, U.K.) or VHBio (Sunderland, U.K.); sequences of primers and
probes are shown in tables 2.1 - 2.4.
2.5.5 Polymerase chain reaction (PCR)
PCRs were initially set up according to a standard method (below) and optimised as
necessary (2.5.7). Reactions were set up in 0.2 ml thin-walled PCR tubes (Perkin
Elmer MicroAmp) to a final volume of 50 pi containing 1 pi (l/20th vol. ofRT
reaction) of cDNA, 50 pmol/1 of each dNTP (Promega, Southampton, U.K.), 200
nmol/1 of each primer, 1 x Roche PCR buffer (50 mM KC1 / 10 mM Tris-Cl / 1.5
mM MgC^) and 2.5 U of taq polymerase (Roche, Lewes, U.K.). Cycle parameters
were - Initial denaturation, 30 s at 94°C followed by 35 cycles of 30 s at 94°C, 30 s
at 55°C and 1 min at 72°C, and a final extension period of 7 min at 72°C. For each
sample, a negative control was set up containing RNA only (no cDNA) to rule out
contamination with genomic DNA, and each PCR experiment included a negative
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Gene Oligo sequence Product Tann.
Size (BP) (°C)
Mg2+ pH~
(mM)
GAPDH
MCP-1
SCF
TGF-P,
RANTES1
MIP-la'
Fractalkine
TECK
mMCP-1J
S-5' GAAGGGCTCATGACCACAGTCCATG 454 55 1.5 8.3
A-5' TGTTGCTGTAGCCGTATTCATTGTC
S-5'GGAAAAATGGATCCACACCTTGC 582 60 1.5 8.6
A-5' TCTCTTCCTCCACCACCATGCAG
P-5' CCAGTGTGACAGTGAACTAGTGTG
S-5' AACTTGGATTATCACTTGCAT 562 + 55 1.5 8.3
A-5' CAATGCCATGGCTGTCCATTG 646 f
P-5' TGACCTCGTGTTATGC
S-5' CGGGGCGACCTGGGCACCATCCATCAG 406 55 1.5 8.3
A-5' CTGCTGCACCTTGGGCTTGCGACCCAC
P-5' CTGGAAAGGGCCCAGCACCT
S-5' TCATCCTCACTGCAGCCGCCC 254 55 1.5 8.3
A-5' CTCTATCCTAGCTCATCTCCAAA
P-5' CCTCTCCCTCGCGCTGCCTCGTG
S-5' GAAGAGTCCCTCGATGTGGCTA 462 55 1.5 8.3
A-5' CCCTTTTCTGTTCTGCTGACAAG
P-5' CCCCGACTGCCTGCTGCTTCTCC
S-5' TGGTCCAGAGCTGGCAATAA 816 50 1.5 8.3
A-5' TGGCTTCCTCACTCTCAGGA
P-5' GTGTAGGGACTTGTGCATGTGTG
S-5' TTTGAAGACTGCTGCCTGG 742 55 1.5 8.3
A-5' GTCTTCTTCCTAACAAGCC
P-5' GAGCGCCTCAGACTCTCAGACTG
S-5' GGAAAACTGGAGAGAAAGAACCTAC 460 63 1.5 8.3
A-5' GACAGCTGGGGACAGAATGGGG
Table 2.1. Primer and probe sequences, and reaction conditions used for
experiments 3.2 and 3.3.
1 pi of cDNA was amplified for 35 cycles, except for measurement ofMCP-1
expression by semi-quantitative PCR, when 1 pi of cDNA was amplified for 22
cycles using primers specific for GAPDH, and 10 pi of cDNA was amplified for 34
cycles using primers specific for MCP-1.
S - sense primer, A - antisense primer, P - probe. Tann. - annealing temperature. + -
secreted form, f - transmembrane form of SCF. All primers were published
sequences (references shown in footnotes) except those for GAPDH, which were
from Stratagene (Amsterdam, The Netherlands).
' Rollo et al, 1999
2 Mitsunari et al, 1999
3 Miller et al, 1999
4 Kanazawa et al, 1999
5 Wurbel et al, 2000
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Gene Oligo Sequence Product Tann. Mg+ pH Cycle
Size (°C) (mM) No.
(BP)
GAPDH S-5' GAAGGGCTCATGACCACAGTCCATG
A-5' TGTTGCTGTAGCCGTATTCATTGTC
454 55 1.5 8.3 35
22*
mMCP-11 S-5' GGAAAACTGGAGAGAAAGAACCTAC
A-5' GACAGCTGGGGACAGAATGGGG
460 63 1.5 8.3 35
CXCR22 S-5' ACCAGTTATGCTGTGGTTGTA
A-5' CAAACGGGATGTATGTTACC
P-5' CTGTTCTTTGCCCTGACCTT
483 50 1.5 8.3 35
CXCR43 S-5' TCTTAGGGACTTGTGCATGTGTG
A-5' CGTCGGCAAAGATGAAGTCAGG
P-5' CGCCTGCACCTGTCAGTGGC
493 55 1.0 9.3 35
Table 2.2. Primer and probe sequences, and reaction conditions used for RT-
PCR in experiments 4.2, 4.3 and 4.4.
1 pi of cDNA was amplified as indicated; GAPDH was amplified for 22 cycles in
semi-quantitative RT-PCR (*).
S - sense primer, A - antisense primer, P - probe. Tann. - annealing temperature. All
primers were published sequences (references shown in footnotes), except those for
GAPDH, which were from Stratagene (Amsterdam, The Netherlands).
' Miller et al, 1999
2 Fischer et al, 2000
3
Papadopoulos et al, 2000
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Gene
Oligo
sequence
Product
Tann.
Mg
pH
Cycle
Ref.
size
(BP)
(°C)
(mM)
no.
a3
S-5'-ATT
GAC
TCA
GAG
CTG
GTG
GAG
GAG
A-5'-TAC
TTG
GGC
ATA
ATC
CGG
TAG
TAG
P-5'
-
GCT
GGG
TTG
CTG
CTG
CTG
GG
a5
S-5'-
TTG
CTG
GAC
TGT
GGT
GAA
GAC
A-5'-
CTG
GTT
GAT
GAG
CTG
GTA
GAC
P-5'
-
CAG
TCT
CTG
GGG
TGG
CCT
TC
cc6
S-5'-
GAG
GAA
TAT
TCC
AAA
CTG
AAC
TAC
A-5'-
GGA
ATG
CTG
TCA
TCG
TAC
CTA
GAG
P-5'
-
CGA
TGC
CAC
CTA
TCA
CAA
GG
av
S-5'-
CCG
CCG
GTG
CCA
GCC
CAT
TGA
G
A-5'-
GCT
ACC
AGG
ACC
ACC
GAG
AAG
T
P-5'
-CTG
TGC
TCC
ATT
GTA
CCA
CT
cc7
S-5'-
CAC
CGG
ATG
TCC
ATC
AGG
AC
A-5'-
GTT
GCT
CAG
AGA
TGC
ATC
C
P-5'
-
CTG
GTA
CTG
CTG
CTG
TGG
AA
(31
S-5'-
GGC
AAC
AAT
GAA
GCT
ATC
GT
A-5'-
CCC
TCA
TAC
TTC
GGA
TTG
AC
P-5'
-
TTG
GGA
TGA
TGT
CGG
GAC
(33
S-5'-
CTG
GTG
TTT
ACC
ACT
GAT
GCC
AAG
A-5'-
TGT
TGA
GGC
AGG
TGG
CAT
TGA
AGG
P-5'
-
CCA
CAG
TGG
GAG
TCC
TGT
CT
LBP
S-5'-
CTG
AAG
TTT
GCT
GCT
GCC
ACA
A-5'-
GCT
GGA
TGG
GCA
CAG
AGG
GAA
P-5'
-
ATG
CCT
GAT
CTT
TAC
TTC
TA
GAPDH
S-5
'-G
AAGGGCTCATGACCAC
AGTCCATG
A-5'-
TGTTGCTGTAGCCGTATTCATTGTC
a3A
305
a3B
161
582a6A
399
a6B
269
337393520454
63555555
cc7A
480
55
a7B
366
605555
2.0
8.3
35
Anderson
et
al,
1999
1.5
8.3
32
2.51.5
8.3
35
8.3
32
1.5
8.3
35
2.5
8.9
38
1.0
8.3
26
1.5
8.3
20
(Dastych
et
al,
2001)
Anderson
et
al,
1999
Illera
et
al,
2000
Ziober
et
al,
1993
(31A
266
55
1.0
8.3
30
Anderson
et
al,
1999
(31D348
Illera
et
al,
2000
Table
2.3.
Primer
and
probe
sequences
and
conditions
used
for
semi-quantitative
RT-PCR
analysis
of
expression
of
integrins
and
LBP
by
mBMMCT"
and
mBMMCT+
in
experiment
6.2.
S
-
sense
primer,
A
-
antisense
primer,
P
-
probe.
Tann.
-
annealing
temperature.
All
primers
were
published
sequences
(references
shown),
except
GAPDH
primers,
which
were
from
Stratagene
(Amsterdam,
The
Netherlands).
gene
Oligo
sequence
Product
size
(BP)
Tann.(°C)
Mg2+(mM)
pH
Cycleno.
Ref.
XI
S-5'
CT
ATCCTTGCGC
AG
A
ATGAC
A-5'
GCCAGGGTGGAGCTCTG
220
55
1.5
8.3
35
Ziober
et
al,
1993
X2
S-5'
CTATCCTTGCGCAGAATGAC
A-5'
GTGACCAACATTGATAGCTC
200
55
1.5
8.3
35
Ziober
et
al,
1993
GAPDH
S-5'
GAAGGGCTCATGACCACAGTCCATG
454
55
1.5
8.3
35
A-5'
TGTTGCTGTAGCCGTATTCATTGTC
Table
2.4.
Primers
and
conditions
used
for
RT-PCR
analysis
of
expression
of
a7Xl
and
a7X2
in
experiment
6.10.
Conditions
shown
for
X2
are
those
used
for
initial
investigations,
but
no
signal
was
obtained
in
positive
control
heart
tissues
after
extensive
optimisation
of
the
protocol.
S
-
sense
primer,
A
-
antisense
primer.
Tann.
-
annealing
temperature.
All
primers
were
published
sequences
(references
shown),
except
GAPDH
primers,
which
were
from
Stratagene
(Amsterdam,
The
Netherlands).
control omitting cDNA. Final reaction conditions used for each primer are shown in
tables 2.1 - 2.4.
PCR products were separated on a 1.4 % agarose gel containing 0.5 pg/ml ethidium
bromide and visualised and recorded under UV light using a Kodak Image Station
440cf imaging system.
2.5.6 Confirmation ofproduct identity by Southern blotting
PCR product identities were confirmed by Southern blotting and detection using an
internal oligonucleotide probe. Each probe was also incubated with the PCR product
from amplification of an unrelated gene (usually GAPDH) to check probe specificity,
and samples were hybridised without probe to confirm the specificity of antibody
binding to digoxigenin (DIG)-labelled probe.
Oligonucleotide probes were DIG-labelled using a Roche 3' end labelling kit,
according to the manufacturer's instructions, and labelled probe diluted into 10 ml of
"Rapidhyb" hybridisation buffer (Roche), resulting in a final concentration of
labelled probe of 10 pmol/ml.
Representative PCR products for each gene were separated on a 1.4 % agarose gel,
denatured for 30 min in 2 changes of denaturing buffer (1.5 M NaCl / 0.5 M NaOH)
and neutralised for 40 min in 2 changes of neutralising buffer (1.5 M NaCl / 0.5 M
Tris-HCl /1 mM EDTA). DNA was then transferred overnight to a nylon membrane
(Hybond N+, Amersham, U.K.) by capillary blotting. Following blotting, the
membrane was washed in 6 x saline-sodium citrate (SSC) and nucleic acid was
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Figure 2.4. Confirmation of PCR product identity by Southern blotting.
a7 integrin is used as an example.
Digoxigenin-labelled a7 oligonucleotide probe hybridised to the 266 BP a7B PCR
product, whereas the probe did not hybridise to the negative control, GAPDH. Also,
no a7 integrin PCR product was detected when oligonucleotide probe was omitted
(a7 no probe).
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fixed by two 12 s exposures to UV light. It was then prehybridised for 30 min at
40°C in hybridisation buffer, and hybridised with probes for 3 h at 40°C before
washing twice for 5 min in 2 x SSC / 0.1% sodium dodecylsulphate (SDS) followed
by two 15 min washes in 0.1 x SSC / 0.1% SDS. Membranes were then rinsed
briefly in maleic acid buffer and blocked by incubating for 60 min at room
temperature or overnight at 4°C in blocking buffer (5 g Roche blocking reagent
dissolved in 500 ml maleic acid buffer). Hybridised probes were labelled by
incubation for 30 min with anti-DIG alkaline phosphatase conjugate (Roche) diluted
1:5000 in blocking buffer, after which unlabelled probe was washed away by two 15
min washes in maleic acid 0.3 % Tween2o-
Alkaline phosphatase - labelled probes were detected using 5-bromo-4-chloro-3-
indoyl phosphate / nitroblue tetrazolium (BCIP/NBT) (Sigma-fast tablets) or
chemiluminescent detection with CDP-star (Roche), and an image acquired using up
to ten 1 min captures on a Kodak Image station 440cf imaging system. An example
of PCR product confirmation by Southern blotting is shown in fig. 2.4.
2.5.7 Optimisation of PCRs
Where necessary, PCRs were optimised as follows so that a product of the
appropriate size was obtained against a background ofminimal non-specific PCR
products. Cycle parameters were as described, but with alterations in annealing
temperature, Mg2+concentration and pH as detailed below.
The initial annealing temperature chosen was 5 - 10°C below the melting
temperature of both primers, and primers were then optimised using a Roche PCR
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optimisation kit for 35 cycles of PCR. PCRs were first optimised with respect to
MgCb concentration, followed by pH and annealing temperature.
Primers were initially tested using buffers of pH 8.3 at Mg CI2 concentrations of 1.0,
1.5, 2.0 and 2.5 mM, then if required they were tested at the optimum MgCft
concentration at pH 8.3, 8.6, 8.9 and 9.2. Finally, as increasing annealing
temperature reduces formation of non-specific PCR products, the annealing
temperature was altered as necessary. If no signal was obtained during initial stages,
annealing temperature was lowered and primers tested using all available buffers.
2.5.8 Semi-quantitative PCR
In order to make PCR semi-quantitative, cycle numbers were optimised so that the
amount of PCR product would be proportional to the amount ofRNA in the initial
sample. Following optimisation of PCRs, reactions were set up to amplify
representative samples for a range of cycle numbers, and PCR products separated on
agarose gel as described (2.5.5). The image was then acquired using multiple
captures, to avoid saturation of the image acquisition system, and band intensities
quantified using Kodak 2D Image software. Net band intensities were then plotted
against cycle number on a logarithmic scale, and a cycle number chosen within the
linear range of the graph which would result in a detectable signal for all samples
(figure 2.5). Expression of the house-keeping gene GAPDH was also optimised as
above for use as a control for the amount of cDNA in each sample, and relative
expression for each sample calculated as the ratio of signal intensity of the gene
investigated to GAPDH.
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Figure 2.5. Optimisation of cycle number for semi-quantitative RT-PCR.
A representative sample was amplified for a range of cycle numbers, and net
intensity of resultant signals measured using Kodak ID software. This was plotted
against cycle number on a logarithmic scale. A cycle number was then chosen for
use in RT-PCR, which would result in a detectable signal whilst remaining in the log
phase of the reaction.
(a) pi integrin - 30 cycles chosen for semi-quantitative RT-PCR (b) a6 integrin - 35
cycles chosen for semi-quantitative RT-PCR.
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When comparing expression of a gene for which levels varied widely between
samples, it was not possible to detect low levels of expression without some degree
of saturation in samples where levels were high. In this case, reactions were
optimised to detect low expression and it was accepted that saturation of the reaction
where the gene was highly expressed would result in underestimation of expression.
Reactions optimised in this way included analysis of expression ofmMCP-1,
CXCR2 and CXCR4 during mBMMC differentiation (4.3) and comparison of
expression of a7 integrin in mBMMC cultured with and without TGF-Pi (6.2).
Reaction conditions used for semi-quantitative RT-PCR are shown in tables 2.1 - 2.3.
2.5.9 Extraction and amplification of genomic DNA
PCR was performed on mouse genomic DNA using the test primers to confirm that
bands of the correct size would only be obtained from amplification of cDNA.
DNA was extracted from mouse tails using a DNeasy kit (Qiagen, Crawley, U.K.).
Briefly, the mouse tail was digested for 4 h at 55°C in 180 pi of tissue lysis buffer
containing 20 pi of Proteinase K. The resulting suspension was vortexed then DNA
extracted using the DNeasy column according to the manufacturer's instructions.
The DNA solution was quantified using spectrophotometry as described previously
for RNA. 100 ng ofDNA was amplified using reaction conditions described for
individual primers.
2.6 MULTIPLEX PCR (mPCR)
Expression ofmRNA for chemokine receptors expressed by mBMMC was detected
using CytoXpress™ multiplex (m) PCR kits (Biosource, Nivelles, Belgium). mPCR
82
can be problematic since the presence ofmany PCR primers in a single reaction can
lead to increased formation ofmis-primed PCR products and "primer dimers", and of
enhanced amplification of shorter DNA fragments. The primer pairs and buffers in
these kits have been optimised to minimise these problems and provide semi¬
quantitative amplification of each gene. Additionally, since the amplification
efficiencies are equivalent, band intensities are proportional to the relative
concentration of target cDNA in the sample, so that expression levels of each
receptor can be compared to others in the same kit.
2.6.1 Basic CytoXpress™ mPCR method
CytoXpress™ CCR setl and CCR set 2 mPCR kits amplified chemokine receptor
genes as detailed in table 2.5. Kits contained optimised primer mixtures, buffers,
dNTP and positive control cDNA.
CCR Set 1 CCR Set 2
GAPDH 532 GAPDH 532
CCR1 363 CCR6 306
CCR2 161 CCR7 204
CCR3 315 CCR8 429
CCR4 282 CCR9 255
CCR5 161 CX3CR1 349
Table 2.5. Primers and expected product sizes (base pairs) in Biosource
CytoXpress™ mPCR kits.
RNA was extracted from samples in TRI reagent, DNase-treated and reverse-
transcribed (2.5.1 and 2.5.3), and 5 pi used in mPCR reactions according to the
manufacturer's instructions. 50 pi mPCRs contained 5 pi of mPCR buffer, 5 pi of
mPCR primers, 4 pi of dNTP (3.12 mM), 5 pi of positive control or test cDNA, 0.5
pi of tag polymerase (5 U/pl) and 30.5 pi of RNase-free water. cDNA was amplified
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using a "hot-start" method starting with a 1 min initial denaturation at 96°C, followed
by 3 cycles of 1 min at 96°C, 4 min at 58°C. This was followed by 28 cycles of 1
min at 94°C, 1 min at 58°C, and an elongation step of 10 min at 70°C. PCR products
were separated on a 2% agarose gel containing 0.5 pg/ml of ethidium bromide, and
visualised and recorded under UV light using a Kodak Image Station 440cf imaging
system. Where indicated, relative expression of genes investigated using
CytoXpress™ kits was calculated as the ratio of intensities of each PCR product to
intensity of the GAPDH for the same sample. Though the multiplex kits were
optimised for semi-quantitative RT-PCR, the manufacturers advised that expression
could be compared to an external GAPDH analysed in the same samples by RT-PCR
if the internal GAPDHs appeared saturated. However, GAPDH signals varied
between samples and did not appear saturated; and variations correlated with
differences in signals within groups, but did not correlate well with signals from
external GAPDH, possibly due to differences in loading or amplification efficiencies.
Therefore, the internal GAPDH was decided to be the most appropriate control.
2.6.2 Optimisation ofmPCR kits
To ensure recommended reaction conditions would be compatible with the PCR
machine used, kits were first tested using the above method with the positive control
provided. This resulted in clear bands of the expected size, with the exception of
CX3CR1, which ran lower than the expected size of 349 BP (figure 2.6a). The
reason for this was not resolved, though the CCR set 1 kit originally provided was
used for experiment 4.2, and a replacement kit was eventually provided by Biosource
(figure. 2.6b), and used for experiment 4.3. The CCR6 PCR product from
amplification of positive control cDNA using the replacement CCR set 2 kit was less
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intense than other bands (figure 2.6b). This suggested less efficient amplification of
CCR6 by this kit but as this receptor was of secondary importance to CX3CR1,
which had previously been shown to be expressed by mast cells, the replacement kit
was deemed adequate for our studies.
CytoXpress ™ kits were also tested using 5 pi of day 14 mBMMCT+ cDNA
synthesised using standard method 2.5.3, alongside positive control samples, to
determine if this amount of cDNA would result in a strong GAPDH signal and
detection of any chemokine receptor signals. PCR ofmast cell samples resulted in
an adequate house-keeping gene signal and amplification of several bands, a result
which was repeatable (figure 2.6a).
Biosource suggested removal of RT enzyme from cDNA before PCR, since it may
inhibit the reaction. We therefore compared results of mPCR amplification, using
both kits, of a non-extracted cDNA sample and the same cDNA sample after
extraction using a "high-pure" spin-column (Roche), according to the manufacturer's
instructions. Two 20 pi cDNA preparations were made from a day 14 mBMMCT+
RNA sample. One 20 pi cDNA preparation was then extracted using the high-pure
kit, and the resultant cDNA resuspended in the minimum volume (50 pi) of Tris
buffer, pH 8.0. PCR was then set up using 0.25 x volume of each cDNA preparation
i.e. 5 pi of the non-extracted and 12.5 pi of extracted preparations, for each of the
two kits. There was little difference between PCR products from extracted and non-
extracted cDNA samples (figure 2.6c), therefore no extraction was performed in
further experiments.
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Figure 2.6. Optimisation of CytoXpress™ mPCR kits.
(a) Testing of CCR set 1 (lanes 1 and 2) and set 2 (lanes 3 and 4) using positive
control cDNA (1 and 3) or dl4 mBMMCT+ cDNA sample (2 and 4). This shows
amplification of chemokine receptor cDNA in positive control resulting in bands
of the expected size, with the exception ofCX3CR1, which is running lower than
the expected 349 BP. Expression of several chemokine receptors is also detected
in mBMMCT+.
(b) Replacement set 2, showing CX3CR1 band running in the correct place (349
BP).
(c) Comparison ofPCR products resulting from amplification of extracted (lanes 2
and 4) and non-extracted (lane 1 and 3) samples using CCR set 1 (lanes 1 and 2)
and replacement set 2 (lanes 3 and 4). Similar expression of chemokine
receptors is detected in both.
(d) Use ofmouse genomic DNA as target for set 1 (lane 1) and replacement set 2
(lane 2) showing several bands amplified strongly, especially CCR2 in set 1, and
CCR7 in set 2.
Lane 5 (a), 2 (b), 5 (c) and 3 (d) = 100 BP ladder. Positive control cDNA was not
included in experiments (c) and (d) due to limited availability.
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Finally, manufacturer's instructions were unclear if the primers were intron-spanning,
or if they amplified genomic DNA and if resulting products would be distinguishable
by size, from those resulting from cDNA amplification. PCR reactions were
therefore set-up, using 1 pi of a mouse-tail genomic DNA sample, prepared in
method 2.5.9, as target. CytoXpress™ kits amplified mouse genomic DNA with
bands of similar sizes to those resulting for amplification of cDNA (figure 2.6d).
2.7 GEARRAY™ ASSAY PROTOCOL
A mouse chemokine Non-rad (non-radioactive) GEArray™ macroarray kit
(Superarray™, Cambridge Bioscience, Cambridge, U.K.) was used to compare
expression of a number of chemokines in jejunal epithelium of uninfected and N.
brasiliensis infected mice. The mouse chemokine GEArray™ is a nylon membrane
spotted in duplicate with gene-specific cDNA fragments for 23 chemokines; their
positions on the array are shown in figure 2.7. House keeping genes GAPDH and P-
actin, and bacterial plasmid DNA are also included as controls. In the non¬
radioactive labelling system, RNA samples are first labelled with biotin before
hybridisation with the array, and hybridised labelled probes are detected with
alkaline phosphatase conjugated streptavidin and addition of a chemiluminescent
substrate.
2.7.1 Probe synthesis
The method followed instructions provided for non-radioactive GEArray™ protocol;
the kit components are shown in table 2.6. The integrity of each RNA sample was
checked by denaturing gel electrophoresis (2.5.2), as RNA degradation was not well
87
Key
(i") ;?) ("3:("4i- "5). 6) (7')V
(a) .9) (10) (il) 12) .13! (14)
(15) (16) (17)48) (19; ■.23) ( 21)
0) 0) 0)0) ;'2& (27') .28)
29) (30) .31) .32) *33) : 34) .35)
536) (37) .38) .39) 40. (41) .42)
•'43 (44) .45) .46) )47> (48) .49)
.50) (51) .52) (53) *54) (55) .56)
Gene GEA location
6 Ckine-ser 1,2
Eotaxin 3,4
Eotaxin-2 5,6
Fractalkine 8,9
GR01 10, 11
1-309 12, 13
IP-10 15, 16
Lymphotactin 17, 18
MCP-1 19, 20
MCP-1 22, 23
MCP-3 24, 25
MCP-5 26, 27
MIG 29,30
MlP-la 31,32
MIP-ip 33,34
MlP-ly 36, 37
MIP-2 38, 39
MIP-3a 40,41
PF4 43,44
RANTES 45,46
SDF-la 47, 48
SDF-2 50, 51
TECK 52, 53
B-actin 21,28
GAPDH 35, 42, 49, 54, 55, 56
PUC18 bacterial plasmid 7, 14
Figure 2.7. Chemokines investigated using the SuperArray™ Mouse
Chemokine GEArray™ kit.
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Nonrad-GEArray labelling kit Nonrad-GEArray detection kit
GEAprimer mix, buffer A GEAblocking solution
5 x non-radioactive GEAlabelling buffer BN AP-streptavidin
10 x stop solution, buffer C 5 x washing buffer F
10 x denaturing solution, buffer D 1 x assay buffer G
2 x neutralising solution, buffer E CDP-star™
GEAhyb hybridisation solution
+ 2 x mouse chemokine GEArray™ membranes
Table 2.6. GEArray components provided in "Nonrad-GEArray" Kit.
Reaction component Vol. (pi)
5 x Non-radioactive-GEAlabelling buffer 16
Biotin-16-dUTP (1 mM, Roche) 8
RNase inhibitor (4 U/pl, Promega) 2
AMV reverse transcriptase (25 U/pl, Roche) 8
RNase free H20 6
Total vol. 40
Table 2.7. GEArray labelling mixture made up for 2 samples.
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tolerated by the GEArray™ system. 3.3 pg ofRNA from each of 3 uninfected and 3
infected samples were then combined to make 9.9 pg ofRNA from uninfected and
infected epithelium, and a labelled RNA probe made from each combined RNA
sample. Each 9.9 pg RNA sample was mixed with 2 pi ofGEAprimer mix (buffer
A) in a final volume of 20 pi. This was heated to 70°C for 2 min and cooled to 42°C
before adding 20 pi of labelling mix (table 2.7) to each sample and incubating at
42°C for 2 h. The labelled probes were then denatured by incubation for 20 min at
68°C with 5 pi of 10 x denaturing solution; denatured probes were neutralised by a
10 min incubation with 50 pi of 2 x neutralising solution.
2.7.2 Hybridisation
15 ml ofGEAhyb hybridisation solution was heated to 68°C, and 100 pg/ml of heat-
denatured sheared salmon sperm DNA added. Two GEArray membranes were then
wetted with deionised water, placed in separate hybridisation bottles and pre-
hybridised, shaking, for 2 h at 68°C in 10 ml of GEAhyb hybridisation solution
prepared as above. Prehybridisation solution was then discarded, and the membranes
incubated overnight at 68°C, shaking, with the denatured probes (100 pi) in 5 ml of
GEAhyb hybridisation solution.
2.7.3 Washes and chemiluminescent detection
The membranes were washed twice for 20 min at 68°C with 50 ml of prewarmed
wash solution 1 (2 x SSC / 1% SDS), and twice for 20 min at 68°C with 50 ml of
prewarmed wash solution 2 (0.1 x SSC / 0.5% SDS). They were then blocked for 40
min at room temperature with GEAblocking solution and incubated for 40 min,
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shaking, with alkaline-phosphatase-conjugated streptavidin diluted 1:5000 in
GEAblocking solution. The membranes were then washed 3 times for 5 min in 10
ml of 1 x washing buffer F and rinsed twice in 1 x alkaline phosphatase detection
buffer G before incubation for 5 min with CDP-star™ (Roche) chemiluminescent
substrate. The image was captured by a 15 min exposure to film, as the Kodak
Image Station 440cf imaging system was not sensitive enough to detect
chemiluminescent signals from the array. To compare expression in two samples,
the membranes were exposed simultaneously.
2.8 MOUSE MAST CELL PROTEASE-1 (mMCP-1) ELISA
2.8.1 Method 1
mMCP-1 in mouse serum was measured using a previously described ELISA
(Scudamore et al, 1997). Standards were diluted from a stock solutions of 20 ng/ml
mMCP-1 in PBS / 4% BSA / 0.05% Tween2o with 2% mouse serum carrier protein.
Dilutions of standards, samples and antibodies were in PBS / 4% BSA / 0.05%
Tween2o. ELISA plates (Immulon, Dynex technologies, Billingham, U.K.) were
coated overnight at 4°C with 50 pi of affinity-purified rat anti-mMCP-1 monoclonal
antibody (RF6.1) diluted to 5 pg/ml in carbonate buffer, pH 9.6. They were then
washed 6 times in 0.9% NaCl / 0.05% Tween2o, and incubated for 1 h at 37°C with
standards and unknown samples (50 pi) before a further 6 washes and incubation for
30 min with 50 pi of sheep anti-mMCP-1 (2 pg/ml (Huntley et al, 1990)). Plates
were then washed again and incubated for 30 min with 50 pi of donkey anti-sheep
IgG-peroxidase (Sigma) conjugate diluted 1:8000, before a further 6 washes and a 20
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min incubation with 50 pi ofTMB substrate. The reaction was stopped with 50 pi of
0.18.M H2SO4, and the optical density of the reaction products read at 450 nm.
2.8.2 Method 2
This method was the result of optimisation of the previous method 1 in an attempt to
reduce background. The ELISA protocol was as in method 2.8.1, with the following
exceptions:
1. The affinity-purified rat anti-mMCP-1 monoclonal antibody RF6.1 was coated at
a dilution of 2 pg/ml.
2. Bound mMCP-1 was detected by incubation with 50 pi of biotinylated sheep anti-
mMCP-1 diluted at 1:1000 in PBS / 4% BSA / 0.05% Tween20 followed by 6
washes with 0.9% NaCl / 0.05% Tween2o and incubation for 30 min with 50 pi of
streptavidin biotinylated horseradish peroxidase complex diluted at 1:4000 in PBS
/ 4% BSA / 0.05% Tween20.
2.9 ELECTROPHORESIS AND WESTERN BLOTTING WITH
IMMUNODETECTION
2.9.1 Sample preparation
Stripped epithelial samples or mBMMC (1 x 107 mBMMC/ml of buffer) were
vortexed vigorously in 2% SDS with protease inhibitors (Complete™ mini EDTA-
free protease inhibitor cocktail tablets, Roche), and passed repeatedly through a 23
gauge needle to rupture the cells. They were then centrifuged for 15 min at 1 OOOOg
and supernatant stored at -70°C. Whole jejunal samples were freeze-thawed once
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and homogenised on ice in high salt buffer (PBS / 0.5 M NaCl / 0.05% Tweengo).
They were then centrifuged for 15 min at lOOOOg and supernatants stored at -70°C.
2.9.2 SDS-PAGE
2.9.2.1 Standard Laemmli gel system
Gels were made up as in table 2.8. The protein content of the extracts was estimated
by spectrophotometry (absorbance at 280 nm) to ensure similar loading. 75 pi of
each extract was diluted 50:50 in sample buffer (table 2.9) and heated to 100°C for 5
min before loading onto a 6 cm long well. 5 pi of broad-range rainbow markers
(Amersham, Little Chalfont, Buckinghamshire, U.K.) were diluted and heated
similarly, and run on each gel. Gels were run at 200 V for 45 min in 0.3% Tris /
1.44% glycine / 0.1% SDS running buffer.
2.9.2.2 Schagger gel system and detection of chemokines
Due to the low molecular weight of the proteins, chemokines from jejunal epithelial
and jejunal protein extracts were separated using the Schagger gel system. The
protein content of extracts was measured using a BCA protein assay kit (Pierce,
Rockford, USA) and 25 pi ofjejunal extract (approximately 2 mg/ml total protein) or
jejunal epithelial extract (approximately 1 mg/ml total protein) were loaded onto the
gel; this was the maximum protein loading possible. Gels were made up as in table
2.10 and samples were diluted 50:50 in tricine sample buffer (table 2.11) and heated
to 100°C for 5 min before loading onto the gel. 5 pi of low-range markers (Bio-Rad,
Hemel Hempstead, U.K.) were similarly heated and run on each gel. Gels were run
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Running gel Stacking gel
Solution 10% 12%
H20 (ml) 4.05 3.35 6.1
1.5 M Tris-HCl, pH 8.8 (ml) 2.5 2.5 2.5
10% SDS (pi) 100 100 100
30% acrylamide / 0.8% bis- 3.3 2.5 1.3
acrylamide (ml)
10% ammonium persulphate (pi) 100 100 100
TEMED (pi) 10 10 10
Table 2.8. Gel solutions, standard Laemmli gel system.
h2o 4.0
0.5 M Tris-HCl, pH 6.8 1.0
Glycerol 0.8
10% SDS 1.6
P-mercaptoethanol 0.4
0.05% (w/v) bromophenol blue 0.2
Final vol. 8.0
Table 2.9. Sample buffer, standard Laemmli gel system (vol. in ml).
62.5 mM Tris-HCl, pH 6.8 / 10% glycerol / 2% SDS / 5% P-mercaptoethanol.
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Gel type - Stacking Spacer Resolving
Distilled H20 (ml) 2.48 3.2 -
3 M Tris 0.3% SDS pH 8.45 (ml) 0.96 3.3 3.3
Glycerol (g) - - 1.25
30% acrylamide / 0.8% bis- 0.53 3.3 5.5
acrylamide (ml)
10% ammonium persulphate (pi) 50 100 100
TEMED (pi) 10 10 10
Total volume (ml) 4 10 10
Table 2.10. Gel solutions, Sehagger gel system.
4 X 0.5 M TrisCl / 0.4% SDS pH 6.8 (ml) 2.4
Glycerol (ml) 2.4
SDS (g) 0.8
Dithiothreitol (g) 0.31
Coomassie blue G-250 (mg) 2
H20 (ml) To 10 ml
Final vol (ml) 10
Table 2.11. Tris-tricine sample buffer.
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at 50 V until the protein had entered the resolving gel, when the voltage was
increased to 100 V for approximately 2 h or until the dye front was within 1 cm of
the bottom of the gel. In a separate experiment (fig 2.8), gels were stained with
Coomassie blue or silver staining to confirm presence of proteins in the chemokine
molecular weight range (6 - 20 kDa) (2.9.3 and 2.9.4).
2.9.3 Staining of gels and membranes
2.9.3.1 Coomassie blue
Gels were fixed and stained for 15 min in 0.5% Coomassie brilliant blue (R250,
Sigma) dissolved in 25% methanol / 10% acetic acid. They were then destained in
50% methanol /10% acetic acid for 1 - 2 h with 2-3 changes of destain.
To check transfer of protein, membranes were stained for 5 min in 0.5% Coomassie
brilliant blue, as above, and destained briefly in 100% methanol followed by 1 h in
50% methanol /10% acetic acid with 2-3 changes of destain (figure 2.8)
2.9.3.2 Silver stain
Gels were fixed for 15 min in 50% methanol / 10% acetic acid. They were then
washed twice for 5 min in 5% methanol / 7% acetic acid and incubated for 15 min in
dithiothreithol (5 pg/ml) in distilled water before washing 3 times for 5 min in
distilled water. Gels were then incubated for 20 min in 0.1% silver nitrate, rinsed for
30 s in distilled water and developed using 100 ml 3% Na2C03 with 50 p.1 of 40%
formaldehyde. Development was stopped by the addition of citric acid crystals.
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Figure 2.8. Separation of jejunal and epithelial extracts on a Schagger gel.
(a) Coomassie blue-stained gel.
(b) Coomassie blue-stained immobilon-P membrane showing transfer of
proteins.
(c) Gel stained using silver stain (2.9.3.2) in order to show, more clearly,
presence of proteins in the chemokine molecular weight range (6 - 20 kDa).
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2.9.4 Western blotting
Proteins were transferred to polyvinylenedifluoride (Immobilon-P, Millipore) using
the semi-dry method of blotting (Kyhse-Andersen, 1984). The transfer buffer was 10
mM 3-[Cyclohexylamino]-propane-sulphonic acid (CAPS, Sigma) in 10% methanol,
and transfer was achieved in 1 h with a current of 80 mA / gel. Membranes were
stained with Coomassie to check transfer, as in 2.9.3.1.
2.9.5 Immunodetection of chemokines
Preliminary studies (not shown) established optimum antibody concentrations and
block buffer for this protocol. Membranes were blocked overnight at 4°C in PBS /
1% Marvel / 0.05% Tween2o (block buffer). They were then incubated for 1 h with
primary antibodies (Santa Cruz Biotechnology goat polyclonal anti MCP-1,
RANTES or MlP-la antibodies (Autogen Bioclear, Calne, Wiltshire, U.K.)) at a
dilution of 1 TOO in block buffer before being washed 3 times in PBS / 0.05%
Tween^) and incubated for 30 min with rabbit anti-goat-alkaline phosphatase
secondary antibodies (Jackson Immunoresearch, Stratatech, Luton, U.K.) diluted
1:1000 - 1:10000 in block buffer. Membranes were then washed a further 3 times,
rinsed briefly in detection buffer, and signals detected using CDP-star™
chemiluminescent substrate (Roche).
2.9.6 Detection of chemokine protein standards using Santa Cruz
Biotechnology goat polyclonal antibodies
Antibodies were tested using recombinant murine chemokine protein standards to
show that chemokines could be recognised under the conditions used. 100, 50, 25
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Figure 2.9. Western blots of different loadings of chemokine
standards.
Murine recombinant chemokine protein standards were electrophoresed
on a Schagger gel, transferred to immobilon-P and detected using Santa
Cruz Biotechnology goat anti-chemokine polyclonal antibodies at 1:100
with rabbit anti-goat-AP secondary antibody at 1:10000.
10 ng ofMCP-1 and MlP-la were detectable, but RANTES was easily
detectable only when 100 ng was loaded.
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Figure 2.10. Western blots of chemokine standards ± jejunal homogenates.
10 ng ofMCP-1 andMlP-la and 100 ng RANTES were electrophoresed on a
Schagger gel alone (1) or added to 25 pi ofjejunal extract (2).
Proteins were transferred to Immobilon-P and detected using Santa Cruz
Biotechnology goat anti-chemokine polyclonal antibodies at 1:100 with rabbit anti-
goat-AP secondary antibody at 1:10000.
MCP-1 and RANTES run in the same place when added to jejunal extract, MlP-la is
running at a higherMW in this example.
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and 10 ng ofMCP-1, RANTES and MlP-la were electrophoresed, blotted and
detected as described above using primary antibodies at a dilution of 1:100 and
secondary antibody at 1:10000. 10 ng ofMlP-la and MCP-1 were easily detectable
(figure 2.9), but 50 ng was the limit of detection for RANTES. 10 ng ofMCP-1 or
MlP-la and 100 ng ofRANTES were used as positive controls in subsequent
experiments. Additionally, the above amounts of protein "spiked" into jejunal
extracts were also shown to be detectable using this method (figure 2.10), although
MlP-la ran at a higher MW in jejunal extracts in some experiments.
2.9.7 Immunodetection of laminin binding protein (LBP)
Membranes were blocked overnight at 4°C in TBS /1% Marvel / 0.05% Tween^)
(block buffer) and cut into 0.5 cm strips, which were incubated for 1 h with primary
antibody at a dilution of 1:100 in block buffer, or block buffer alone. Primary
antibody was the rabbit anti-LBP polyclonal serum HK 149, which was raised to a
17-mer synthetic peptide from the NE^-terminal of murine LBP (residues 25-41),
and was kindly provided by Dr H. Kleinmann, National Institute ofDental Research,
NIH, Bethesda, U.S.A. The control antibody was normal rabbit serum (Sigma).
Membranes were then washed 3 times in TBS / 0.05% Tween^), and incubated for 30
min with 2° antibody (mouse anti-rabbit IgG alkaline phosphatase conjugate, Sigma)
diluted 1:20000 in block buffer. Membranes were washed a further 3 times and
rinsed briefly in TBS before detection using 5-bromo-4-chloro-3-indoyl phosphate /
nitroblue tetrazolium (BCIP/NBT) (Sigma-fast tablets).
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2.10 IMMUNOHISTOCHEMISTRY
2.10.1 Antigen retrieval in paraformaldehyde-fixed sections
Slides were dewaxed in xylene and hydrated through graded alcohols then covered in
10 mM Sodium Citrate buffer, pH 6 in a "Tender Cooker" microwave pressure
cooker (Biogenics, CA, U.S.A.) and heated in a microwave until the buffer was
boiling. Sections were then simmered for 4 min, and allowed to cool for 20 min
prior to immunostaining as detailed below.
2.10.2 Preparation of frozen sections
Proximal jejunum from male BALB/c mice was opened longitudinally and wrapped
around the barrel of a plastic pipette in a "swiss roll" style with the luminal surface
outward. The samples were then immersed in OCT compound (BDH), immobilised
on cork discs and snap frozen in isopentane cooled on dry ice. Samples were stored
at -70°C until ready for use, when 6 pm sections were cut using a cryostat
(Shandon). Sections were stored at -70°C, and were thawed and allowed to air-dry
overnight at room temperature before fixation for 10 min in acetone at -20°C and
rinsing twice in PBS before use.
2.10.3 Immunohistochemical detection ofmMCP-1 expression in cytospin
preparations ofmBMMC
Paraformaldehyde - fixed slides (method 2.4.9) were rinsed in deionised water before
blocking for endogenous peroxidase in 1% v/v hydrogen peroxide in methanol for 20
min. They were then rinsed for 5 min in tap water, blocked for 30 min in PBS / 0.5
M NaCl / 0.5% Tweengo (blocking buffer) and incubated for 1 h with the anti-
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mMCP-1 monoclonal RF6.1 (Scudamore et al, 1997) supernatant diluted 1:10 in
block buffer or, for control purposes, with 1 pg/ml rat IgGl (BD Pharmingen).
Slides were then washed twice in PBS and incubated for 30 min with biotinylated
anti-rat IgG (Vector laboratories, Peterborough, U.K.) diluted 1:100 in block buffer
before being washed twice more and incubated for 30 min with Vectastain ABC Elite
avidin-biotin detection system, made up according to the manufacturer's instructions
(Vector labs). They were then incubated for 5 min with DAB peroxidase substrate
(Vector labs) made up according to the manufacturer's instructions, washed twice in
PBS, and counterstained for 5 min in 0.1% Mayers' haematoxylin solution (Sigma).
Finally, sections were "blued up" in Scott's tap water before rinsing in tap water,
dehydrating through graded alcohols, clearing in Xylene and mounting in DPX
(Surgipath, Peterborough, U.K.)
2.10.4 Immunohistochemical detection of chemokine expression in murine
jejunum using Santa Cruz Biotechnology polyclonal antibodies
After antigen retrieval of formalin fixed paraffin embedded sections, or fixation of
frozen sections in acetone, sections were blocked for endogenous peroxidase activity
by incubating for 20 min with 3% hydrogen peroxide in deionised water. However,
due to difficulties in blocking endoperoxidase activity without loss of morphology in
frozen sections using this method, endoperoxidase activity in frozen sections was
blocked by a 10 min incubation with 100 pi of Dako peroxidase blocking reagent
(Dako Ltd., Ely, U.K.). Sections were then incubated for 1 h in blocking solution
(PBS /1.5% rabbit serum) and washed twice in PBS before incubating with goat
anti-chemokine polyclonal antibodies (Santa Cruz Biotechnology)(200 pg/ml) or
normal goat IgG diluted 1:50 - 1:500 in blocking solution. These dilutions were as
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suggested by the manufacturer's protocols. Sections were again washed twice in
PBS and incubated for 30 min in biotinylated rabbit anti-goat IgG 2° antibody
(Vector labs) at a dilution of 1:100 - 1:1000 before washing twice in PBS.
Biotinylated antibody was detected using the ABC-DAB method, and sections were
counter-stained, dehydrated and mounted (2.10.3).
2.10.5 Immunohistochemical detection of MCP-1 using an R&D Systems
polyclonal antibody
The recommended R&D Systems method included paraformaldehyde fixation and
permeabilisation using saponin. Thawed frozen sections were fixed for 10 min in
2% paraformaldehyde in PBS, pH 7.4. before rinsing in PBS and blocking
endogenous peroxidase activity by incubating for 10 min with Dako peroxidase
blocking reagent. Sections were then washed in PBS and blocked for 30 min in 1.5%
rabbit serum / 0.01% saponin in PBS before incubating for 1 h with R&D Systems
goat anti-mouse MCP-1 polyclonal antibody (100 p.g/ml) or normal goat IgG diluted
1:40 or 1:80. Sections were then washed in PBS and incubated with biotinylated
rabbit anti-goat 2° antibody (Vector labs) at 1:500 in 1.5% rabbit serum / 0.01%
saponin in PBS before washing and detection of biotinyated antibody using the
ABC-DAB method. Sections were then counter-stained, dehydrated and mounted
(2.10.3).
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2.11 ADHESION ASSAYS
2.11.1 Coating ofplates
All coating proteins were obtained from Sigma and solubilised and stored as
recommended (appendix 1, table A1.1). Proteins were diluted to the required
concentration in sterile PBS and 96 well ELISA plates (Immulon) were coated
overnight at 4°C with 100 pi of diluted protein. Excess proteins were then removed,
and non-specific binding blocked by incubation for 2 h at 37°C with 3% BSA in
PBS.
2.11.2 Adhesion assay
mBMMC or MC/9 cells were washed twice in PBS / 0.1% BSA before resuspending
at 5 x 105 cells/ml in their respective basic culture media (without cytokines or T-
stim, including FCS). 100 pi of cells were then loaded in quadruplicate into wells
and incubated for 1 or 2 h at 37 °C / 5% CO2, after which non-adherent cells were
aspirated, and the wells washed 3 times with PBS. The number of cells adherent to
wells was estimated using the B-hexoseaminidase assay (Landegren, 1983). Standard
wells were prepared by the addition of the required volumes of cells at 5 x 105 /ml to
make 0.25 - 5 x 104 cells/well, and the volume made up to 100 pi with PBS. When
adhesion of two mast cell types was compared, separate standards were made up for
each so that differences in p-hexoseaminidase content would not affect estimations
of adhesion. Test wells were also made up to 100 pi volumes with PBS and plates
were incubated at 37°C for 2 h with 60 pi of substrate buffer (7.5 mM p-nitrophenol
-N-P-glucosaminide, Sigma). The reaction was stopped by the addition of 90 pi of
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stop buffer (50 mM glycine / 5 mM EDTA, pH 10.5), and the optical density of the
reaction products was read at 405 nm.
2.11.3 Stimulation of mBMMC adhesion by FcsRI cross-linking or treatment
with calcium ionophore A23187
For stimulation by FcsRI cross-linking, mBMMC were first sensitised by incubation
overnight in complete culture medium with 100 ng/ml of IgE anti-DNP (Sigma).
They were then washed twice in PBS / 0.1% BSA and resuspended in culture
medium (without cytokines) before loading into wells and immediate addition of 10
ng/ml ofDNP-HSA (Sigma). This protocol was based on unpublished work in our
laboratory investigating stimulation of degranulation ofmBMMCT+ by FcsRI cross-
linking.
For stimulation by calcium ionophore, mBMMC, washed and resuspended in culture
medium without cytokines, were loaded into wells and 1 pM calcium ionophore
A23187 (Sigma) immediately added. Cells to which 50 ng/ml ofPMA (Sigma) was
added immediately after loading into wells were included as a positive control for
stimulation of adhesion and, as a negative control, cells to which no activating agent
was added were included. In some experiments, additional controls of IgE-sensitised
cells to which no antigen was added, and unsensitised cells to which antigen was
added were included. The adhesion assay was then performed as in 2.11.2.
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2.12 ANTIBODIES USED IN FLOW CYTOMETRY AND BLOCKING
STUDIES
Mouse IgGl monoclonal antibodies to a7pi integrins were kindly provided by Dr H.
von der Mark (Institute ofExperimental Medicine, Friedrich-Alexander-University
Erlangen-Nurnberg, Erlangen, Germany). They were obtained by immunisation of
a7-deficient mice with wild-type primary myoblasts, as described (Schober et al,
2000). Clone 6A11 was used for inhibition of adhesion ofmBMMCT+to laminin-1
since it has the strongest adhesion-inhibition activity of all the anti-a7 clones
obtained. Clone 3C12 did not inhibit cell adhesion to laminin and was used for flow
cytometry.
Murine IgGl and rat IgGl and IgG2a isotype controls, rat anti-mouse av IgGl
(clone RMV-7), rat anti-mouse a5 IgG2a (clone 5H10-27), rat anti-mouse a6 IgG2a
(clone GoH3) and rat anti-mouse FcyR-III/II (Fc block, clone 2.4G2) were obtained
from BD Pharmingen. Biotinylated-anti rat IgG2a or IgGl secondary antibodies
were also obtained from BD Pharmingen and anti-mouse IgGl-Alexa Fluor 488 was
obtained from Molecular Probes (Leiden, The Netherlands).
2.13 FLOW CYTOMETRY
Surface expression of integrins was analysed by flow cytometry, with linear
amplification for forward/side scatter and logarithmic amplification for FITC green
fluorescence or phycoerythrin red fluorescence. This was performed by Mr. Andrew
Sanderson, Institute of Cell, Animal and Population Biology, Department of
Biological Sciences, University of Edinburgh using a FACScan (Becton Dickenson).
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The machine was set for the population of cells to be analysed by ensuring that
forward scatter, side scatter and fluorescence fell within the analytical range of the
instrument. Events were gated to exclude erythrocytes and dead cells on the basis of
forward and side scatter (Rl, figure 2.11). Each population of cells tested comprised
105 - 106 cells and each flow cytometric analysis was based on 104 cells. Results
were displayed as histograms with log fluorescence intensity along the x-axis
(arbitrary units), and number of cells on the y-axis.
Figure 2.11. Flow cytometric analysis of integrin expression in mBMMC.
Example of a gate (Rl) used to exclude erythrocytes and dead cells from the
analysis.
2.13.1 Flow cytometric analysis of expression of a5, a6 and av integrins by
mBMMC using rat monoclonal antibodies
1 x 106 mBMMC cells were incubated for 5 min with 0.5 pg ofmurine Fc block
followed by incubation for 1 h with 1 pg of rat monoclonal antibody or isotype
control in PBS 10% mouse serum. The cells were then washed twice in wash buffer
(WB)(PBS / 0.1% BSA) and incubated for 30 min with 1 pg of biotin-anti rat IgG2a
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or IgGl in PBS 10% mouse serum before washing twice and incubating for 30 min
with 100 gig of streptavidin-phycoerythrin (Vector labs). After labelling, cells were
washed twice and fixed for 10 min in 2% paraformaldehyde before analysis by flow
cytometry; all procedures were performed on ice.
2.13.2 Flow cytometric analysis of a7 integrin expression by mBMMC using
the mouse anti-mouse a7 monoclonal antibody, 3C12
Optimum conditions for this experiment were established by pilot experiments
incubating 3C12 or isotype control at 1, 2, 4 or 10 pg/106 cells; and secondary
antibody at 1:2000 or 1:5000.
2 x lO5 cells were incubated for 5 min with 0.1 pg of murine Fc block before
incubation for 1 h with 2 pg of the mouse anti-a7 3C12, or mouse IgGi control in
PBS 5% FCS. They were then washed twice in wash buffer and incubated for 30
min with anti-mouse IgGl-Alexa Fluor 488 diluted 1:2000 in PBS 5% FCS. After
labelling, cells were washed and fixed as above. All procedures were performed on
ice.
2.14 OPTIMISATION OF MC/9 CELLS AS POSITIVE CONTROLS FOR
INVESTIGATION OF THE ROLE OF a6 INTEGRIN IN ADHESION OF
mBMMCT+ TO LAMININ-1
2.14.1 Adhesion of MC/9 cells to ECM proteins
MC/9 cells are reported to adhere to laminin-1, and this adhesion can be blocked by
the a6-neutralising antibody, GoH3. Therefore, these cells were cultured for use as a
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positive control in experiments investigating the effect ofGoH3 on adhesion of
mBMMC to laminin-1 (6.5). An initial experiment was set up to confirm that
MC/9 cells would adhere to laminin-1 using the adhesion assay developed to
investigate adhesion ofmBMMC to ECM proteins. In addition, adhesion ofMC/9
cells to type I collagen, type IV collagen, fibronectin and vitronectin was analysed,
as described (2.11.1 - 2.11.2). Proteins were coated at 20 pg/ml, with the exception
of vitronectin, which was coated at 10 pg/ml; adhesion to wells coated with 3% BSA
in PBS was also measured as a negative control. Adhesion of unstimulated cells and
cells stimulated with 50 ng/ml PMA, which was added immediately after loading of
cells into wells, was analysed after incubation for 1 h.
MC/9 cells adhered spontaneously to fibronectin and, after treatment with PMA, they
also adhered to laminin-1 and type IV collagen (figure 2.12). Adhesion to laminin-1
confirmed their potential usefulness as a positive control for use ofGoH3.
2.14.2 The effect ofpreincubation of MC/9 cells with GoH3 on adhesion to
laminin-1
The above experiment (2.14.1) showed that MC/9 cells adhered to laminin-1 (20
pg/ml) following stimulation with PMA, but in order to establish optimum
conditions for blocking experiments, the effect of preincubation with the anti-a6
integrin monoclonal, GoH3 at 1, 5 or 10 pg/ml on adhesion to laminin-1 was
investigated. MC/9 cells were preincubated with GoH3 or IgG2a isotype control for
5 min at room temperature, as preliminary experiments (2.15.1) showed these to be
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Figure 2.12. Adhesion of MC/9 cells to extracellular matrix proteins.
Each protein was coated at 20 pg/ml except vitronectin, which was coated at 10
pg/ml. 3% BSA is included as a negative control.
MC/9 cells adhered spontaneously to fibronectin and, following stimulation with
PMA, there was increased adhesion to fibronectin, laminin-1 and collagens.
Results are median (range) of one experiment, n=4 wells.
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Figure 2.13. Antibody blocking of the adhesion ofMC/9 cells to laminin-1.
MC/9 cells were preincubated for 5 min at room temperature with 1, 5 or 10 pg/ml of
the anti-a6 integrin monoclonal GoH3 or IgG2a isotype control.
Preincubation with GoH3 at all concentrations examined blocked adhesion ofMC/9
cells to laminin-1. Results are expressed as median (range) of one experiment, n=3
wells.
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optimum conditions. Adhesion to laminin-1 after incubation for 1 h was then
analysed as described (2.11.2). GoH3 (>1 pg/ml) blocked adhesion of MC/9 cells to
laminin-1, whereas preincubation with isotype control IgG2a (>1 pg/ml) resulted in
only a small and variable reduction in adhesion to laminin-1 (figure 2.13).
Inhibition of adhesion ofMC/9 cells to fibronectin by preincubation with anti-a5
integrin antibody has been reported (Fehlner-Gardiner et al, 1996b), therefore
preliminary experiments investigated use of these cells as a positive control for
investigation of the role of a5 in adhesion ofmBMMC7" to fibronectin. However,
adhesion ofMC/9 cells to fibronectin was not blocked by the a5 neutralising
monoclonal 5H10-27 (not shown), though flow cytometric analysis using the same
antibody showed surface expression of this integrin. The reason for this was
unknown, but these cells were not considered suitable as a positive control for
blocking experiments using 5H10-27.
2.15 PREINCUBATION CONDITIONS FOR INVESTIGATION OF THE
ROLE OF INTEGRINS IN ADHESION OF mBMMC TO ECM
PROTEINS
2.15.1 Pilot experiments to optimise preincubation conditions
Conditions for preincubation of neutralising antibodies were established in pilot
experiments (data not shown). Antibodies were preincubated at 1, 5 or 10 pg/ml
with mBMMC or MC/9 cells (2.14.2) for 5-30 min on-ice or at room temperature.
These starting conditions were chosen on the basis of published work (Fehlner-
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Gardiner et al, 1996a; Schober et al, 2000), or manufacturers' data sheets for
commercial antibodies. In all experiments, cells incubated with isotype control and
with no antibody were included as negative controls.
2.15.2 Preincubation ofmBMMCT+ with 6A11
The role of a7 integrin in adhesion ofmBMMCT+to laminin-1 was investigated by
preincubation ofmBMMCT+ for 30 min on ice with the anti-a7 monoclonal 6A11
(10 pg/ml). This concentration had previously been shown to inhibit adhesion of a7-
transfected HEK293 cells to laminin-1 (Schober et al, 2000).
2.15.3 Preincubation ofmBMMCT+ with GoH3
Preincubation with GoH3 at up to 10 pg/ml did not block adhesion ofmBMMCT+ to
laminin-1 in preliminary experiments (not shown). Therefore MC/9 cells, adhesion
ofwhich to laminin-1 can be blocked by GoH3 (Fehlner-Gardiner et al, 1996a), were
used as positive controls for this antibody. Optimum conditions were established
using MC/9 cells (2.14.2), and MC/9 cells preincubated with GoH3 under these
conditions were included in each experiment to investigate the effect of this antibody
on adhesion ofmBMMCT+ to laminin-1.
T+
To determine the role of a6 integrin in adhesion ofmBMMC to laminin-1,
mBMMCT+ or MC/9 cells were preincubated for 10 min at room temperature with
the anti-a6 monoclonal GoH3 or isotype control (1 pg/ml).
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2.15.4 Preincubation ofmBMMC7' with 5H10-27 or RMV-7
The role of a5 in adhesion ofmBMMC7" to fibronectin was investigated by
preincubation for 10 min at room temperature with 1, 5 or 10 pg/ml of 5H10-27 or
isotype control in one pilot experiment, and with 10 pg/ml in subsequent
experiments. The role of av in adhesion ofmBMMC1" to vitronectin was
investigated by preincubation for 10 min at room temperature with 10 pg/ml of
RMV-7 or isotype control.
2.16 STATISTICAL ANALYSIS
Statistical analysis was performed using non-parametric tests with GraphPad Prism
version 4.00 for Windows, GraphPad Software, San Diego California, U.S.A. The
Mann Whitney-U test was used to compare up to three groups of data (n=4). Four or
more groups of data (n=4) were compared using the Kruskal-Wallis test with Dunn's
multiple comparison post-test. Data are represented as graphs ofmedian (range);
when repeat experiments were performed; results are shown in tabular form in
appendix 2.
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CHAPTER 3
EXPRESSION OF MAST CELL CHEMOATTRACTANTS IN MURINE
JEJUNAL EPITHELIUM FOLLOWING N. BRASILIENSIS INFECTION
3.1 INTRODUCTION
Mast cell precursors are recruited into the jejunal mucosa following nematode
infection (Kasugai et al, 1995), where they are thought to differentiate into mucosal
mast cells (MMC) under the influence of cytokines expressed in the lamina propria,
and subsequently migrate intraepithelially. The mechanisms directing this migration
are not yet clear but, as described in 1.10, variations in chemokine expression
regulate migration of other immune cells throughout the body, and mast cells are
likely to be no exception to this regulatory system. In support of this, chemokines
including MCP-1, MlP-la, RANTES, (Taub et al, 1995) and fractalkine
(Papadopoulos et al, 2000) are chemotactic for several mast cell phenotypes.
There is considerable evidence that modulation of epithelial chemokine expression
plays an important role in initiation of the immune response to intestinal infections
by attracting the necessary spectrum of immune cells. Interaction of invasive
bacteria stimulates upregulation ofmonocyte chemoattractant protein-1 (MCP-1) and
interleukin-8 (IL-8) in cultured colon epithelial cells (Jung et al, 1995) and rotavirus
infection of cultured intestinal epithelium stimulates upregulation ofmacrophage
inflammatory protein-ip (MIP-ip), MCP-1 and RANTES (Rollo et al, 1999). Also,
stimulation of epithelium by pro-inflammatory cytokines such as interleukin -1 (IL-
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1) and tumour necrosis factor-a (TNF-a) can upregulate chemokine expression
(Panja et al, 1995).
Less is known about the intestinal epithelial response to gut-dwelling parasites, but
studies using both cell culture (Li et al, 1998) and epithelial isolation methods
(Stadnyk & Kearsey, 1996) have shown increases in IL-1(3, IL-8 and epithelial -
neutrophil activating peptide-78 (ENA-78), which are chemoattactants for
neutrophils, in response to infection with the nematode parasite, Trichinella spiralis.
Expression ofmast cell chemoattractants by intestinal epithelium following
gastrointestinal nematode infection has not been studied, and alterations in
expression could attract mast cells or their precursors into the epithelium. Therefore,
expression of the chemokines RANTES, MCP-1 and MlP-la, and cytokines SCF
and TGF-(3i, which are also mast cell chemoattractants (Meininger et al, 1992;
Gruber et al, 1994), was investigated in a N. brasiliensis model of intestinal
mastocytosis. In addition, expression of the chemokine TECK, which may attract
IEL into the epithelium (Kunkel et al, 2000), was also investigated, since IEL and
MMC may share common recruitment mechanisms. Epithelium from infected and
uninfected mice was collected using a modification of the perfusion technique first
described by Bjerknes and Cheng (Bjerknes & Cheng, 1981), thus enabling
characterisation of the epithelial immune response to an in vivo infection.
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3.2 RT-PCR ANALYSIS OF CHEMOKINE AND CYTOKINE EXPRESSION
IN MURINE JEJUNAL EPITHELIUM FOLLOWING N. BRASILIENSIS
INFECTION
3.2.1 Experimental aim and design
The aim of this experiment was to investigate the expression of putative mast cell
chemoattractants and the lymphocyte chemoattractant, TECK, by jejunal epithelium
ofN. brasiliensis infected mice. Fifteen 12-week-old mice were infected with 500 N.
brasiliensis larvae (2.2.1). After subcutaneous injection, N. brasiliensis migrates via
the lungs arriving in the intestine between 48 and 72 h after infection. Numbers of
MMC begin to increase on day 7 post-infection (Wastling et al, 1997), but in order to
examine both early and late responses, mice were killed and expression of
chemokines and cytokines in jejunal epithelium was examined (in triplicate) on days
1, 2, 4, 7 and 14 post-infection. Uninfected control mice were also included.
Jejunal epithelium was collected by the modified Bjerknes EDTA perfusion
technique (2.3.2). Prior to euthanasia, anaesthetised mice were bled (2.3.1) and
serum retained for measurement ofmMCP-1 (2.8.1) to confirm that there was a
mastocytosis in association with a successful infection (Wastling et al, 1997).
Epithelium was collected into TRI reagent for RT-PCR, and into 4%
paraformaldehyde for morphological examination (2.3.3); and after perfusion, a 2 cm
section ofwhole jejunum was collected into RNA later™ and processed for use in
RT-PCR (2.3.4).
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Expression of transcripts for MCP-1, MlP-la, RANTES, TECK, fractalkine, TGF-
Pi, SCF and mMCP-1 in epithelial RNA samples was detected by RT-PCR (2.5.1 -
2.5.7 and table 2.1). As very low expression ofMCP-1 was detected in epithelial
samples, expression of this chemokine in whole jejunum was also measured by RT-
PCR. Also, initial experiments suggested increased MCP-1 expression in jejunal
epithelium on day 7 post-infection, therefore this was further investigated using
semi-quantitative PCR (2.5.8).
3.2.2 Results
3.2.2.1 Examination of stripped epithelium
Examination of stripped epithelium under low power using a dissecting microscope
showed that collected samples consisted of epithelium in small sheets, discrete crypt-
villous units or separated crypts and villi (figure 3.1). Haematoxylin and eosin-
stained histological sections confirmed this and, with the exception of one sample,
levels of contaminating non-epithelial cells were below 5% (table 3.1). Differential
expression of MCP-1 in whole jejunal and epithelial samples (see below) further
supported evidence that these represented two different cell populations.
The Bjerknes method of epithelial isolation is superior to other chelating, enzymic or
mechanical methods because intact pieces of epithelium are recovered with little
contamination with lamina propria cells and with high cell viability (Bjerknes &
Cheng, 1981). Our modification of this method was easier to perform and resulted in
a similar recovery of epithelium, with comparable viability (>95%).
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(a)
Figure 3.1. Exfoliated jejunal epithelium obtained by the modified Bjerknes
technique.
(a) Haematoxylin and eosin stained epithelial preparations (x 100) showing the
relative absence of non-epithelial elements. A few contaminating non-epithelial
cells are present (arrows)(see table 3.1).
(b) Whole mount of freshly isolated epithelium viewed with the dissecting
microscope (x 25). Note that both villi and crypts are recovered by this method.
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Time post-infection
(days)
n= % contaminating
cells
0 3 3.6 (2.0 - 7.6)
1 3 2.4 (2.2 - 2.4)
2 2 3.0(3.0-3.0)
4 3 2.2(1.8-3.6)
7 3 3.0(1.8-4.6)
14 2 1.8 (1.6-2.0)
Table 3.1. Contamination of epithelial preparations with other cell types.
500 epithelial cells were counted in haematoxylin and eosin stained preparations, and
the number of associated non-epithelial cells estimated. Contaminating cells
consisted ofmainly lymphocytes with some neutrophils.
Results are expressed as median (range); n= number of preparations examined.
3.2.2.2 Expression ofmMCP-1 in serum and epithelium
Serum mMCP-1 levels and levels ofmMCP-1 mRNA in jejunal epithelium were
measured as an indication ofmast cell numbers in the jejunum. The mast cell
response to N. brasiliensis has been previously characterised, and the increase in
mast cell numbers shown to be closely paralleled by increased serum and jejunal
mMCP-1 (Scudamore et al, 1997; Wastling et a/, 1997).
mMCP-1 was detected in the serum of all mice, but was at very low levels prior to
day 7. Median (range) serum mMCP-1 concentrations on day 4 post-infection were
4.0 ng/ml (1.7-4.1 ng/ml) (n=3 mice). Serum mMCP-1 concentrations were
increased above control values on days 7 (0.4 pg/ml (0.07 - 0.7 pg/ml)) and 14 (20
pg/ml (0.014 - 24.4 pg/ml)) post-infection (figure 3.2).
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Time post-infection (days)
Figure 3.2. Serum mMCP-1 concentrations in male BALB/c mice following
infection with TV. brasiliensis.
Values are median (range) (n=3 mice).
To confirm the intraepithelial location ofMMC, expression ofmMCP-1 was
measured in jejunal epithelial samples by RT-PCR. Expression was detected in all
samples collected on days 7 and 14 post-infection (figure 3.3), but low-to-
undetectable levels of expression were seen in samples on days 0 (uninfected
controls), 1 and 2 and 4 post-infection. This is consistent with a previous study of
jejunal mMCP-1 expression using Northern blotting (Wastling et al, 1997).
3.2.2.3 Expression of chemokines and cytokines in jejunal epithelium
Expression ofmRNA for the chemokines MlP-la, RANTES, TECK and fractalkine,
and of the cytokines SCF and TGF-(3i was detected in both control (uninfected)
epithelial samples and in epithelial samples collected at all time-points from infected
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Figure 3.3. Expression of cytokines and chemokines in murine jejunal
epithelium or jejunum during infection with TV. brasiliensis.
a) RT-PCR - Expression ofmMCP-1 on days 7 and 14 confirms movement ofmast
cells into the epithelium as a result of infection. All chemoattractants are
constitutively expressed with the exception ofMCP-1, which is detected only on
day 7 (shown by arrow) in this example. For comparison, jejunal MCP-1
expression is shown. It is constitutive and expression appears to be at much
higher levels than in epithelium.
Results are representative of data from 3 separate mice. Upper and lower bands of
the SCF signal represent transmembrane and secreted forms, respectively.
b) Southern blot ofPCR products from amplification ofjejunal epithelial cDNA
using primers specific for MCP-1. Arrows indicate faint bands. Positive controls
are whole jejunal samples, in which there is strong expression ofMCP-1.
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mice (figure 3.3). No consistent changes in expression were detected using this
method. All PCR products were of the expected size, and hybridised, as expected, to
complementary oligonucleotide probes (table 2.1).
Expression of the chemokine MCP-1 was initially undetectable by RT-PCR in any
sample except those collected on day 7, and one sample collected on day 14 post¬
infection (figure 3.3). Southern blotting revealed low levels of expression in 2
control samples, 2 samples collected on day 1 and in one sample collected on day 2
post-infection, and confirmed the increased levels of expression in all day 7 samples
and one day 14 sample (figure 3.3). Use of 10-fold more cDNA for semi¬
quantitative PCR showed low level expression ofMCP-1 in all samples, with
increased expression in 2 samples collected on day 7 and 2 samples on day 14 post¬
infection (figure 3.4).
3.2.2.4 Expression of MCP-1 in whole jejunum
In contrast to that seen in epithelium, MCP-1 expression was detected by RT-PCR in
control jejunal samples, and at all time points post-infection (figure 3.3.) No
increase in expression was detected following N. brasiliensis infection. Expression
of MCP-1 in jejunum was more abundant than in epithelium (figure 3.3).
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Figure 3.4. Expression of MCP-1 in jejunal epithelium during infection with N.
brasiliensis, analysed using semi-quantitive RT-PCR.
(a) Ethidium bromide-stained gels showing MCP-1 and respective GAPDH signals.
(b) Scatter graph of semi-quantitative MCP-1 expression in intestinal epithelium.
Values plotted are ratios of intensity ofMCP-1 signal / GAPDH signal for 3 sets
of animals.
Points represent relative expression in epithelium from individual mice and
horizontal bars indicate medians.
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3.3 EXPRESSION OF CHEMOKINES AND CYTOKINES BY CULTURED
MAST CELLS AND THE CMT-93 MURINE INTESTINAL EPITHELIAL
CELL LINE
3.3.1 Experimental aim and design
The previous experiment showed expression of several cytokines and chemokines
from intestinal epithelium, and upregulation ofMCP-1 expression following
infection with N. brasiliensis. Several cell types within epithelium may express
these molecules including epithelial cells, IEL and mast cells. The aim of the
following experiment, therefore, was to investigate the likely source of expression of
the cytokines and chemokines detected in 3.2.
Expression of transcripts for MCP-1, MlP-la, RANTES, TECK, fractalkine, TGF-(3i
and SCF in the epithelial cell line CMT-93, which was derived from a murine rectal
T-F •
carcinoma, and in cultured mBMMC (MMC homologues) was investigated. CMT-
93 cells and mBMMCT+ were cultured (2.4.1 and 2.4.3), and cells collected for RNA
extraction (2.4.10.) Expression of cytokines and chemokines was analysed in 3
cultures of both mBMMCT+ and CMT-93 cells by RT-PCR (2.5.1 - 7); specific
conditions for each primer were as in 3.2, and are detailed in table 2.1.
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Figure 3.5. Expression of chemoattractants by cultured mBMMCT+ and the
murine intestinal epithelial cell line, CMT-93.
SCF, TGF-|3], fractalkine and MCP-1 were expressed in CMT-93 cells; whereas
expression of TGF-pi, MlP-la and MCP-1 was detected in mBMMCT+.
RANTES was also expressed at low levels by mBMMCT+ and inconsistently by
CMT-93 cells. Expression of TECK was detected inconsistently and at very low
levels in both cell types.
3.3.2 Results
RT-PCR analysis showed expression of a number of cytokines and chemokines by
mBMMCT+ and CMT-93 epithelial cells. Both MCP-1 and TGF-|3i were strongly
expressed by both mBMMCT+ and CMT-93 epithelial cells (figure 3.5). Expression
ofMlP-la was detected in mBMMCT+ but not in CMT-93 epithelial cells. In
contrast, expression of fractalkine and SCF was detected in CMT-93 epithelial cells,
but not mBMMCT+ (figure 3.5). RANTES was expressed at very low levels in
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mBMMCT+ and inconsistently in CMT-93 epithelial cells; TECK was detected
inconsistently and at low levels in mBMMCT+ and CMT-93 epithelial cells.
3.4 USE OF A MACROARRAY FOR ANALYSIS OF CHEMOKINE
EXPRESSION IN MURINE JEJUNAL EPITHELIUM FOLLOWING N.
BRASILIENSIS INFECTION
3.4.1 Experimental aim and design
Constitutive expression of a number of cytokines and chemokines was detected in
intestinal epithelium, but expression of the majority of these remained unchanged
after infection with N. brasiliensis (3.2.2.3). Expression ofMCP-1 was upregulated,
but levels of this chemokine remained low, even in infected epithelium. It was
thought possible, however, that expression of other chemokines not previously
investigated may be altered following N brasiliensis infection. A mouse chemokine
Non-rad (non radioactive) GEArray™ macroarray kit (2.7) was therefore used to
investigate expression of chemokines in jejunal epithelium collected from uninfected
mice, and mice infected 7 days previously with N. brasiliensis.
Epithelium from three infected and three uninfected mice was collected into TRI
reagent (2.3.3), and RNA extracted and DNase treated (2.5.1 - 2.5.2). Expression of
chemokines was then examined in combined uninfected and infected epithelial
samples using the GEArray kit, using separate membranes for uninfected and
infected samples (2.7).
3.4.2 Results
The chemokines analysed by the GEArray are shown in figure 2.7. Use of the
GEArray™ to detect expression of chemokines in intestinal epithelium confirmed
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Control
Figure 3.6. Expression of chemokine transcripts in murine jejunal epithelium.
Epithelium was collected from uninfected (control) mice and from mice infected 7
days previously with N. brasiliensis.
Chemokines TECK (3, 4), RANTES (10, 11) andMlP-la (16, 17) were clearly
detected in both control and infected epithelium. Expression of SDF-2 (1, 2), PF-4
(8, 9) and fractalkine (21, 22) was less obvious in control epithelium, and MIP-2 (13,
14) may be expressed in infected epithelium.
5, 6, 7, 12, 13, 18 are GAPDH controls, 19 and 20 are P-actin controls, and 23 and 24
are bacterial plasmid negative controls.
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several results from RT-PCR and revealed expression of 2 other chemokines in
uninfected epithelium (figure 3.6). Strong expression of TECK and RANTES, and
weaker expression ofMlP-la in both uninfected and infected epithelium was
confirmed (figure 3.6). However, expression of fractalkine was detected only in
uninfected epithelium, but higher background in this area of the array may have
prevented detection in the infected sample (figure 3.6). Weak expression of
chemokines SDF-2 and PF4 was detected in uninfected, but not in infected
epithelium (figure 3.6).
3.5 INVESTIGATION OF CHEMOKINE PROTEIN EXPRESSION IN
MURINE JEJUNUM BY WESTERN BLOTTING
3.5.1 Experimental aim and design
The experiments described in 3.3 and 3.4 established that transcripts encoding
chemokines and cytokines are constitutively expressed in intestinal epithelium. It
was of interest, therefore, to determine whether the relevant protein products could
also be detected by Western blotting. In this preliminary study, expression of
RANTES, MlP-la and MCP-1 protein was investigated in uninfected epithelial and
whole jejunal samples since transcripts for RANTES and MlP-la in epithelium, and
ofMCP-1 in whole jejunum, were detected both in the presence and absence of
infection.
Protein was extracted (2.9.1) from previously collected and stored epithelial or whole
jejunal samples (2.3.2 - 2.3.4). Samples were electrophoresed on a Schagger gel
(2.9.2.2) and proteins transferred onto Imobilon inert supports (2.9.4). Chemokines
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were detected using an immunodetection protocol with chemiluminescent detection
(2.9.5). In each experiment, 10 ng (100 pg RANTES) of protein standards
(recombinant murine chemokine proteins, Autogen Bioclear, Calne, Wiltshire, UK)
and 10 ng (100 ng RANTES) of protein standards "spiked" into epithelial or whole
jejunal extracts were also run alongside test samples as positive controls. These
standards were derived through titration experiments (2.9.6).
3.5.2 Results
Investigation of epithelial expression ofRANTES, MlP-la and MCP-1 by Western
blotting produced variable results. Though chemokine standards were readily
detected on blots (figures 2.9 and 2.10), no chemokines were detected in intestinal
epithelium, and neither RANTES nor MCP-1 were detected in homogenates of
whole jejunum (data not shown). Antibodies to RANTES appeared least sensitive,
as 100 ng was the minimum amount of standard detected as opposed to 10 ng
standards for MCP-1 and MlP-la (2.9.6, figure 2.9); and positive controls for
RANTES were inconsistently detected, therefore results from experiments to detect
RANTES were considered unreliable. A positive band was detected on blots in
jejunal samples using polyclonal antibody to MlP-la (figure 3.7) in 3 separate
experiments using 2 different jejunal extracts. This band was of higher molecular
weight (15 kDa) than the expected 8 kDa, butMlP-la was detected as a 15 kDa
band in blots from jejunal samples "spiked" with standard.
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Figure 3.7. Western blot to detectMlP-la in uninfected murine jejunum.
Lane 1 - 10 ng murine recombinant MLP-la standard.
Lane 2 - jejunal extract + 10 ngMlP-la standard.
Lanes 3 and 4 - jejunal extract.
Lanes 1-3 were incubated with goat anti-MIP-la polyclonal primary antibody
(1:100) and lane 4 (negative control) was incubated with normal goat polyclonal
antibody (1:100).
Standards (lanes 1 and 2) were detected using rabbit anti-goat AP secondary
antibody at a dilution of 1:10000, whereas incubation with secondary antibody at a
dilution of 1:5000 was required for detection ofMlP-la in jejunum only (lanes 3 and
4)-
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3.6 INVESTIGATION OF CHEMOKINE PROTEIN EXPRESSION IN
MURINE JEJUNUM BY IMMUNOHISTOCHEMISTRY
3.6.1 Experimental aim and design
As results from Western blotting to detect chemokines in jejunal samples were
equivocal (3.5.2), immunohistochemistry was used in an attempt to show expression
of chemokine protein in murine jejunum and in jejunal epithelium. Additionally,
RT-PCR showed much higher expression ofMCP-1 in whole jejunum than in
epithelium, and we were interested to know the cellular source of this expression.
The goat polyclonal antibodies (Santa Cruz Biotechnology) used for Western
blotting were also used in immunohistochemical protocols. Expression ofMlP-la,
MCP-1 and RANTES was investigated by immunohistochemistry (2.10.4) in
paraformaldehyde-fixed (2.4.9) sections following antigen retrieval (2.10.1).
Jejunum from control mice, and from mice infected with N. brasiliensis 7 and 10
days earlier was used for these experiments. Expression was also investigated using
acetone-fixed frozen sections (2.10.2) from an uninfected mouse by
immunohistochemistry (2.10.4).
In addition to Santa Cruz antibodies, further attempts were made to detect MCP-1 in
frozen sections from an uninfected mouse using a goat anti-MCP-1 polyclonal
antibody obtained from R&D Systems. The method was as recommended by R&D
Systems (2.10.5).
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3.6.2 Results
Although Western blotting showed detection of recombinant chemokine standards
(figure 2.9), no convincing staining for any of the chemokines was detected using
Santa Cruz polyclonal antibodies or the R&D systems anti-MCP-1 polyclonal
antibody in the fixed and frozen tissue sections examined (not shown).
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3.7 DISCUSSION
Upregulation of several chemokines and cytokines occurs in epithelium in response
to viruses (Rollo et al, 1999), bacteria (Jung et al, 1995; Eck et al, 2000) and
nematode parasites (Stadnyk & Kearsey, 1996; Li et al, 1998). The present study
showed constitutive expression of transcripts for a number of chemokines and
cytokines in murine intestinal epithelium, and increased expression ofMCP-1
following N. brasiliensis infection.
MCP-1 is well-established as a monocyte chemoattractant and is chemotactic for
murine IL-3-dependent bone marrow mast cells (Taub et al, 1995) and mouse skin
mast cells (Conti et al, 1997). Expression ofMCP-1 has been correlated with an
increase in mast cell numbers in wound healing and in chronic airway inflammation
(de Boer et al, 2000; Trautmann et al, 2000). In the intestinal tract, MCP-1
expression has been detected by immunohistochemistry in normal colonic epithelium
(Reinecker et al, 1995), lamina propria and endothelial cells (Mazzucchelli et al,
1996) making it a potential candidate for mast cell recruitment to the intestine. The
high levels of expression ofMCP-1 seen in whole jejunum in this study (3.2.2.4)
suggest it could be involved in initial recruitment ofmast cell precursors from the
circulation into tissues, which normally occurs as early as day 3 post-infection of
mice with Strongyloides venesuelensis (Tegoshi et al, 1997). Although the increased
expression ofMCP-1 identified in epithelium may be important in intraepithelial
migration ofMMC, it seems unlikely that a significant chemotactic gradient could be
established against the apparently higher expression levels in the lamina propria.
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The precise source of expression ofMCP-1 and of the other molecules examined in
the epithelial fraction is unknown, but may include both epithelial cells and
intraepithelial inflammatory cells such as lymphocytes and mast cells. Cultured
murine epithelial (CMT-93) cells strongly expressed MCP-1, TGF-Pi, SCF and
fractalkine and expressed low levels ofRANTES and TECK (3.3.2). Expression of
RANTES (Yang et al, 1997), TECK (Muehlhoefer et al, 2000) and fractalkine
(Wurbel et al, 2000) has also been demonstrated previously in intestinal epithelial
cells or epithelial cell lines.
Expression ofMCP-1, (Baghestanian et al, 1997), MlP-la and RANTES (Selvan et
al, 1994) has been reported in mast cells, and mBMMCT+ cultured in our lab also
expressed these three chemokines, and TGF-Pi (3.3.2). Expression of these
molecules by newly recruited intraepithelial mast cells could contribute to the
apparent increase in MCP-1 against the low background expression of this
chemokine in epithelium. Intraepithelial lymphocytes (IEL) are able to express MIP-
la, RANTES and TGF-Pi (Boismenu et al, 1996; Kearsey & Stadnyk, 1996) and
may contribute to constitutive expression in exfoliated epithelium. Alterations in the
population of IEL following infection were not examined in this study, however,
other authors have shown a marked decrease in numbers of IEL following infection
with the nematode parasite Trichinella spiralis (Garside et al, 1992; Bozic et al,
1998). If a similar decrease was seen following N. brasiliensis infection, this could
make IEL a less likely source of the chemoattractants examined, although RANTES
is a major product of IEL (Shires et al, 2001).
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The chemokines MlP-la and RANTES, which are also chemotactic for mast cells,
(Taub et al, 1995; Conti et al, 1998) were expressed constitutively in intestinal
epithelium, but upregulation was not seen following N. brasiliensis infection. This
was surprising since these molecules have been shown to be upregulated in other
inflammatory diseases including asthma (Teran, 2000) and inflammatory bowel
disease (Mazzucchelli et al, 1996; Vainer et al, 1998). Additionally, upregulation of
RANTES expression in a rat model of colitis was correlated with an increase in mast
cell numbers, this increase was abrogated by use ofMet-RANTES, a specific
antagonist ofRANTES receptors CCR1 and CCR5 (Ajuebor et al, 2001).
The observation of constitutive expression of TECK and fractalkine is in agreement
with previous studies, which have implicated these molecules in lymphocyte
trafficking (Wurbel et al, 2000; Muehlhoefer et al, 2000), but fractalkine has recently
also been shown to be chemotactic for mast cells (Papadopoulos et al, 2000).
Expression may therefore contribute towards non-inflammatory recruitment of the
small numbers ofmast cells that reside in the non-parasitised jejunum.
Expression of the cytokines SCF and TGF-Pi was also measured in epithelial
samples since these molecules are both growth factors for MMC homologues (Miller
et al, 1999), and chemoattractants for mast cells (Meininger et al, 1992; Gruber et al,
1994). Expression of SCF has been correlated with mast cell accumulation in
arthritis (Ceponis et al, 1998) and pollen allergies (Nilsson et al, 1998); and is
upregulated in intestinal epithelial cell cultures following infection with Salmonella
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typhimurium (Klimpel et al, 1996). Both molecules were expressed in epithelium in
this study, but no alteration in expression was seen following nematode infection.
There was no evidence for a change in expression of the majority of the
chemoattractants examined by RT-PCR following N. brasiliensis infection. One
reason for this may be that invasion and damage of epithelial cells is necessary to
evoke alteration in inflammatory gene transcription. This is considered to be the case
for bacterial infection of the gut because of the high bacterial load of normal gut
contents (Svanborg et al, 1999), and may explain the epithelial response to the
invasive parasite, T. spiralis (Stadnyk & Kearsey, 1996; Li et al, 1998), though
expression of a different set of chemokines was analysed in these studies. Alteration
of chemokine expression in response to non-invasive parasites may, however, be
possible via other mechanisms; excretory-secretory products are key allergens in the
immune response to N. brasiliensis and those from plerocoids of the parasite
Spirometra erinaceieuropaei can modulate chemokine expression in macrophages
(Fukumoto et al, 1997). The limitations ofRT-PCR in measurement of changes in
gene expression must also be considered; small changes in expression may not be
detected by the methods used and changes in expression may not correlate with
protein production.
The specific recruitment ofMMC following N. brasiliensis infection is difficult to
explain in the light of this evidence of constitutive expression of several mast cell
chemoattractants from intestinal epithelium, especially since chapter 4 shows that
cultured mBMMCT+ express several of the corresponding receptors for the
chemoattractants expressed. However, mast cell recruitment may depend on other
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chemoattractants that were not investigated in this study, or may be limited by other
factors, such as seeding ofmast cell precursors into tissues and expression of the
necessary integrins or proteases to allow cells to move through the extracellular
matrix.
Results from further investigation of the importance of other chemoattractants using
a macroarray (3.4.2) were consistent with constitutive expression ofRANTES,
TECK and MlP-la in intestinal epithelium. The macroarray also showed low level
expression of fractalkine, SDF-2 and PF-4 in uninfected epithelium. As PF-4 is
chemotactic for mast cells (Taub et al, 1995), its expression may contribute towards
mast cell recruitment. The function of SDF-2 has yet to be determined.
Because of the detection method used and the high background seen in the arrays,
these results would be unsuitable for reliable comparison of expression between the
two samples. Therefore, expression of chemokines only in uninfected epithelium
would need to be confirmed by repeat experiments after refinement of the technique,
and more quantitative techniques such as RT-PCR or real-time PCR.
Expression of other chemokines shown to be chemotactic for mast cells, including
eotaxin (Romagnani et al, 1999; Ochi et al, 1999) and SDF-la (Juremalm et al,
2000), was also examined using the macroarray, but mRNA levels were probably
below those detectable using this method.
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The data from Western blots and immunohistochemistry were disappointing. It is
possible that there were technical problems, but it is also likely that the techniques
were not sensitive enough to detect low levels of protein. Only expression ofMIP-
la was suggested at protein level (3.5.2); the MW shift in the presence of jejunal
extract may suggest dimer formation, as previously reported for MlP-la (Hoogewerf
et al, 1997). Other chemokines may have been below levels detectable by Western
blotting and immunohistochemistry using these antibodies.
Possibly because of low and transient expression, and the labile nature of these
molecules, chemokines are difficult to detect in tissue sections. Consequently, a
large number of studies rely on molecular techniques such as in .shw-hybridisation
(Mazzucchelli et al, 1996; Trautmann et al, 2000) and RT-PCR (Ajuebor et al,
2001). However, immunohistochemical detection ofMCP-1 has been reported in
human inflammatory bowel disease mucosa (Reinecker et al, 1995) and human
COPD airways (de Boer et al, 2000), and expression ofMlP-la was also detected by
immunohistochemistry in ulcerative colitis mucosa, though inappropriate "no
primary antibody" controls were used in this study (Vainer et al, 1998).
Reports of immunohistochemical detection of chemokines in mouse or rat tissue are
few, possibly due to limited availability of suitable antibodies, but expression of
MCP-1 has been detected in rat myocytes using a goat polyclonal antibody from
Santa Cruz Biotechnology (Reyes-Reyna et al, 2002).
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In conclusion, we have shown both increased expression ofMCP-1 mRNA following
N. brasiliensis infection, and constitutive expression ofmRNA for the chemokines
MlP-la, RANTES, TECK and fractalkine; and cytokines SCF and TGF-pi in murine
intestinal epithelium. These molecules could contribute towards recruitment ofmast
cells or their precursors into the jejunal epithelium.
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CHAPTER 4
CHEMOKINE RECEPTOR EXPRESSION DURING MAST CELL
DIFFERENTIATION IN CULTURE
4.1 INTRODUCTION
The experiments described in the previous chapter showed expression of a number of
chemokines and cytokines by murine intestinal epithelium, and expression of
putative mast cell chemoattractants MCP-1 (Mazzucchelli et al, 1996), RANTES
(Reinecker et al, 1995), MlP-la (Vainer et al, 1998) and fractalkine (Muehlhoefer et
al, 2000) has been shown in both normal and diseased human intestine. However, in
order to be recruited into the mucosa and epithelium by these chemoattractants,
MMC or their precursors would need to express the corresponding receptors.
Chemokines including MCP-1, MlP-la, RANTES, PF-4 (Taub et al, 1995),
fractalkine (Papadopoulos et al, 2000), IL-8 (Lippert et al, 1998; Nilsson et al,
1999), SDF-la (Juremalm et al, 2000) and eotaxin (Romagnani et al, 1999; Ochi et
al, 1999) are all chemotactic for mast cells in vitro, and expression ofmany of the
corresponding chemokine receptors has been identified.
MMC, however, differ phenotypically from the cultured mast cells used for previous
investigations of chemotaxis and chemokine receptor expression, and therefore may
differ in their expression of chemokine receptors. A growing body of evidence
suggests tissue-specific chemokine-mediated control of lymphocyte migration
(Kunkel & Butcher, 2002), and similar mechanisms may apply to MMC. Therefore
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expression of chemokine receptors by MMC may differ from that ofmast cells in
other tissues. As MMC are located intraepithelial^, they may express chemokine
receptors in common with IEL, which express CX3CR1, CCR3, CCR5 and CXCR3
(Muehlhoefer et al, 2000; Agace et al, 2000).
MMC differentiate from immature precursor cells during the course of their
migration (Friend et al, 1996), and changes in chemokine receptor expression during
mast cell differentiation may regulate this migration. Mast cell progenitors may
express chemokine receptors important in initial recruitment across vascular
endothelium, and those expressed by mature MMC could facilitate intraepithelial
migration. Study of chemokine receptor expression by mast cell progenitors is
limited by the difficulty of isolating these cells. However, in a recently developed in
vitro culture system, murine bone marrow cells can be induced to differentiate into
100% MMC-like homologues after 10 days of culture with IL-3, IL-9, SCF and
TGF-Pi (Wright et al, 2002). Although this system does not enable examination of
chemokine receptor expression by mast cell progenitors, investigation of chemokine
• T+ •
receptor expression during differentiation ofmBMMC would allow correlation
T+ •
with increasing numbers ofmBMMC over time.
As a key regulator of the mucosal phenotype (Miller et al, 1999), TGF-Pi may also
regulate expression of chemokine receptors important in intraepithelial mast cell
migration. Therefore, the initial aims of these experiments were to investigate
T+
chemokine receptor expression in mBMMC , to correlate trends in chemokine
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T+ • •
receptor expression with differentiation ofmBMMC in vitro and to investigate the
role of TGF-pi in control of chemokine receptor expression in mBMMC.
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4.2 PRELIMINARY INVESTIGATION OF CHEMOKINE RECEPTOR
EXPRESSION DURING MAST CELL DIFFERENTIATION IN VITRO IN
THE PRESENCE OR ABSENCE OF TGF-p!
4.2.1 Experimental aim and design
Having described some of the chemokines present in normal and parasitised jejunum
(chapter 3) the aim of this chapter was to investigate expression of chemokine
T+
receptors by mBMMC (MMC homologues). This preliminary experiment also
aimed to investigate chemokine receptor expression during differentiation of
mBMMC from bone marrow cells, and examine the effect of TGF-Pi on chemokine
receptor expression.
Bone marrow cells from 10 mice were pooled and allocated to mBMMC " and
mBMMCT+ cultures for up to 14 days (2.4.1). On day 10, the mBMMC1" culture
was divided into two and one culture supplemented with 10 ng/ml of anti-TGF-Pi
antibody, based on preliminary results from antibody titration (2.4.2), in order to
abrogate the effect of endogenous TGF-Pi on mast cell differentiation. At time-point
0 (at the time of bone marrow harvest), and on days 2, 4, 7 and 14 of culture, 2.5 x
106- 1 x 107 mBMMCT+ were removed into TRI reagent (2.4.10) for RNA extraction
(2.5.1). mBMMC1" were removed only on days 7 and 14 of culture as at earlier time
points, cells were used for titration of anti-TGF-Pi antibody (2.4.2). Additionally,
cytospin-preparations were made and stained with Leishman's (2.4.7), or fixed with
paraformadehyde (2.4.9) for mMCP-1 immunohistochemistry (2.10.3).
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Expression ofCCR1 - 5, and of CCR6 - 9 and CX3CR1 was examined in mBMMC
using CytoXpress™ mPCR kits CCR set 1 and set 2, respectively. These sets include
several chemokine receptors shown to be expressed by other mast cell phenotypes.
Expression ofCXCR2 and CXCR4 has also been shown in mast cells (Lippert et al,
1998; Nilsson et al, 1999; Juremalm et al, 2000) but primers amplifying these genes
were not included in the mPCR kits, therefore expression was investigated using RT-
PCR (2.5.1 - 2.5.7 and table 2.2).
4.2.2 Results
Leishman-stained cytospin preparations from cell cultures confirmed that mouse
bone marrow cells differentiated into mast cells, based on morphology (table 4.1).
Quantification ofmMCP-1 expression by immunohistochemistry (table 4.1) and RT-
PCR (figure 4.1) confirmed that differentiation into MMC homologues occurred in
cultures supplemented with TGF-pi.
Culture Time % MC % MMCh
(days) (Leishman's) (mMCP-1+)
mBMMCl + 0 0 0
2 7 2
4 53 29
7 97 98
14 99 100
mBMMC1"" 7 81 6
14 98 3
14* 98 0
Table 4.1. Cell counts from experiment 4.2.
Results show numbers ofmast cells (MC), as assessed by morphology on Leishman's
staining, and mucosal mast cell homologues (MMCh), as assessed by
immunohistochemical staining for expression ofmMCP-1.
500 cells were counted, * indicates inclusion of anti-TGF-Pi antibody in this culture.
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Expression of chemokine receptors varied during differentiation (figures 4.1 and
4.2), but there were no differences between mBMMC cultured with or without TGF-
pi. Expression ofCXCR2, CXCR4 (figure 4.1), CCR6 and CCR7 (figure 4.2b)
appeared to decrease, whereas expression ofCCR2 and CCR5 increased with time as
the percentage ofmast cells increased (figure 4.2a). CCR1 was expressed at all
stages, low expression ofCX3CR1 and CCR8 was detected in day 14 mBMMCT+
and no expression ofCCR3, 4 or 9 was detected in any cultures. On the basis of this,
a larger scale experiment was set up to confirm trends in chemokine receptor
expression during the differentiation ofmBMMCT+ in the presence of TGF-Pi.
TGF-p-i
GAPDH
4
+
14
Figure 4.1. Expression of chemokine receptors during mast cell differentiation
in experiment 4.2.
Downregulation ofCXCR2 and CXCR4 expression occurred during mast cell
differentiation. Expression ofmMCP-1 indicated differentiation into MMC
homologues in cultures supplemented with TGF-Pi.
Expression of both CXCR2 and CXCR4 was comparable in day 14 mast cells
cultured with and without the inclusion of TGF-Pi.
* indicates that this culture included chicken anti-human TGF-pi from day 10
onwards.
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Figure 4.2. Expression of chemokine receptors during mast cell differentiation
in experiment 4.2.
(a) Analysis ofCCR1 - 5 (CytoXpress™ CCR set 1 mPCR kit), showing expression
ofCCR1 in all samples and upregulation of expression ofCCR2 and CCR5
during mast cell differentiation.
(b) Analysis ofCCR6 - 9 and CX3CR1 (CytoXpress™ CCR set 2 mPCR kit),
showing high expression ofCCR7 in early cultures, but low expression in day 14
mBMMC. Expression ofCCR6 was also downregulated during mast cell
differentiation. Expression ofCCR8 and CX3CR1 was weakly detected in day
14 mBMMC.
Expression of chemokine receptors analysed using both multiplex kits was
comparable in day 14 mast cells cultured with and without TGF-Pi.
* indicates that this culture included chicken anti-human TGF-Pi from day 10
onwards.
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4.3 CHEMOKINE RECEPTOR EXPRESSION DURING MAST CELL
DIFFERENTIATION IN THE PRESENCE OF TGF-^
4.3.1 Experimental aim and design
The aim of this experiment was to further explore and to provide statistical
evaluation of the expression of chemokine receptors during mBMMCT+
differentiation in the presence of TGF-Pi. To ensure sufficient cell numbers on day 2
of culture, bone marrow cells from 7 mice were pooled for each of 4 replicate
T+mBMMC cultures. Samples were collected and processed, and chemokine
receptor expression investigated as in experiment 4.2, except that expression of
CXCR2 and CXCR4 was analysed by semi-quantitative RT-PCR (2.5.8) and relative
expression of chemokine receptors analysed using mPCR kits was also calculated as
described (2.6.1). In this experiment, mast cell differentiation was monitored using
both Leishman's (2.4.7) and toluidine blue (2.4.8) staining, as these are well-
established methods for identification ofmast cells (Enerback, 1966b).
4.3.2 Results
Examination of Leishman-stained cells and enumeration of toluidine blue-stained
cells in cytospin preparations confirmed that cultured mouse bone marrow cells
differentiated into mast cells (table 4.2). Differences between results from the two
methods were largely due to difficulties in identification of immature cells by both
methods in earlier cultures. 49% toluidine blue-positive cells on day 4 is similar to
results reported previously (Wright et al, 2002), but proportions ofmMCP-l+ cells
on day 4 and 7 were lower than in the previous experiment (table 4.1), and than
previously reported (Wright et al, 2002). The reason for this was unknown, but may
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have been the result of difficulties in accurately distinguishing positive cells against
the high background staining during immunohistochemical detection ofmMCP-1 for
this experiment. However, as expected, 100% ofmBMMCT+ on day 14 expressed
mMCP-1 (table 4.2) and RT-PCR analysis of expression ofmMCP-1 (figure 4.3a)
further confirmed the differentiation of bone marrow cells into MMC homologues.
Time (days) % MC % MC % MMCh
(Leishman's) (toluidine blue) (mMCP-1+)
0 0.0 (0.0 - 0.0) 0.0 (0.0 - 0.0) 0.0(0.0-0.0)
2 15.0(13.0-17.0) 18.5 (15.0-27.0) 0.0 (0.0 - 0.0)
4 61.0(58.0 -63.0) 48.5 (45.0- 55.0) 14.0(11.0-22.0)
7 98.0 (97.0 - 99.0) 94.5 (93.0 - 96.0) 69.5 (51.0 - 78.0)
14 100.0 (100.0 - 100.0) 99.0 (98.0- 100.0) 100.0(100.0 - 100.0)
Table 4.2. Cell counts from mBMMC1+ cultures in experiment 4.3.
Results show median (range) ofmast cells (MC), as assessed by Leishman's, and
toluidine blue staining; and ofmucosal mast cell homologues (MMCh), as assessed
by immunohistochemical staining for expression ofmMCP-1.
500 cells were counted in cytospin preparations from each of 4 cultures at each time-
point.
Analysis of chemokine receptor expression was generally in agreement with the
results of experiment 4.2. There was down-regulation of CXCR2, CXCR4 (figure
4.3a) and CCR7 (figure 4.3c) expression with time, though CXCR4 was still
detectable in mBMMCT+ on day 14. Expression ofCXCR2 was significantly lower
on day 14 than on days 0 (p<0.01) and 2 (p<0.05)(figure 4.4) and expression of
CXCR4 on both days 7 and 14 was significantly lower than on day 0 (p<0.05)(figure
4.4).
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Figure 4.3. Expression of chemokine receptors during differentiation of
mBMMCT+ (MMC homologues) in experiment 4.3.
(a) Semi-quantitative RT-PCR showed down-regulation of expression of CXCR2
and CXCR4 as mMCP-1 expression increased.
(b) Analysis ofCCR1 - 5 using CytoXpress™ CCR set 1 mPCR kit showed
expression ofCCR1 at all stages ofmast cell differentiation and upregulation of
CCR2 and CCR5 on days 7 and 14.
(c) Analysis ofCCR6 - 9 and CX3CR1 using CytoXpress™ CCR set 2 mPCR kit
showed downregulation ofCCR7 and upregulation ofCX3CR1 expression.
Weak expression of CCR6 in several cultures, and ofCCR8 mainly in day 7 and
14 cultures was also detected.
Results are representative gels from quadruplicate cultures. + - positive control.
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Figure 4.4. Relative expression of chemokine receptors CXCR2 and CXCR4,
T+
(MMC homologues) inand mMCP-1 during differentiation of mBMMC
experiment 4.3.
Expression of chemokine receptors and mMCP-1 was analysed over 14 days during
culture ofmBMMCT+from murine bone marrow cells.
Results are shown as median (range), n=4 cultures, and statistical analysis was
performed using the Kruskal-Wallis test, with Dunn's multiple comparison post-test.
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Figure 4.5. Relative expression of chemokine receptors CCR1, CCR2 and
CCR5 during differentiation ofmBMMCT+ (MMC homologues) in experiment
4.3.
Expression of chemokine receptors was analysed over 14 days during culture of
mBMMCT+ from murine bone marrow cells.
Results are shown as median (range), n=4 cultures, and statistical analysis was
performed using the Kruskal-Wallis test, with Dunn's multiple comparison post-test.
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Figure 4.6. Relative expression of chemokine receptors CCR6, CCR7, CCR8
,T+
(MMC homologues) inand CX3CR1 during differentiation of mBMMC
experiment 4.3.
Expression of chemokine receptors was analysed over 14 days during culture of
mBMMCT+ from murine bone marrow cells.
Results are shown as median (range), n=4 cultures, and statistical analysis was
performed using the Kruskal-Wallis test, with Dunn's multiple comparison post-test.
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CCR2 and CCR5 were expressed on days 7 and 14 (figure 4.3b). However, though
there was a trend towards increasing expression of CCR2 and CCR5 with time,
strong expression was also detected in some day 0 samples (figure 4.5). Expression
ofCCR2 was significantly (p<0.01) greater on day 7 than on day 2, and CCR5
expression was significantly (p<0.01) greater on day 14 than on day 2 (figure 4.5).
Expression of CX3CR1 also increased with time, and was significantly greater
(p<0.05) on day 14 than on days 0 and 2 (figure 4.6).
Expression of CCR1 at all time points was confirmed, (figure 4.3b), with no
significant differences between cultures (figure 4.5). Expression ofCCR6 was low
in all samples (figure 4.3) and, as suggested by the previous experiment, there was a
slight trend towards decreasing expression with time. Values were significantly
lower (p<0.05) than day 0 on day 7, but not on day 14, when weak expression was
detected in all samples (figure 4.6). As described in 2.6.2, the lower intensity of this
band in the positive control suggests less efficient amplification ofCCR6 than of
other PCR products in this kit, thus, in reality, expression relative to other receptors
may be higher than shown. Low expression of CCR8 was detected mainly in day 7
and 14 cultures and there was a slight trend towards increasing expression with time
(figure 4.6), but this was not significant. As shown in the previous experiment,
expression of CCR3, CCR4 and CCR9 was below detectable levels in all cultures.
Since the manufacturers claimed that amplification efficiencies of each primer pair
were equivalent within Biosource multiplex PCR kits, relative expression of those
chemokine receptors detected could be compared. Therefore, expression of different
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chemokine receptors in day 14 mBMMCT+ was compared as, at this stage of
differentiation, cultures contain a homogeneous population of cells representative of
mucosal mast cells. The levels of expression of chemokine receptors analysed by
different kits could not be compared, as their amplification efficiencies may be
different.
Expression ofmRNA for chemokine receptors CCR1 - 5 was investigated using a
CytoXpress™ CCR set 1 mPCR kit. Expression of CCR1, 2, and 5 was detected in
14 day old mBMMCT+, but no significant differences in levels of expression between
any of the 3 receptors were found using the Mann-Whitney U test (figure 4.7). As
stated above, expression ofCCR3 and CCR4 was not detected, implying that mRNA
for these chemokines was expressed at lower levels than for CCR1, 2 and 5.
mRNA for chemokine receptors CCR6 - 9 and CX3CR1 was amplified using a
CytoXpress™ CCR set 2 mPCR kit. CX3CR1 was the most highly expressed
receptor of this set in mBMMCT+ (figure 4.7). CCR6, 7 and 8 were expressed at
much lower levels, and mRNA levels ofCCR7 were found to be significantly
(p<0.05) lower than those of CX3CR1 using the Kruskal-Wallis test with Dunn's
multiple comparison post-test. Expression of CCR9 was below detectable levels in
mBMMCT+
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Figure 4.7. Relative expression of chemokine receptors by MMC homologues
analysed in experiment 4.3 using mPCR.
(a) Expression ofCCR1 - 5, analysed using CytoXpress™ CCR set 1 mPCR kit.
There was no significant difference between expression of CCR1, 2 and 5 using
the Mann-Whitney U test, and expression ofCCR3 and 4 was not detected.
(b) Expression of CCR6 - 9 and CX3CR1, analysed using CytoXpress™ CCR set 1
mPCR kit. Expression of CX3CR1 was significantly greater (p<0.05) than CCR7
using the Kruskal-Wallis test with Dunn's multiple comparison post-test.
Expression ofCCR9 was not detected. Results are expressed as median (range),
n=4.
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4.4 EXPRESSION OF CHEMOKINE RECEPTORS IN MURINE JEJUNAL
EPITHELIUM
4.4.1 Experimental aim and design
Expression of transcripts for several chemokine receptors has been shown by
mBMMCT+, but it is not known if these receptors are expressed by intraepithelial
MMC in vivo. If expression of chemokine receptors by MMC was high, this might
be reflected by increased expression of these receptors in intestinal epithelium on
days 7 and 14 post-infection, when mast cell recruitment is at a maximum (3.2.2.2).
Expression of chemokine receptors in control (uninfected) murine jejunal epithelium,
and in jejunal epithelium collected on days 7 and 14 post-TV. brasiliensis infection for
use in experiment 3.2 was therefore analysed. As in experiments 4.2 and 4.3,
expression ofCCR1 - 9 and CX3CR1 was analysed using mPCR (2.6), and CXCR2
and CXCR4 were analysed by RT-PCR (2.5.1 - 2.5.8). Additionally, expression was
analysed in 3 samples of CMT-93 cells (2.4.4).
4.4.2 Results
Chemokine receptor expression in the majority of jejunal epithelial samples was
below levels detectable by the mPCR kits under the conditions used. However,
expression ofmRNA for CCR1, 2 and 5 was detected in epithelium from one
uninfected mouse; expression of CCR1, 2, 3 and 5 was detected in one sample
collected on day 7 and expression of CCR1 only was detectable in one sample
collected on day 14 post-infection with TV. brasiliensis, using CCR set 1 (figure 4.8).
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Figure 4.8. Expression of chemokine receptors in murine jejunal epithelium
during N. brasiliensis infection.
a) Expression ofCCR1 - 5, analysed using CytoXpress™ CCR set 1 mPCR kit.
CCR1, 2 and 5 were expressed in epithelium from an uninfected mouse and a
mouse infected 7 days previously. Expression ofCCR3 in epithelium collected
on day 7, and ofCCR1 in epithelium collected on day 14 post-infection was also
detected.
b) Expression ofCCR6 - 9 and CX3CR1, analysed using CytoXpress™ CCR set 2
mPCR kit. Expression ofCCR7 in uninfected epithelium, and ofCCR7 and
CX3CR1 in epithelium collected 14 days after infection was detected.
c) Expression ofCCR6 - 9 and CX3CR1 in CMT 93 epithelial cells, analysed as
above. CCR7 was expressed in all three samples.
+ positive, - negative control.
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Using CCR set 2, expression ofCX3CR1 and CCR7 was detected in an epithelial
sample collected on day 14 post-iV. brasiliensis infection, and expression ofCCR7
was also detected in epithelium from one uninfected mouse.
Expression ofCCR7 was detected in all three samples ofCMT-93 epithelial cells
(figure 4.8) suggesting epithelial cells as a potential source of expression of this
receptor, but expression of chemokine receptors analysed using CCR set 1 was below
detectable levels in CMT-93 cells (not shown).
Figure 4.9. Expression of chemokine receptors in murine jejunal epithelium
during N. brasiliensis infection.
Expression ofCXCR4 was detected in all except one epithelial sample.
CXCR2 was expressed only in epithelial samples collected on day 7 post-infection,
and was below detectable levels in epithelium from uninfected mice and from mice
infected 14 days previously.
Using RT-PCR, weak expression ofCXCR4 was detected in all jejunal epithelial
samples with the exception of one sample collected on day 14 post-infection (figure
4.9), but expression ofCXCR4 was below detectable levels in CMT-93 cells (not
shown). CXCR2, which was not detectable in mBMMCT+, was undetectable in
CMT-93 cells (not shown) but was expressed in epithelial samples collected on day 7
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post-vV. brasiliensis infection only. This may represent an upregulation of expression
on day 7 post-infection, but semi-quantitative analysis of expression would be
required to confirm this. Saturation of the GAPDH signal in some samples, and the
lack of detectable bands in uninfected epithelium and epithelium collected on day 14
post-infection would lead to inaccuracies in comparison of expression semi-
quantitatively, therefore this was not attempted.
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4.5 DISCUSSION
Chemokine receptors CCR1, CCR2, CCR5 and CX3CR1 were most strongly
expressed by mature mBMMCT+, and experiments described in chapter 3 showed
expression of several potential chemokine ligands for these receptors by intestinal
epithelium, including RANTES, MlP-la and fractalkine.
Chemokine receptor expression by mBMMCT+ shares similarities with expression in
other MC phenotypes. IL3-dependent mBMMC, which resemble MMC in that they
contain chondroitin sulphate proteoglycan (Razin et al, 1984; Haig et al, 1988),
migrate towards chemokine ligands for CCR1, 2 and 5 (Taub et al, 1995) and
express CX3CR1 (Papadopoulos et al, 2000), and mBMMC cultured in IL-3 and
SCF express functional CCR1, 2, 3 and 5 (Oliveira & Lukacs, 2001). mBMMC
cultured in IL-4 and SCF, and used to represent connective tissue MC, and freshly
harvested human skin MC, also express CX3CR1 (Papadopoulos et al, 2000).
hCBMC cultured for 4 weeks in SCF, IL-6 and IL-10, and said to represent mast cell
progenitors, expressed CCR5 and CXCR4, along with CXCR2 and CCR3 which are
T I
not expressed by mBMMC .
Expression of the same chemokine receptors by MC of different phenotypes and
cultured in the presence of different cytokines brings into question the role ofMC
growth factors in regulation of chemokine receptor expression. Experiment 4.2
showed TGF-Pi to have no effect on chemokine receptor expression in mBMMC, but
Oliveira & Lukacs (Oliveira & Lukacs, 2001) noted upregulation of several CC
chemokine receptors by SCF. However, the same receptors are expressed by mast
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cells cultured in IL-3 only (Taub et al, 1995), therefore chemokine receptor
expression by mast cells may be regulated by several overlapping pathways or may
be programmed in mature mast cells irrespective of phenotype.
mBMMCT+ express receptors to chemokines frequently associated with
inflammatory and allergic diseases, such as asthma and IBD (Conti et al, 1999;
Homey & Zlotnik, 1999; Macdermott, 1999; Teran, 2000), where mast cells have a
proposed role in the pathogenesis. Furthermore, the chemokine receptors expressed
T-f-
by mBMMC are consistent with those implicated in recruitment ofMC in
inflammatory states. Administration ofmet-RANTES, a specific inhibitor of CCR1
and CCR5, reduced recruitment ofmast cells into the colon in a rat model of chronic
colitis (Ajuebor et al, 2001). Also, in COPD in humans, increased MCP-1
expression by bronchiolar epithelial cells correlated with CCR2 expression on mast
cells and increased numbers intraepithelially (de Boer et al, 2000). Low expression
ofMCP-1 in jejunal epithelium suggests that CCR2 is unlikely to regulate MMC
recruitment following N. brasiliensis infection, but this receptor may control MMC
recruitment in other tissues or inflammatory diseases.
T i
CCR5 and CX3CR1, which are expressed by mBMMC , are also expressed by IEL
(Muehlhoefer et al, 2000; Agace et al, 2000), and are thought to play a role in
lymphocyte recruitment under inflammatory conditions. If comparable expression of
chemokine receptors occurs by MMC in vivo, it would suggest recruitment
mechanisms that are common in both cell types; further work should be directed
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T+
towards investigation of the expression, by mBMMC , of the IEL-expressed
chemokine receptor, CXCR3, (Agace et al, 2000).
Chemokine receptors expressed by mBMMCT+ are expressed by both TH1 and TH2
cells. mBMMCT+ expressed mRNA for CCR5, which is expressed by TH1 cells
(Rottman, 1999; Homey & Zlotnik, 1999) and weak expression of CCR8, a TH2
chemokine receptor, was also detected. Other TH2-type chemokine receptors, CCR3
and CCR4, were not expressed, so that a marked polarisation towards the pattern
seen in TH1 or TH2 subsets was not present. The chemokine receptor expression
T,
profile ofmBMMC is also similar to that reported in monocytes, which express
CCR1, 2, 5 and 8; CXCR4 and CX3CR1 (Rottman, 1999).
Other notable absences from the chemokine receptor profile ofmBMMCT+ included
CCR3 and CCR9. Expression of CCR3 has been previously shown in hCBMC
cultured in IL-6, SCF and IL-10 (Ochi et al, 1999), human skin mast cells
(Romagnani et al, 1999), TH2 cells, basophils and eosinophils (Ochi et al, 1999).
Expression of the CCR3 chemokine ligand, eotaxin, has been demonstrated in the
bronchial mucosa of asthmatic patients and in allergic dermatitis (Homey & Zlotnik,
1999), and, as mast cells are key players in allergic reactions, it is perhaps surprising
that CCR3 expression in mBMMCT+ was below detectable levels.
CCR9 transcripts were also below detectable levels in mBMMCT+. The CCR9
ligand TECK is almost exclusively expressed by small intestinal epithelium and a
key role has been suggested for CCR9 in recruitment of T-cells including IEL to
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mucosal sites (Wurbel et al, 2000; Kunkel et al, 2000). As previously stated,
T"F •mBMMC , in common with IEL, express CCR5 and CX3CR1, but these receptors
are thought to recruit lymphocytes in inflammatory states (Muehlhoefer et al, 2000;
Agace et al, 2000). The primary involvement of CCR9 in basal lymphocyte
trafficking may explain the lack of expression by mBMMCT+, as homologues of
MMC which are recruited primarily in allergic reactions, and may not traffic at all.
Low CCR6 expression by mBMMCT+ is not surprising as this receptor is expressed
mainly on memory T-cells, B cells and dendritic cells (Murdoch & Finn, 2000), and
is involved in specific recruitment of Langerhan's cell precursors to the skin (Caux et
al, 2000).
The changes in chemokine receptor expression during mast cell differentiation
should be interpreted with care, as in the earlier stages of culture, a mixed population
of cells is present in which there are few mast cells. Therefore whilst it is probable
that receptors such as CCR7 and CXCR2, which are highly expressed in early
cultures but expressed at low-to-undetectable levels in mature mBMMC do not
play a key role in intraepithelial mast cell migration, it is not yet clear whether mast
cell progenitors present in earlier cultures express these receptors. As CCR7 is
expressed in mature dendritic cells (Caux et al, 2000) and memory and effector T-
cells (Kunkel & Butcher, 2002), and is important in homing to lymph nodes, loss of
this receptor from cultures as mast cell numbers increase is not surprising. However,
CXCR2, which is primarily expressed by neutrophils (Rottman, 1999), is also
expressed by HMC-1 cells (Lippert et al, 1998; Nilsson et al, 1999). The latter are
often described as an immature mast cell phenotype, therefore CXCR2 may be
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expressed by mast cell progenitors and play a role in the initial recruitment into
tissues, but may be down-regulated in mature MMC. In support of this, Ochi et al
(Ochi et al, 1999) found expression of CXCR2 in hPrMC but not in mature mast
cells.
The same group also found expression ofCXCR4 in hPrMC but not mature cells,
and in our experiments, CXCR4 was down-regulated during mast cell differentiation,
T+
but still detectable in mature mBMMC . Therefore, CXCR4 may also be important
in migration ofmature cells and Juremalm et al (Juremalm et al, 2000) showed
expression ofCXCR4 by cultured cells resembling both immature and mature mast
cell phenotypes. However, as the CXCR4 ligand SDF-1 is expressed mainly by
stromal cells and not epithelium, its main role may be in recruitment ofmast cell
progenitors, as suggested by others (Juremalm et al, 2000; Lin et al, 2000).
Upregulation of CCR2 and 5 and CX3CR1 during mast cell differentiation indicates
their probable importance in the mature phenotype, but variable expression of CCR2
and 5 in freshly isolated bone marrow cells is not in keeping with this trend. The
reason for this is unknown, and may be due to the presence of a mixed cell
population; further experiments to investigate chemokine receptor expression by
mast cell progenitors would clarify the picture. In contrast to our findings, Ochi et al
(Ochi et al, 1999) suggested down-regulation of expression of CCR5 during
differentiation of hCBMC in IL-6, IL-10 and SCF. This may reflect differences in
the cytokines used to culture these cell types.
165
Additional experimental work is required to resolve the problem of chemokine
receptor expression in mast cell progenitors, and to further investigate the role of
chemokine receptor expression by mast cells in intraepithelial migration; this is
discussed in the final chapter.
Weak expression ofmRNA for several chemokine receptors including CCR1, 2, 3, 5,
7 and CX3CR1 was detected in jejunal epithelium, and expression ofCXCR4 was
detected in all but one jejunal epithelial sample. However, no pattern emerged which
would suggest intraepithelial MMC as the source of expression. Epithelial cells
themselves may express these chemokines; in support of this, CMT-93 cells
expressed CCR7 and human intestinal epithelial cells lines express CCR1 - 8 and
CXCR4 (Dwinell et al, 2001); expression of CX3CR1 has not been investigated.
Detection ofCXCR2 mRNA only in epithelium collected 7 days post-infection with
N. brasiliensis may result from more target cDNA being present in these samples, or
expression may truly be higher. If this is the case, the cellular source of expression is
debatable as CXCR2 is primarily expressed by neutrophils (Rottman, 1999), which
are not a major feature of the immune response to N. brasiliensis. However, low
numbers of contaminating neutrophils were present in some epithelial samples (table
3.1). Expression ofCXCR2 was not detected in mBMMCT+, making MMC a less
likely source of expression. Furthermore, expression was not detected in CMT-93
epithelial cells, but low expression in other human intestinal epithelial cell lines
(Dwinell et al, 2001), suggests epithelial cells as a possible source of this receptor.
Further optimisation of the semi-quantitative RT-PCR method, or other more
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quantitative methods would be required to confirm upregulation ofCXCR2 in jejunal
epithelium from N. brasiliensis infected mice.
The multiplex PCR method was useful as a screening technique to analyse
expression of several chemokine receptor genes at once, and the ability to analyse
relative expression ofmRNAs was a useful indicator of their likely importance.
However, the limitations of these kits for semi-quantitative analysis should be
appreciated. Also, receptors for which mRNA was not detected may have been
expressed at a level undetectable by the method used.
In conclusion, this study suggests that the chemokine receptor expression profile of
mBMMCT+ shares some similarities but is distinct from those previously reported in
other mast cell phenotypes and IEL. \
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CHAPTER 5
ADHESION OF mBMMC TO EXTRACELLULAR MATRIX PROTEINS
5.1 INTRODUCTION
In this thesis it has been speculated that chemotactic molecules may direct MMC or
their precursors across the intestinal lamina propria and into the epithelium.
However, migration and location of different types of cells, including immune cells,
within tissues is also regulated by other factors including the ability to adhere to the
extracellular matrix (ECM)(Springer, 1994).
As described in 1.9.3 and 1.9.4, the ECM is a complex network of high molecular
weight proteins. Proteins such as type I collagen, fibronectin and vitronectin make
up the ECM of the intestinal lamina propria, whereas laminin and type IV collagen
are components of basement membranes, which support epithelia throughout the
body (Hynes, 1993; Mosher, 1993; Olson, 1993a; Olson, 1993b). Adhesion of
several mast cell phenotypes to ECM proteins has been described. Murine IL-3-
dependent BMMC and several murine mast cell lines (Thompson et al, 1989a;
Dastych et al, 1991; Bianchine et al, 1992), human skin mast cells (Columbo et al,
1995) (Columbo & Bochner, 2001) and HMC-1 cells (Kruger-Krasagakes et al,
1996) adhere to laminin, fibronectin and vitronectin; HMC-1 cells also adhere to type
I and type IV collagens (Kruger-Krasagakes et al, 1996).
Stimulation by PMA or FcsRI cross-linking is generally required for adhesion of
murine mast cells to ECM proteins (Thompson et al, 1989a; Dastych et al, 1991), but
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adhesion can also be regulated by cytokines. SCF stimulates adhesion of IL-3-
dependent mBMMC to fibronectin (Dastych & Metcalfe, 1994) and of human
intestinal mast cells to fibronectin, laminin and several collagens (Lorentz et al,
2002). Culture of IL-3-dependent mBMMC with TGF-pi for up to 48 h also
increased adhesion to laminin-1 (Thompson et al, 1990), and since this phenomenon
occurred over a prolonged period of time, the mechanism was suggested to be
regulation of expression of integrins, the major molecules mediating cell adhesion to
the ECM.
As previously described, TGF-pi regulates in vitro differentiation of bone marrow
cells into cells resembling MMC in the mouse (mBMMCT+, 2.4.1) (Miller et al,
1999) but their adhesion to ECM has not been studied. Previous work has shown
regulation of expression of integrins during mast cell differentiation (Gurish et al,
1992a; Smith et al, 1994), therefore it was hypothesised that TGF-Pi might also
T+
regulate adhesion ofmBMMC , possibly by alteration of integrins expressed. Since
MMC are located intraepithelially (Scudamore et al, 1997) our current hypothesis is
that TGF-Pi might upregulate adhesion to basement membrane proteins such as
laminin, and that this might facilitate intraepithelial location.
• • T-F
The aim of these studies, therefore, was to investigate the adhesion ofmBMMC to
ECM proteins, and to evaluate the effect of TGF-Pi and ofmast cell activating agents
on the adhesion process.
169
5.2 PRELIMINARY INVESTIGATION OF THE ADHESION OF mBMMCT+
TO ECM PROTEINS
5.2.1 Experimental aim and design
Adhesion of unstimulated mBMMCT+ to laminin-1, fibronectin, vitronectin and
collagens type I and IV was investigated first, as previous studies have shown
adhesion ofmast cells to these proteins. Other work (Thompson et al, 1989a;
Dastych et al, 1991; Bianchine et al, 1992) suggested 20 pg/ml to be the optimum
concentration for the ECM proteins examined, therefore ELISA plate wells were
coated, in triplicate, with proteins at 20 pg/ml, or with 3% BSA in PBS as a negative
control. Maximal adhesion of murine and human mast cells was reported after
incubation for 60 min in most previous studies (Thompson et al, 1989a; Dastych et
al, 1991; Kruger-Krasagakes et al, 1996), therefore adhesion ofmBMMC to laminin-
1, fibronectin, vitronectin, type I collagen and type IV collagen was investigated after
1 or 2h to confirm the optimum timing for mBMMCT+. Adhesion assays were
performed as described in 2.11.1 and 2.11.2.
5.2.2 Results
After incubation for 1 h, mBMMCT+ adhered spontaneously to laminin-1 (42.6%
(38.3 - 58.1%)(median (range), n=3) and a much smaller proportion (4.3% (5.3 -
6.0%)) adhered to fibronectin (figure 5.1). After 2 h, no cells were adherent to
fibronectin, and a lower number of cells (26.6% (25.0 - 54.5%)) adhered to laminin-
1. mBMMCT+ adherent to laminin-1 flattened and took on a polarised morphology,
and a smaller proportion ofmBMMCT+ were flattened onto fibronectin coated wells,
T I
#
but did not become polarised. mBMMC did not adhere to vitronectin, type I
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collagen or type IV collagen. The above experiment was repeated twice (once for 2
h incubation), with similar results (appendix 2, table A2.1).
In summary, mBMMCT+ flattened and adhered to laminin-1 (20 pg/ml), and 60 min
was confirmed as a suitable incubation time for investigation of the adhesion of
mBMMCT+ to ECM proteins.
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Figure 5.1. Adhesion of unstimulated mBMMCT+ to extracellular matrix
proteins.
5 x 104 mBMMCT+ suspended in 100 pi of culture medium (without cytokines) were
incubated for 1 or 2 h in wells coated with type I collagen, type IV collagen,
fibronectin, vitronectin or laminin-1 at 20 pg/ml. Wells coated with 3% BSA were
also included as negative controls.
Results are expressed as median (range)(n=3 wells) of one representative experiment,
which was repeated twice (once for 2 h investigations), with similar results.
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5.3 THE EFFECT OF PMA AND SUPPLEMENTATION WITH TGF-p! ON
ADHESION OF mBMMC TO LAMININ-1
5.3.1 Experimental aim and design
Though initial experiments showed spontaneous adhesion ofmBMMCT+ to laminin-
1, this was inconsistent, with subsequent experiments showing more variable results
(data not shown). Previous studies (Thompson et dl, 1990) showed a requirement for
cell activation using agents such as PMA for adhesion ofmast cells to laminin,
therefore the effect ofPMA on adhesion ofmBMMCT+ to laminin-1 was
investigated.
As discussed in 5.1, we also wished to investigate the effect of supplementing with
TGF-P i on adhesion ofmBMMC to laminin, therefore adhesion ofmBMMC1"
(cultured without TGF-Pi) and mBMMCT+ (cultured with TGF-Pi) to laminin-1 (20
pg/ml) was examined in the presence or absence of 50 ng/ml PMA, which was added
immediately after loading cells into wells. This concentration ofPMA was shown by
others to stimulate adhesion of IL-3-dependent mBMMC to ECM proteins
(Thompson et al, 1989a; Dastych et al, 1991). The possible requirement for anti-
TGF-Pi in culture ofmBMMC7" was investigated in 2.4.2, where it was concluded
+ T
that low numbers of mMCP-1 cells were present in mBMMC " cultured without
T •
antibody. Therefore, mBMMC " for this and subsequent experiments were cultured
without anti-TGF-Pi antibody, and numbers ofmMCP-l+ cells were generally below
2%.
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5.3.2 Results
Addition ofPMA significantly (p<0.05) increased adhesion ofmBMMCT+ to
laminin-1 from 3.3% (1.6 - 3.5%) (median (range), n=4) to 28.2% (26.6 - 33.6%)
(figure 5.2). In contrast, adhesion of both control (0.0% (0.0 - 0.0%) and PMA-
stimulated (2.2% (1.0 - 11.0%) mBMMC7" to laminin-1 was low. Adhesion of
PMA-stimulated mBMMCT+ to laminin-1 was significantly higher (p<0.05) than that
ofmBMMC1". Adhesion of both mBMMC1" and mBMMCT+ to BSA was <1% (not
shown).
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Figure 5.2. Adhesion of control and PMA (50 ng/ml)-stimulated mBMMC7" and
mBMMCT+ to laminin-1 (20 pg/ml).
Ti
PMA significantly (p<0.05) increased adhesion ofmBMMC to laminin-1, and the
proportion ofmBMMCT+ adherent to laminin-1 was significantly higher (p<0.05)
than that ofmBMMC7".
Results are expressed as median (range) of one experiment, n=4 wells.
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5.4 THE EFFECT OF TGF-p1 ON ADHESION OF mBMMC TO ECM
PROTEINS
5.4.1 Experimental aim and design
As mBMMC1" showed little adhesion to laminin-1, the effect ofmBMMC culture
with and without TGF-Pi on adhesion to laminin-1 and other ECM proteins
fibronectin, vitronectin, type I collagen and type IV collagen was further
investigated. Proteins were coated at 20 pg/ml (2.11.1), and adhesion of
unstimulated and PMA-stimulated cells was investigated after incubation for 1 h, as
described in 2.11.2. After this experiment, optimisation experiments were set up to
confirm that the concentrations of protein solutions used to coat wells (5.5), and the
PMA concentration used resulted in maximum cell adhesion (5.6); and to confirm the
validity of the P-hexoseaminidase assay for estimation of adhesion ofmast cells to
ECM proteins (5.7). The experiment was then repeated 3 times using cells from
different cultures.
5.4.2 Results
Results, expressed as median (range) of the medians from each of 4 experiments,
showed that a proportion (23.0% (5.5 - 57.7%)) ofmBMMCT+ adhered
spontaneously to laminin-1, but there was much variability between cultures (figure
T_i_
5.3a; appendix 2, table A2.2). Adhesion ofmBMMC to laminin-1 increased to
56.4% (51.8 - 67.4%) following PMA stimulation (figure 5.3a), and adhesion of both
control (unstimulated) and PMA-stimulated populations ofmBMMCT+ was
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Figure 5.3. Adhesion of unstimulated (control) and PMA-stimuIated mBMMC
T-
T+and mBMMC to (a) laminin-1, (b) fibronectin and (c) vitronectin.
mBMMCT+ grown in the presence of TGF-Pi adhered to laminin-1, but not to
fibronectin or vitronectin, whereas mBMMC1" grown in the absence of TGF-Pi
adhered poorly to laminin-1, but adhered to fibronectin and vitronectin following
PMA-stimulation.
Adhesion of both control and PMA-stimulated mBMMCT+ to laminin was
significantly greater (p<0.05) than adhesion of equivalently-stimulated mBMMC7".
Also, adhesion ofmBMMC7" to fibronectin and vitronectin was significantly greater
(p<0.05) than adhesion of PMA-stimulated mBMMCT+.
Results are expressed as median (range) of the medians from 4 separate experiments,
each performed in quadruplicate wells and using cells from 4 different cultures
(appendix 2, table A2.2).
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Figure 5.4. Adhesion of unstimulated (control) and PMA-stimuIated mBMMC7
and mBMMCT+ to (a) type I collagen, (b) type IV collagen and (c) BSA.
mBMMC " adhered to type I collagen in two experiments, and type IV collagen in
one experiment (see appendix 2, table A2.3), but this was inconsistent, therefore not
statistically significant. Adhesion of both mBMMC7" and mBMMC7+ to BSA was
<2% in all experiments.
Results are median (range) of the medians from 4 separate experiments, each
performed in quadruplicate wells and using cells from 4 different cultures.
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(a)
(b)
(c)
Figure 5.5. Adhesion ofPMA-stimulated mBMMC to ECM proteins.
mBMMCT+ adhered to laminin-1 (a), the inset shows the lack of adhesion of
mBMMC1" on the same surface.
mBMMC1" adhere to fibronectin (b) and vitronectin (c). Insets show the lack of
adhesion ofmBMMCT+ on these surfaces.
177
significantly greater (p<0.05) than that of equivalently-stimulated mBMMCT\ A
small proportion (6.7% (0.0 - 14.5%)) ofmBMMCT+ also adhered to fibronectin
following PMA-stimulation.
As previously shown (experiment 5.3) neither control nor PMA-stimulated
mBMMC7" adhered to laminin-1. However, control (unstimulated) mBMMC1"
exhibited low (2.9% (0.8 - 19.2%)) spontaneous adhesion to fibronectin (figure 5.3b;
appendix 2, table A2.2) and, after PMA stimulation, mBMMC7" adhered to
fibronectin (67.5% (51.0 - 81.5%)) and vitronectin (40.2% (5.5 - 67.3%)) at levels
which were significantly greater (p<0.05) than those observed for mBMMCT+ (figure
5.3b and c; appendix 2, table A2.2). PMA-stimulated mBMMC7" also adhered to
collagens in some experiments (figure 5.4; appendix 2, table A2.3), but this was
variable, and there were no significant differences between adhesion ofmBMMC7"
and mBMMC7+ to type I or type IV collagen. mBMMC7+ adherent to laminin-1
flattened and took on a more polarised morphology (figure 5.5), and mBMMC7"
flattened onto wells coated with fibronectin or vitronectin. In all experiments,
mBMMC adhesion to BSA was <2% (appendix 2, table A2.3).
5.5 CONFIRMATION OF OPTIMUM COATING CONCENTRATIONS OF
ECM PROTEINS
5.5.7 Experimental aim and design
To confirm that concentrations ofECM protein solutions used for coating ofwells in
experiment 5.4 resulted in maximal cell adhesion, dose-response experiments were
Ti
performed. PMA (50 ng/ml)-stimulated mBMMC were incubated (in
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quadruplicates) in wells coated with 2.5, 5, 10, 20 or 50 pg/ml of laminin-1, and
PMA-stimulated mBMMC " were incubated (in quadruplicate) in wells coated with
0.5, 1, 2, 5, 10, 20 or 50 pg/ml of fibronectin; 2.5, 5, 10 or 20 pg/ml of vitronectin or
2.5, 5, 10, 20 or 50 pg/ml of type I collagen. Wells coated with BSA served as "0
pg/ml" controls. Cell adhesion was measured as described in 2.11.2.
5.5.2 Results
A high proportion of both mBMMC1" and mBMMCT+ adhered to ECM proteins even
at the lowest coating concentrations (figure 5.6) and maximal adhesion of
X+ • •
mBMMC to laminin-1 was obtained on wells coated with 20 pg/ml. Maximum
adhesion ofmBMMC1" to fibronectin was obtained on wells coated with 50 pg/ml,
but high (89% ofmaximum) adhesion was obtained on wells coated with 20 pg/ml,
therefore 20 pg/ml of both laminin-1 and fibronectin was considered acceptable for
• X
further experiments. Adhesion ofmBMMC " to vitronectin reached a maximum at
10 pg/ml, therefore this concentration was used for further experiments due to the
• T
high cost of this reagent. Adhesion ofmBMMC " to type I collagen appeared to
peak when coating was at 5 pg/ml, but was variable, therefore 20 pg/ml was
considered acceptable for coating in further experiments. These results show that
mBMMC7" and mBMMCT+ adhere to ECM proteins when coated at similar
concentrations to those required for adhesion of IL-3-dependent mBMMC
(Thompson et al, 1989a; Dastych et al, 1991; Bianchine et al, 1992).
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Figure 5.6. The effect of varying concentrations of ECM proteins on adhesion
of PMA-stimulated mBMMC.
Adhesion ofmBMMCT+ to laminin-l(a), and ofmBMMC1" to fibronectin (b),
vitronectin (c) and type I collagen (d).
These results confirm that there is close to maximum adhesion ofmBMMC on wells
coated with 20 pg/ml laminin-1, fibronectin, vitronectin or type I collagen.
Results shown are median (range) of one experiment, n=4 wells.
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5.6 OPTIMISATION OF PMA TREATMENT
5.6.1 Experimental aim and design
Previous studies (Thompson et al, 1990; Dastych et al, 1991) reported the use of 50
ng/ml PMA to stimulate adhesion of IL-3-dependent mBMMC to laminin and
fibronectin, therefore this concentration was used to stimulate adhesion of
mBMMC1" and mBMMCT+ to ECM proteins. To confirm, retrospectively, that this
concentration ofPMA stimulated maximum adhesion, titration experiments were set
up.
Adhesion ofmBMMC7" to fibronectin, and ofmBMMCT+ to laminin-1 was
investigated as described in 2.11.1 and 2.11.2. mBMMC were incubated for 60 min
in the presence of 0, 5, 50 or 500 ng/ml ofPMA, which was added immediately after
loading of cells into coated wells.
5.6.2 Results
nr_l_
High spontaneous adhesion, particularly ofmBMMC to laminin-1, in this
experiment made it difficult to assess the effect ofPMA on adhesion. However, use
ofPMA at 50 ng/ml significantly (p<0.05) increased adhesion ofmBMMCT+ to
T •laminin-l (figure 5.7). Spontaneous adhesion ofmBMMC " to fibronectin was
lower, and addition ofPMA at final concentrations of >5 ng/ml significantly
(p<0.05) increased adhesion (figure 5.7). In a small pilot experiment, vehicle
controls for PMA (appendix 1) were shown to have no effect on adhesion of
mBMMCT+ to laminin-l or ofmBMMC7" to fibronectin (data not shown).
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Figure 5.7. The effect of varying concentration of PMA on adhesion of
mBMMC to ECM proteins (20 pg/ml).
Graphs show (a) adhesion ofmBMMCT+ to laminin-1 and (b) adhesion of
mBMMC7" to fibronectin.
(a) Addition of 50 ng/ml PMA significantly (p<0.05) increased numbers of
mBMMCT+ adherent to laminin-1.
(b) Adhesion ofmBMMC " to fibronectin was significantly (p<0.05) increased by
addition of >5 ng/ml PMA.
Results are expressed as median (range) of one experiment (n=4 wells).
182
These results suggest that adhesion ofmBMMC7" to fibronectin, and ofmBMMCT+
to laminin-1 is maximally stimulated by concentrations ofPMA that are similar to
those required to stimulate adhesion of IL-3-dependent mBMMC to these ECM
proteins (Thompson et al, 1989a; Dastych et al, 1991).
5.7 COMPARISON OF MANUAL COUNTING METHODS WITH THE p-
HEXOSEAMINIDASE ASSAY METHOD OF ESTIMATION OF mBMMC
ADHESION TO ECM PROTEINS
5.7.1 Experimental aim and design
In order to validate the fi-hexoseaminidase assay as a method for measurement of cell
adhesion to ECM, an experiment was performed, in parallel with the conventional
enzyme assay, in which adherent cells were counted manually. Adhesion of PMA-
stimulated mBMMC7" and mBMMCT+ to ECM proteins (as in experiment 5.4) was
measured in duplicate wells by manual counting after incubation for 60 min. After
removal of non-adherent cells, 200 pi of trypsin-EDTA was added to facilitate
removal of adherent cells, and incubated for 20 min at 37°C. Cells were then
resuspended by gentle agitation, and 10 pi of the cell suspension counted using an
improved Neubauer haemocytometer.
5.7.2 Results
A lower number of cells adherent to laminin-1, type I collagen, fibronectin and
vitronectin were counted manually compared to estimates using the (3-
hexoseaminidase assay. However, the trends in each data set using manual counts
for adhesion ofmBMMC7" and mBMMC7+ were comparable to those estimated
using the P-hexoseaminidase assay (figure 5.8). It was not possible to compare
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Figure 5.8. Validation of the (3-hexoseaminidase assay.
Comparison of (a) manual counting of duplicate wells and (b) use of the |3-
hexoseaminidase assay (quadruplicate wells) to enumerate PMA-stimulated
mBMMC adherent to ECM protein-coated wells.
Although numbers of adherent cells counted by the P-hexoseaminidase assay were
higher than those counted manually, similar trends are seen using both methods.
Results are median (range), (a) n=2 wells and (b) n=4 wells.
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estimations of adherent cell numbers after manual counting and use of the P-
hexoseaminidase assay statistically as adhesion by manual counting was assessed in
duplicate only. However, as the trends were similar, it was concluded that, under
these conditions, the p-hexoseaminidase assay provided a valid estimate ofmast cell
adhesion.
5.8 OPTIMISATION OF CALCIUM IONOPHORE A23187 TREATMENT
5.8.1 Experimental aim and design
Previous work (Thompson et al, 1990; Dastych & Metcalfe, 1994) showed
stimulation of adhesion of IL-3-dependent mBMMC to laminin-1 or fibronectin by
addition of 0.1 pM calcium ionophore A23187. However, preliminary experiments
established that a 1 pM concentration of ionophore was required for stimulation of
increased adhesion ofmBMMCT+ to laminin-1, or ofmBMMC1" to fibronectin.
Therefore a titration experiment was set up to confirm that this concentration of
calcium ionophore stimulated maximum adhesion, in preparation for further
experiments investigating mechanisms stimulating adhesion ofmBMMC to ECM
proteins (5.9). Adhesion ofmBMMC1" to fibronectin, and ofmBMMCT+ to laminin-
1 was investigated as described in 2.11.1 and 2.11.2. mBMMC were incubated for 1
h in the presence of 0, 0.1, 1 or 10 pM calcium ionophore A23187, which was added
immediately after loading of cells into coated wells.
5.8.2 Results
Calcium ionophore A23187, when used at 0.1 or 1 pM did not upregulate adhesion
ofmBMMCT+ to laminin-1 above control values in this experiment (figure 5.9).
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Figure 5.9. The effect of varying concentration of calcium ionophore A23187 on
adhesion ofmBMMC to ECM proteins.
Graphs show (a) adhesion ofmBMMCT+ to laminin-1 and (b) adhesion of
mBMMC1" to fibronectin.
(a) Adhesion ofmBMMCT+ to laminin-1 was significantly reduced (p<0.05) by
addition of 10 pM A23187.
(b) Addition of 1 pM A23187 significantly increased (p<0.05) numbers of
mBMMC1" adherent to fibronectin, but addition of 10 pM A23187 resulted in a
significant decrease (p<0.05) in adherent mBMMC ".
Results are expressed as median (range), n=4 wells.
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However, this was probably due to the high spontaneous adhesion, since in other
experiments where there was lower spontaneous adhesion (5.9; appendix 2, table
A2.4), adhesion ofmBMMCT+ to laminin-1 was increased by treatment with 1 pM
A23187. Cells adherent to laminin-1 in the presence ofA23187 did not undergo the
shape change seen in spontaneously adherent cells, indicating a different mechanism
of adhesion. Addition of 1 pM A23187 to mBMMC7" significantly (p<0.05)
increased adhesion to fibronectin (figure 5.9), but adherent cells did not flatten onto
wells. Addition of 10 pM A23187 to both mBMMC7" and mBMMCT+ significantly
(p<0.05) reduced numbers of cells adherent to ECM proteins, this was presumed to
be due to a cytotoxic effect. In a small pilot experiment, vehicle controls for A23187
T+
(appendix 1) were shown to have no effect on adhesion ofmBMMC to laminin-1
or ofmBMMC7" to fibronectin (data not shown).
Results of this experiment and other experiments (5.9) suggest that 1 pM calcium
ionophore A23187 stimulates maximum adhesion ofmBMMC to ECM proteins.
5.9 REGULATION OF THE ADHESION of mBMMC TO ECM PROTEINS
5.9.1 Experimental aim and design
Other published studies (Thompson et al, 1990; Dastych et al, 1991) showed that
adhesion ofmast cell phenotypes to ECM proteins was regulated by FcsRI cross-
linking or by addition of calcium ionophore A23187. Therefore, the primary aim of
these experiments was to determine ifmBMMC7+, as MMC homologues, could be
stimulated to adhere to laminin-1 by similar mechanisms. Regulation of adhesion of
187
T •mBMMC " was also investigated, although an in vivo homologue of this mast cell
phenotype has not been identified.
The effects of IgE cross-linking and of calcium ionophore A23187 on adhesion of
mBMMCT+ laminin, and ofmBMMC1" to fibronectin and vitronectin was analysed
in quadruplicate using method 2.11.4.
5.9.2 Results
There was a trend in that numbers ofmBMMCT+ adherent to laminin-1 were
increased above that seen in controls (unstimulated mBMMCT+) by treatment with
Ag/IgE in four out of five experiments (appendix 2, table A2.4), and with calcium
ionophore A23187 in four experiments using cells from separate cultures. In one
experiment (appendix 2, table A2.4, experiment 2; figure 5.10) this increase was
statistically significant following stimulation by both Ag/IgE and calcium ionophore.
Cells adherent to laminin-1 after Ag/IgE treatment flattened and took on a polarised
appearance, but A23187 treated cells retained a rounded shape. Increased adhesion
after Ag/IgE or A23187 treatment was less easily demonstrable where there was high
spontaneous adhesion ofmBMMCT+ (appendix 2, table A2.4, experiments 3, 4 and
5). Also, there was some variability in adhesion of Ag/IgE treated cells, where
decreased adhesion was detected in one experiment (appendix 2, table A2.4,
experiment 3). The possible reasons for this are addressed in 5.10 below.
Adhesion ofmBMMC1" to fibronectin was increased by Ag/IgE in three separate
experiments using cells from different cultures (figure 5.10, table A2.5), this increase
was statistically significant in one experiment (figure 5.10; table A2.5, experiment
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Figure 5.10. Signals stimulating adhesion of mBMMC to ECM proteins.
(a) Adhesion ofmBMMCT+ to laminin-1 was significantly (p<0.05) increased by
treatment with Ag/IgE and calcium ionophore A23187.
(b) Adhesion ofmBMMC7" to fibronectin was significantly (p<0.05) increased by
Ag/IgE treatment, but no response to A23187 was seen in this experiment.
However, this treatment did increase adhesion ofmBMMC7" to fibronectin in
other experiments (appendix 2, table A2.5).
(c) Ag/IgE significantly (p<0.05) increased adhesion ofmBMMC " to vitronectin; a
more substantial increase in adhesion was shown in a pilot experiment performed
in triplicate (appendix 2, table A2.6). A small but significant (p<0.05) increase in
adhesion ofmBMMC7" to vitronectin was also seen after treatment with A23187.
Results are median (range) of one experiment (n=4 wells). The results of repeat
experiments are shown in appendix 2, tables A2.4 - A2.6.
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3). Adhesion ofmBMMC7" to fibronectin was also increased by A23187 in one
experiment (table A2.5, experiment 2), but this increase was not statistically
significant, and was not found in the repeat experiment (figure 5.10; table A2.5,
experiment 3). However, lpM A23187 significantly (p<0.05) increased adhesion of
mBMMC to fibronectin in the dose-response experiment (5.8). An increase in
adhesion ofmBMMC " to vitronectin was found after Ag/IgE treatment in two
experiments (figure 5.10, table A2.6), and in the experiment that was performed in
quadruplicate, this increase was statistically significant (figure 5.10). A significant
T
(p<0.05) increase in mBMMC " adhesion to vitronectin was also seen after treatment
with A23187, but this increase was very small, and median adhesion was only 3.3%
(table A2.6).
In conclusion, adhesion ofmBMMCT+ to laminin-1 was increased by treatment with
Ag/IgE and calcium ionophore A23187. Adhesion ofmBMMC " to both fibronectin
and vitronectin could be increased by treatment with Ag/IgE, but results from
stimulation of adhesion ofmBMMC1" to these ECM proteins with calcium ionophore
were variable.
5.10 THE EFFECT OF DEGRANULATION OF mBMMCT+ ON THE
VALIDITY OF RESULTS OF ADHESION MEASURED USING THE (3-
HEXOSEAMINIDASE ASSAY
5.10.1 Experimental aim and design
In 5.9.2 above, there was some variability in results of experiments measuring
adhesion ofAg/IgE-treated mBMMCx+ to laminin-1 using the P-hexoseaminidase
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assay, and in preliminary experiments investigating this further (not shown), visual
examination of numbers of cells adherent after Ag/IgE stimulation suggested that
they were comparable to the number of cells adherent to laminin-1 after stimulation
by PMA. The p-hexoseaminidase assay estimates cells by measurement of the
amount of the lysosomal enzyme, P-hexoseaminidase, which is present in the lysates
from adherent cells. It was hypothesised, therefore, that differences in the extent of
degranulation following the two different stimuli may result in inaccuracies in
quantification of adherent cells using this method. Specifically, high levels of
degranulation after stimulation with Ag/IgE may result in an underestimation of the
numbers of adherent cells.
An experiment was therefore set up to compare, using the P-hexoseaminidase assay
and manual counting, adhesion ofmBMMCT+ to laminin-1 when stimulated by
PMA, Ag/IgE or A23187. Control wells containing unstimulated cells were
included; estimations using the P-hexoseaminidase assay were in quadruplicate, and
manual counting was performed in duplicate.
In addition to this, supernatants from wells containing adherent cells were collected
for measurement of degranulation by analysis ofmMCP-1 release (2.8.2).
mBMMCT+ contain abundant mMCP-1, and unpublished data from our laboratory
T4-
showed that Ag/IgE stimulation causes release ofmMCP-1 from mBMMC . This
correlates closely with release of P-hexoseaminidase, which is conventionally used to
measure degranulation. Therefore, as pH constraints and the presence of indicator
dye in the culture medium made direct measurement of p-hexoseaminidase
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technically infeasible, release ofmMCP-1 into the culture supernatant was measured
instead.
5.10.2 Results
Quantitation of adhesion ofmBMMCT+ to laminin-1 using the p-hexoseaminidase
assay indicated high spontaneous adhesion ofmBMMCT+ after 30 min and 60 min
incubations (figure 5.11a). Stimulation with Ag/IgE, PMA and A23187 increased
adhesion, although only PMA treatment resulted in a significant increase (p<0.05).
As previously described in 5.9, adherent cells treated with A23187 did not flatten
onto laminin-1. After 60 min, adhesion of control and PMA-stimulated cells and of
cells treated with A23187 measured using the P-hexoseaminidase assay remained
high, but there was a significant (p<0.05) reduction in number of cells adherent to
laminin-coated wells after Ag/IgE treatment (figure 5.11a).
Visual estimation of adherent cells after 30 min and 60 min incubations did not agree
with these results; high numbers of Ag/IgE-stimulated cells were observed to be
adherent to laminin-coated wells after both 30 min and 60 min incubations, and after
30 min, adherent Ag/IgE stimulated cells appeared to be more abundant than PMA
stimulated cells. Manual counting supported visual estimations of adherent cells.
After a 30 min incubation, treatment with both Ag/IgE and PMA increased adhesion
ofmBMMCT+ to laminin-1, but numbers adherent after Ag/IgE treatment were
higher than after PMA treatment (figure 5.11b). After 60 min of incubation,
increased numbers of adherent cells were counted in control, PMA or A23187 treated
wells (figure 5.1 lb), and adhesion of Ag/IgE-treated cells remained high.
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Figure 5.11. Validation of the P-hexoseaminidase assay for comparison of
adhesion ofmBMMC1 + to laminin-1 after different methods of stimulation.
Adhesion of unstimulated (control) mBMMCT+ and mBMMCT+ stimulated by
Ag/lgE, A23187 or PMA was analysed by (a) the P-hexoseaminindase assay (n=4
wells) or (b) manual counting (n=2 wells).
a) The p-hexoaseaminidase assay indicated only a small increase in adhesion above
that in controls after incubation for 30 min with Ag/lgE, A23187 or PMA. After
incubation for 60 min, a significant (p<0.05) reduction in numbers of adherent
Ag/IgE-treated cells was detected.
b) Manual counting indicated that treatment with Ag/lgE and PMA increased
numbers of adherent cells after 30 min. After 60 min, adhesion of cells
stimulated with PMA and A23187, and of control cells had increased. Numbers
of adherent Ag/lgE treated cells after 60 min was similar to those seen after 30
min.
Results are expressed as median (range) of one experiment.
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Quantification ofmMCP-1 in cell supernatants established that after incubation for
30 min, there was significantly (p<0.05) higher release ofmMCP-1 in Ag/IgE-treated
cells than in both control and PMA stimulated cells (figure 5.12). After a 60 min
incubation, mMCP-1 release from cells treated with both PMA and Ag/IgE was
significantly greater than release from the same cells after 30 min, and release by
control mBMMCT+ after 60 min. Unexpectedly, low release was measured after
treatment with A23187 (figure 5.12).
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Figure 5.12. Degranulation ofmBMMCT+ adherent to laminin-1 in experiment
5.10.
Cells were stimulated with Ag/IgE, A23187 or PMA. mMCP-1 release in Ag/IgE-
stimulated cells was significantly higher (p<0.05) than in control cells after both 30
min and 60 min incubations. Also, release after 30 min was significantly higher
(p<0.05) than in PMA-stimulated cells.
mMCP-1 release in mBMMCT+ stimulated by both Ag/IgE and PMA was
significantly (p<0.05) higher after 60 min than 30 min.
Results are median (range) of one experiment (n=4 wells). Significant differences
are omitted from the graph for clarity.
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To summarise, manual estimation of adhesion ofmBMMCT+ to laminin-1 either
spontaneously or after treatment with Ag/IgE or calcium ionophore showed
stimulation of adhesion by all three mechanisms, but Ag/IgE treatment resulted in
more rapid adhesion which peaked at 30 min and was maintained for 60 min (figure
5.1 lb). In comparison to manual estimation, the (3-hexoseaminidase assay appeared
to overestimate adhesion of unstimulated mBMMCT+ and ofmBMMCT+ stimulated
by PMA and A23187 to laminin-1 after 30 min; and underestimate adhesion of
Ag/IgE treated cells relative to others at both time points (figure 5.11). These
differences may, in part, be explained by the comparatively high degranulation of
Ag/IgE-treated cells (figure 5.12).
5.11 COMPARISON OF ADHESION OF mBMMCT+ FROM mMCP-1
KNOCK-OUT AND WILD-TYPE MICE TO LAMININ-1 AND
FIBRONECTIN
5.11.1 Experimental aim and design
mMCP-1-expressing mBMMCT+ adhered poorly to fibronectin, and unpublished data
from our lab suggested fibronectin to be a possible substrate for mMCP-1, which is
continually released from mBMMCT+ (Miller et al, 1999). Therefore, it was
hypothesised that adhesion ofmBMMCT+ to fibronectin may be attenuated by
degradation of this protein by mMCP-1 released during incubation.
To test this hypothesis, adhesion of PMA-stimulated mBMMCT+ from mMCP-1
knock-out and wild-type mice to fibronectin was compared in one experiment using
quadruplicate wells. Adhesion to laminin-1 was also compared, and BSA-coated
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wells were included as controls. PMA (50 ng/ml) was added immediately after
loading of cells into coated wells and adhesion estimated after incubation for 1 h
(2.11.2).
5.11.2 Results
Ti
Adhesion ofmBMMC from mMCP-1 knock-out mice to both fibronectin and
laminin-1 was significantly (p<0.05) lower than that ofmBMMCT+ from wild-type
mice (figure 5.13). This does not support the proposed hypothesis that degradation
of fibronectin by mMCP-1 inhibits mBMMCT+ adhesion to fibronectin. Adhesion of
both cell-types to BSA was <5%.
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Figure 5.13. Adhesion ofmBMMCT+ from mMCP-1 wild-type and knock-out
mice to extracellular matrix proteins.
Results are expressed as median (range), n=4 wells.
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5.12 DISCUSSION
Mast cells grown in vitro and recovered ex vivo have been shown to adhere to
laminin, fibronectin and vitronectin (Thompson et al, 1989a; Dastych et al, 1991;
Bianchine et al, 1992; Columbo et al, 1995; Columbo & Bochner, 2001). The
current study has shown that TGF-Pi profoundly regulates adhesion ofmBMMCT+
(MMC homologues) to ECM proteins. The mechanism of TGF-Pi-upregulated
adhesion to laminin-1, and down-regulated adhesion to fibronectin and vitronectin
may be through alteration in expression of integrins, and this is addressed in chapter
6.
TGF-Pi-regulated expression of Pi integrins has been shown in several cell types
(Ignotz & Massague, 1987; Heino et al, 1989), and in both IL-3-dependent mBMMC
T+
and mBMMC cultured in our lab, TGF-Pi regulates expression of aE integrin
(Smith et al, 1994; Wright et al, 2002). The non-integrin LBP has also been shown
to be important in adhesion of IL-3-dependent mBMMC to laminin-1, thus TGF-Pi
• T+
regulated expression of this protein might mediate adhesion ofmBMMC to
laminin-1. Mast cell adhesion to laminin and fibronectin is regulated by other mast
cell growth factors including IL-3, SCF and IL-4 (Thompson et al, 1989a; Dastych &
Metcalfe, 1994; Lorentz et al, 2002). However, this upregulation was over the 60
min time period of the adhesion assay itself, and is likely to result from cytoskeletal
rearrangements similar to those associated with activation by PMA (Danilov &
Juliano, 1989), rather than any up or down-regulation of integrin expression.
197
The differential adhesion ofmBMMCT+ to laminin, and mBMMC7" to fibronectin
and vitronectin contrasts with IL-3-dependent mBMMC, which adhere to all three
ECM proteins. This may reflect different levels of differentiation ofmBMMC7" and
mBMMCT+ in comparison to IL-3-dependent mBMMC, which are said to represent
immature mast cells, but which have never been shown to have any in vivo
counterpart. The human mast cell line, HMC-1, which may also represent an
immature mast cell (Butterfield et al, 1988) similarly adheres to a number ofECM
proteins including laminin, fibronectin, vitronectin and collagens. However, as
mature human skin mast cells also adhere to laminin, fibronectin and vitronectin
(Columbo et al, 1995; Columbo & Bochner, 2001), mast cell adhesion properties
cannot be easily associated with a particular phenotype.
mBMMC " showed variable adhesion to type I and type IV collagen (appendix 2,
table A2.3). Similarly, IL-3-dependent mBMMC do not adhere to collagens, but the
rat basophilic leukaemia cell line, RBL-2H3, and HMC-1 cells adhere to both type I
and type IV collagen as well as to fibronectin and laminin (Hamawy et al, 1992;
Kruger-Krasagakes et al, 1996).
Adhesion of IL-3-dependent mBMMC to laminins and fibronectin required
activation by PMA, A23187 or LccRI cross-linking. Our studies suggested a similar
T I
requirement for activation by mBMMC for adhesion to laminin-1, though high
spontaneous adhesion and difficulties in enumeration ofmast cells adherent after
different methods of stimulation made it difficult to obtain statistically significant
results. Spontaneous adhesion varied between cultures (appendix 2, tables A2.2 and
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A2.4), and may have been due to low levels of endotoxin contamination, as LPS has
been shown to cause mast cell degranulation (Iuvone et al, 1999).
Comparison of the adhesion properties ofmBMMCT+ stimulated by different
mechanisms using the P-hexoseaminidase assay was not always accurate; in some
experiments, visual assessment of the number of cells adherent to coated wells was
not reflected by results measured using the P-hexoseaminidase assay. The P-
hexoseaminidase assay produced results comparable to those achieved by manual
counting when adhesion ofPMA-stimulated mBMMCT+ was compared to that of
mBMMC7" (figure 5.8). However, when comparing adhesion ofmBMMCT+
stimulated by Ag/IgE, A23187, PMA or of unstimulated mBMMCT+ using the P-
hexoseaminidase assay, results were different from those obtained by manual
counting (figure 5.11). In particular, the P-hexoseaminidase assay may
underestimate numbers ofAg/IgE - stimulated cells adherent to laminin-1.
Analysis of mMCP-1 release into supernatants in order to measure degranulation of
cells stimulated by the different mechanisms suggested that the comparatively high
levels of degranulation of Ag/IgE-stimulated cells after 30 min and 60 min
incubations may account for these underestimations, as the P-hexoseaminidase assay
measures cell numbers based on the amount of the lysosomal enzyme, P-
hexoseaminidase, present. Release of this enzyme from cells during degranulation
may lead to an underestimation of adherent cells. The results also suggest that the P-
hexoseaminidase assay may underestimate numbers of PMA-stimulated cells
adherent, relative to control cells, due to their extensive degranulation (figure 5.12).
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Surprisingly, no release was measured in cells treated with A23187, suggesting either
a problem with this method of stimulation, or with the measurement of
degranulation. However, as this experiment was only performed once, further
repeats would be required to confirm these results. Nevertheless, this preliminary
experiment assaying the release ofmMCP-1 to quantify degranulation helped to
explain the variability in the results ofAg/IgE-mediated adhesion ofmBMMCT+ to
laminin-1, and supported our conclusion that adhesion ofmBMMCT+ to laminin-1 is
stimulated by this method.
Proteases may be important for cell migration by degrading ECM components
(Murphy & Gavrilovic, 1999), and unpublished work in our laboratory showed
degradation of fibronectin by mMCP-1. However, comparison of adhesion of
TI t t
mBMMC from mMCP-1 knock-out and wild-type mice did not support the
hypothesis that degradation by mMCP-1 might inhibit adhesion ofmBMMCT+ to
• ... T-t-
fibronectin. Contrary to our hypothesis, significantly lower numbers ofmBMMC
from knock-out mice than from wild-type mice adhered to fibronectin and laminin-1.
The reason for this is not known, and further experiments would be required to show
that this was a repeatable result. Comparison of surface expression of the relevant
adhesion molecules might help explain these differences.
Since mBMMC1" are phenotypically undefined mast cells, the mechanisms
stimulating their adhesion to fibronectin and vitronectin were not rigorously
investigated. However FcsRI cross-linking stimulated adhesion ofmBMMC1" to
both fibronectin and vitronectin, although variable results were obtained by
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stimulation with A23187. This may have been due to technical problems, or it may
be that, as the same reagent did increase adhesion ofmBMMCT+ to laminin-1,
mBMMC7" have a higher threshold for stimulation than mBMMCT+, which adhere
spontaneously to laminin-1 in some experiments. In contrast to mBMMC7", IL-3-
dependent mBMMC adhere spontaneously to vitronectin; this may reflect the
different culture conditions of the two cell types, as cytokines SCF and IL-9 are also
included in culture ofmBMMC7".
Epithelial basement membranes are rich in laminin, therefore ifMMC in vivo adhere
to laminin, this may support intraepithelial migration ofMMC and their maintenance
intraepithelially. However, although some studies (Nomizu et al, 1995; De
Arcangelis et al, 1996) have reported laminin-1 to be a major component of
basement membranes and located in the mouse and human small intestine (Beaulieu
& Vachon, 1994; Simon-Assmann et al, 1994) others (Falk et al, 1999; Kortesmaa et
al, 2000) reported that the isoform studied, laminin-1, is uncommon in vivo and is
not expressed in the small intestine. This may be of relevance to the present study as
some variation in affinity of laminin binding integrins for different laminin isoforms
has been reported (Belkin & Stepp, 2000). The full significance will be easier to
assess when the molecules mediating adhesion ofmBMMC7+ to laminin are
identified. Low levels of adhesion ofmBMMC7+ to fibronectin and vitronectin,
which may be expressed in the intestinal lamina propria but not basement membrane,
may also reflect differentiation towards the intraepithelially located MMC phenotype
driven by TGF-Pi.
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In addition to facilitating cell migration and location within tissues, adhesion of
mBMMC to ECM proteins may regulate their cellular function. Adhesion of IL-3-
dependent mBMMC to vitronectin enhances proliferation in response to IL-3
(Bianchine et al, 1992), and adhesion of HMC-1 cells to fibronectin or vitronectin
provided a co-stimulatory signal for cytokine production (Kruger-Krasagakes et al,
1999). Also, adhesion ofmBMMC to laminin-2 (Vliagoftis & Metcalfe, 1997) and
of RBL-2H3 cells to fxbronectin (Hamawy et al, 1992) enhanced secretion of
mediators. Thus, mast cell adhesion to ECM proteins may act as a signal indicating
their arrival at their target location within tissues, and may initiate the inflammatory
response.
In conclusion, this work has shown differential adhesion ofmBMMC cultured with
and without TGF-Pi to ECM proteins; further work will aim to identify the
mechanisms involved.
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CHAPTER 6
THE ROLE OF INTEGRINS AND LAMININ BINDING PROTEIN IN
ADHESION OF mBMMC TO EXTRACELLULAR MATRIX PROTEINS
6.1 INTRODUCTION
Results of experiments described in the previous chapter showed that TGF-pi-
mediated differentiation ofmBMMC into MMC homologues was accompanied by a
down-regulation of adhesion to fibronectin and vitronectin, and upregulation of
adhesion to laminin-1. Integrins mediate cell adhesion to ECM proteins (Hynes,
1992), and TGF-Pi-regulated integrin expression has been shown in several cell
types including mast cells (Ignotz & Massague, 1987; Heino et al, 1989; Smith et al,
1994; Bauvois et al, 1996; Rich et al, 1996), by mechanisms which include increased
mRNA levels, increased maturation of p subunits and transfer of these to the plasma
membrane, and increased ap subunit assembly (Ignotz & Massague, 1987). TGF-Pi-
regulated expression of integrins might therefore account for alterations in adhesion
ofmBMMC to ECM proteins.
Integrins play a role in adhesion of several mast cell phenotypes to ECM proteins.
a6pi, a4 and a5 pi and avp3 regulate adhesion of IL-3-dependent mBMMC and
murine mast cell lines to laminin (Fehlner-Gardiner et al, 1996a; Vliagoftis &
Metcalfe, 1997), fibronectin (Fehlner-Gardiner et al, 1996b) and vitronectin
(Bianchine et al, 1992), respectively. Expression of the laminin binding integrins al
and a3 by IL-3-dependent mBMMC has also been shown, although a role in
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adhesion has been identified for neither of these integrins (Vliagoftis & Metcalfe,
1997). Adhesion ofmBMMC7" to fibronectin and vitronectin, and ofmBMMCT+ to
laminin is likely to depend on similar integrins, expression ofwhich could be
regulated by TGF-pi. Additionally, the non-integrin laminin binding protein (LBP)
has been shown to participate in adhesion of IL-3-dependent mBMMC to laminin-1
(Thompson et al, 1989a), and may also regulate adhesion ofmBMMCT+ to this
protein.
The aim of the following experiments was to investigate the hypothesis that TGF-(3i
regulates adhesion ofmBMMC to ECM proteins via alteration of expression of
adhesion molecules, including integrins and LBP. To this end, expression of several
integrins and LBP has been compared in mBMMC7" and mBMMC7+, and their role
in adhesion to ECM proteins investigated using neutralising antibodies. In addition
to integrins previously implicated in mast cell adhesion, the role of the laminin
Ti
binding integrin, a7 in adhesion ofmBMMC has been investigated. This integrin
was originally thought to be skeletal muscle-specific (von der Mark et al, 1991), but
expression of the a7B isoform has since been found in other tissues, including
intestinal epithelium, where it correlates with intestinal cell differentiation (Basora et
al, 1997).
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6.2 ANALYSIS OF EXPRESSION OF ADHESION MOLECULES BY
mBMMC1'AND mBMMCT+ USING SEMI-QUANTITATIVE RT-PCR
6.2.1 Experimental aim and design
Alteration of the rate of transcription or in the stability ofmRNA is one possible
mechanism of regulation of adhesion molecule expression by TGF-Pi (Ignotz &
Massague, 1987). Therefore, as published primer sequences are available for many
of the integrins previously implicated in mast cell adhesion to ECM proteins,
expression of adhesion molecules by mBMMC7' and mBMMCT+ was first examined
by RT-PCR. Expression of integrin subunits pi, a3, a5, a6, av and p3, which has
been previously described in murine IL-3-dependent BMMC (Bianchine et al, 1992;
Fehlner-Gardiner et al, 1996a; Fehlner-Gardiner et al, 1996b; Vliagoftis & Metcalfe,
1997), was analysed. Additionally, expression of the non-integrin LBP, and the
laminin binding integrin a7 was investigated.
T T"F
Expression of adhesion molecules was analysed in mBMMC " and mBMMC from
4 separate cultures. Mast cells used for all studies in this chapter were generally
between 14 and 30 days old (2.4.1). mBMMC were collected into TRI reagent
(2.4.10), and expression of adhesion molecules analysed by RT-PCR (2.5.1 - 8) with
each primer being optimised for semi-quantitative analysis (2.5.8). Specific
conditions for each primer are shown in table 2.3.
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6.2.2 Results
RT-PCR analysis of adhesion molecule expression by mBMMC1" and mBMMCT+
showed a consistent and substantial upregulation of a7 transcripts in the presence of
TGF-Pi (figure 6.1). Expression of a7 integrin was low-to-undetectable after 35
cycles of PCR in mBMMC7", whereas inclusion of 1 ng/ml TGF-pi in cultures
resulted in a significant (p<0.05) increase in a7B mRNA expression by mBMMCT+
(figures 6.1 and 6.2). The a7 primers could amplify both a7A and a7B mRNA
resulting in PCR products of 480 BP and 366 BP respectively (table 2.3), but only a
single band of 366 BP was detected, indicating expression of a7B transcripts only.
mBMMC1" mBMMCT+
Figure 6.1. Analysis of adhesion molecule expression in mBMMC7" and
mBMMCT+.
Expression was analysed in 4 separate cultures of each cell type by semi-quantitative
RT-PCR. a7B integrin mRNA was highly upregulated in mBMMC cultured with
TGF-Pi, whereas TGF-pi moderately down-regulated expression of integrin P3.
Transcripts for other adhesion molecules were expressed at comparable levels by
both mBMMC1" and mBMMCx+.
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Figure 6.2^. Relative expression of integrin subunits and LBP by mBMMC " and
mBMMC,T+
Expression was analysed in cells from 4 separate cultures by semi-quantitative RT-
PCR. Expression of a7B integrin was significantly (p<0.05) higher in mBMMCT+
than mBMMC7". Also, expression of P3 integrin was significantly (p<0.05) higher
mBMMC7" then mBMMC7+.
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In contrast, expression of 03 mRNA, whilst being detected in both cell types, was
significantly down-regulated by TGF-01 (p<0.05)(figures 6.1 and 6.2). Expression
of 01A, a3A, a5, a6A, av and LBP was detected at comparable levels in both
mBMMC1" and mBMMCT+.
6.3 FLOW CYTOMETRIC ANALYSIS OF SURFACE EXPRESSION OF
INTEGRINS BY mBMMC1" AND mBMMCT+
6.3.1 Experimental aim and design
RT-PCR analysis showed expression ofmRNA for the laminin binding integrin a7B
Ti
in mBMMC , and down-regulated expression of 03 integrin, compared to levels in
mBMMC Since the main focus of this work was on mBMMCT+, as potential
MMC homologues, flow cytometry was used to confirm that TGF-0i-mediated
upregulation of a7B mRNA resulted in surface expression of a7 integrin. Also, in
the absence of differences at the mRNA level, and as surface expression of these
integrins by IL-3-dependent mBMMC and a role in adhesion to ECM proteins has
T T+
previously been reported, expression of a5, a6 and av by mBMMC " and mBMMC
from 3 separate cultures was analysed by flow cytometry (2.12 and 2.13). In
addition, a murine mast cell line, MC/9 (2.4.3), which has been shown previously to
express integrin a5 (Fehlner-Gardiner et dl, 1996b) and a6 (Fehlner-Gardiner et al,
1996a) was used as a positive control for expression of these integrins.
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Figure 6.3. Surface expression of integrins in mBMMC " and mBMMC .
MC/9 cells were included as positive controls for expression of a5 and a6 integrins.
T+ • • i i •mBMMC expressed al integrin, whereas no expression was detected in
mBMMC7" cultured without TGF-Pi.
T T"h
Expression of a6 was virtually absent in both mBMMC " and mBMMC ; high
expression was detected in the positive control MC/9 cells.
a5 integrin was expressed by mBMMC " but there was decreased expression in
mBMMCT+, and high expression in MC/9 cells.
Expression of integrin av was virtually absent in both mBMMC1" and mBMMC7+.
These flow cytometry experiments were repeated twice more using cells from
separate cultures, with similar results.
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6.3.2 Results
Surface expression of a7 was consistently detected in TGF-Pi-supplemented
mBMMCT+, whereas no expression was detected in mBMMC7" (figure 6.3). In
contrast, surface expression of a5 was increased in mBMMC7" compared to
T-F • •
mBMMC , but expression in both mBMMC phenotypes was lower that seen in the
positive control MC/9 cells. Expression of a6 was virtually absent in mBMMCT+
and mBMMC " but, as expected, was high in MC/9 cells (figure 6.3). Expression of
av was low-to-absent in both mBMMC7" and mBMMCT+.
6.4 ANALYSIS OF EXPRESSION OF LAMININ BINDING PROTEIN BY
mBMMC7" AND mBMMCT+ USING WESTERN BLOTTING
6.4.1 Experimental aim and design
mRNA for LBP was detected at similar levels in both mBMMC7" and mBMMC7+,
but LBP is reported to be post-transcriptionally regulated (Landowski et al, 1995) so
mRNA levels might not reflect cellular protein levels, therefore expression of LBP in
mBMMC7" and mBMMC7+ was further investigated by Western blotting.
Protein was extracted from one sample ofmBMMC7" and mBMMC7+ (2.9.1.)
Samples were then electrophoresed on separate Laemmli gels (2.9.2.1), transferred
onto membranes (2.9.4), and immunodetection performed using rabbit polyclonal
antiserum raised against the N-terminal region of LBP (2.9.7).
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6.4.2 Results
Bands reactive with the anti-LBP polyclonal serum HK149 were detected on
Western blots at approximately 25 kDa and 37 kDa in proteins separated from
mBMMC1" and mBMMCT+ (figure 6.4). These were lower values than the published
32 and 45 kDa molecular weights (Clement et al, 1990). Blots exposed to normal
rabbit serum or incubated in the absence of primary antibody were negative (figure
6.4).
mBMMC1" mBMMCT+
HK149 NRS No Ab HK149 NRS No Ab
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Figure 6.4. Western blots of laminin binding protein (LBP) in mBMMC1" and
mBMMCT+.
To detect LBP, HK149 polyclonal serum raised against a 17-mer synthetic peptide
from the NTL-terminal region ofLBP-32 (residues 25 - 41) was used. The 25 and 37
kDa proteins detected (arrowed) were of lower molecular weight than the 32 and 45
kDa LBP bands reported to be recognised by this antibody.
Control blots were incubated with normal rabbit serum (NRS) or blocking buffer
only, with no antibody (no Ab); and were negative.
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6.5 USE OF NEUTRALISING ANTIBODIES TO INVESTIGATE THE ROLE
OF INTEGRINS IN ADHESION OF mBMMC TO ECM PROTEINS
6.5.1 Experimental aim and design
Experiment 6.4 demonstrated expression of a7 integrin by mBMMCT+ only, and that
there was higher surface expression of a5 integrin by mBMMC " than by
T+mBMMC . We therefore wished to determine if expression of these integrins
accounted for the differences in adhesion to laminin and fibronectin in these cells.
Also, whereas previous studies (Fehlner-Gardiner et al, 1996a; Vliagoftis &
Metcalfe, 1997) showed expression of a6 integrin by IL-3-dependent mBMMC and
adhesion of these cells to laminin-1 was inhibited by preincubation with the a6-
neutralising antibody GoH3, expression of a6 was low in both mBMMC7" and
T+ • ....
mBMMC . We were therefore interested to know what role, if any, this integrin
• T+
had to play in adhesion ofmBMMC to laminin-1. Use of the anti-av monoclonal
RMV-7 in flow cytometry showed low-to-absent expression in both mBMMC " and
mBMMCT+, but as antibodies to avp3 have previously been shown to block
adhesion of IL-3-dependent mBMMC to vitronectin, the effect ofRMV-7 on
mBMMC7" adhesion to vitronectin was also investigated.
In order to investigate the role of a6 and al integrins in the adhesion ofmBMMC7+
to laminin-1, and of a.5 and av integrins in the adhesion ofmBMMC " to fibronectin
and vitronectin, respectively, cells were preincubated with appropriate antibodies
(2.15) before pipetting into laminin, fibronectin or vitronectin-coated wells (2.11.1).
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PMA (50 ng/ml) was then immediately added, and the number of adherent cells after
incubation for 1 h measured (2.11.2).
As others (Thompson et al, 1989a; Thompson et al, 1990) showed a role for LBP in
adhesion of IL-3-dependent mBMMC to laminin-1, the role of LBP in adhesion of
T"ft •mBMMC was also investigated in preliminary experiments, by preincubation with
either rabbit anti-LBP polyclonal serum (HK48, raised against a LBP fusion protein
as described in (Clement et al, 1990), kindly provided by Hynda Kleinmann,
National Institute of Dental Research, N.I.H., Bethesda, U.S.A.) or normal rabbit
serum. However, these attempts were unsuccessful due to background inhibition of
adhesion by normal rabbit serum, and this line of investigation was not pursued.
6.5.2 Results
Use of the neutralising antibody, 6A11, clearly demonstrated a role for a7 integrin in
adhesion ofmBMMCT+ to laminin-1. Preincubation with 6A11 at 10 pg/ml resulted
T"bin a 98% reduction in adhesion ofPMA-stimulated mBMMC to laminin-1 (Figure
6.5a), which was statistically significant (p<0.05). This experiment was repeated
twice more in quadruplicate and triplicate, with a reduction in adhesion of 99.8% and
100% (appendix 2, table A2.7). In contrast, use of the anti-a6 monoclonal GoH3 (1
Ti
pg/ml) had no effect on adhesion ofmBMMC to laminin-1 (figure 6.5b; appendix
2, table A2.8), whereas adhesion ofMC/9 cells, which are reported to express the
integrin a6pi (Fehlner-Gardiner et al, 1996a) and were used as a positive control for
this antibody, was reduced by 98% in the presence ofGoH3 (figure 6.5b).
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Figure 6.5. Antibody blocking of the adhesion of mBMMCT+ to laminin-1.
(a) The a7 integrin-neutralising antibody 6A11 (10 pg/ml) significantly reduced
adhesion of PMA-stimulated mBMMCT+ to laminin-1 by 98% (p<0.05).
(b) In contrast, the a6-neutralising antibody GoH3 (1 pg/ml) had no effect on
adhesion ofmBMMCT+, but significantly (p<0.05) reduced adhesion ofMC/9
cells to laminin-1 by 98%.
Results are median (range) (n=4 wells) for single experiments which were
repeated twice with similar results (appendix 2, table A2.7 and A2.8).
T
Preincubation ofmBMMC " with the anti-a.5 monoclonal antibody 5H10-27 resulted
in a partial inhibition of adhesion to fibronectin. In a quadruplicate experiment
where mBMMC1" were pre-incubated with 5H10-27 at 1, 5 or 10 pg/ml, statistically
significant reductions in adhesion to fibronectin of 52.0% and 48.7% were obtained
at 1 and 5 pg/ml, and a 65.0% reduction was obtained by preincubation at 10 pg/ml,
though this was not statistically significant (figure 6.6; appendix 2, table A2.9).
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Figure 6.6. Antibody blocking of the adhesion ofmBMMC1" to fibronectin.
Effect of the anti-a5 integrin blocking antibody, 5H10-27 or IgG2a control on
adhesion ofmBMMC1" to fibronectin (20 pg/ml).
5H10-27 resulted in a significant (p<0.05) reduction in adhesion when used at 1 or 5
fig/ml. Results are shown as median (range) of one experiment, n=4 wells. Repeat
experiments are shown in appendix 2, table A2.9.
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Figure 6.7. Failure of antibody to block the adhesion ofmBMMC1' to
vitronectin.
Effect of anti-av monoclonal RMV-7 or IgGl control (10 pg/ml) on adhesion of
mBMMC7" to vitronectin (10 pg/ml).
Preincubation with RMV-7 did not significantly inhibit adhesion ofmBMMC7" to
vitronectin. Results are shown as median (range) of one experiment (n=4 wells).
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However, results of repeat experiments, where cells were preincubated with 5H10-27
or isotype control at 10 pg/ml, were more variable (appendix 2, table A2.9), though
statistically significant reductions in adhesion ofmBMMC7" to fibronectin of 19.0%
and 26.8% were obtained. Preincubation ofmBMMC7" with the anti-a7 monoclonal
RMV-7 had no effect on adhesion to vitronectin (figure 6.7).
6.6 USE OF NEUTRALISING ANTIBODIES TO INVESTIGATE THE ROLE
OF a7 INTEGRIN IN SPONTANEOUS, Ag/lgE-STIMULATED AND
CALCIUM IONOPHORE A23187-STIMULATED ADHESION OF
mBMMCT+ TO LAMININ-1.
6.6.7 Experimental aim and design
The a7-neutralising antibody, 6A11 blocked adhesion of PMA-stimulated
mBMMC7+ to laminin-1. However, mBMMC7+ adhere spontaneously to laminin-1,
and adhesion is increased by treatment with Ag/IgE or calcium ionophore A23187.
This experiment aimed to investigate if adhesion via these mechanisms was also
mediated by a7 integrin, and could therefore be blocked by 6A11.
To investigate the role of a7 in spontaneous and A23187-stimulated adhesion of
mBMMC7+ to laminin-1, mBMMC7+ were preincubated with 6A11 as described in
6.5, before loading into quadruplicate wells and addition of no stimulating agent, or 1
pM A23187. For investigation of the role of a7 in adhesion ofAg/IgE-stimulated
mBMMC7+ to laminin-1, mBMMC7+, sensitised by overnight incubation with IgE
anti-DNP (2.11.3), were preincubated with 6A11 before loading into quadruplicate
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Figure 6.8. Antibody blocking of the adhesion of mBMMC to laminin after
stimulation by different mechanisms.
The effect of the a7 integrin-neutralising antibody 6A11 (10 |J.g/ml) on (a)
spontaneous, (b) Ag/IgE-stimulated and (c) calcium ionophore A23187-stimulated
adhesion ofmBMMC + to laminin. 6A11 almost completely blocks adhesion
stimulated by all 3 mechanisms.
Results are expressed as median (range) of one experiment (n=4 wells).
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laminin-coated (2.11.1) wells and addition ofDNP-HSA (2.11.3). The number of
T+
mBMMC adherent after incubation for 1 h was then analysed (2.11.2).
6.6.2 Results
Spontaneous, Ag/IgE-stimulated and A23187-stimulated adhesion ofmBMMCT+ to
laminin-1 was almost completely blocked by incubation with 6A11, but not control
IgGl (figure 6.8). This shows that a7 integrin also mediates adhesion ofmBMMCT+
stimulated by these mechanisms.
6.7 EXPRESSION OF a7 INTEGRIN IN MURINE JEJUNAL EPITHELIUM
6.7.1 Experimental aim and design
Surface expression of a7 integrin has been shown in mBMMCT+, and a role for this
• • T-f-
integrin in mBMMC adhesion to laminin-1 demonstrated, but it is not known if this
integrin is expressed by intraepithelial MMC in vivo. Expression ofmMCP-1 in
intestinal epithelium was detected on days 7 and 14 post N. brasiliensis infection
(3.2.2.2), coinciding with increased numbers of intraepithelial mast cells. Therefore,
if expression of a7 integrin by MMC was high in comparison to background
epithelial expression, increased expression of a7 mRNA might also be detected in
intestinal epithelium on days 7 and 14 post-infection.
Expression of a7 integrin in control (uninfected) murine jejunal epithelium, and in
jejunal epithelium collected on days 7 and 14 post-infection (experiment 3.2) was
therefore analysed by RT-PCR (6.2). Additionally, expression of a7 was analysed by
RT-PCR in 3 samples of CMT-93 cells (2.4.4).
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6.7.2 Results
Using RT-PCR, expression of a7B integrin was detected in both uninfected and day
7 and 14 infected epithelial samples (figure 6.9). Although semi-quantitative
analysis was not performed, a7B integrin appeared to be expressed at similar levels
in all jejunal epithelial samples. Expression of a7B was also detected in 2 out of 3
samples of CMT-93 epithelial cells, suggesting that epithelial cells may be a
constitutive source of a7 expression in jejunal epithelium.
Jejunal epithelium CMT-93 cells
Time (days) 0 7 14
Figure 6.9. Expression of a7B integrin in jejunal epithelium.
Expression was analysed in murine jejunal epithelium collected 0 (uninfected
control), 7 and 14 days post-infection with A. brasiliensis\ and in CMT-93 epithelial
cells.
a7 was expressed in both control and infected jejunal epithelium, and expression was
detected in 2 out of 3 samples of CMT-93 epithelial cells.
6.8 EXPRESSION OF EXTRACELLULAR SPLICE VARIANTS OF al
INTEGRIN BYmBMMCT+
6.8.1 Experimental aim and design
Isoforms of a7 integrin, a7A and a7B, result from alternative splicing of an
intracellular region of a7, and expression of a7B was shown in mBMMCT+ by RT-
PCR. However, two extracellular splice variants of a7, named a7Xl and a7X2,
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have also been described (Ziober et al, 1993), and cells expressing either isoform
adhere differentially to isoforms of laminin (von der Mark et al, 2002). It was
therefore important to identify the extracellular splice variants ofal that are
expressed by mBMMCT+. To this end, expression of a7Xl and X2 in mBMMCT+
was investigated by RT-PCR (2.5.1 - 7) in one sample ofmBMMCT+ RNA extracted
for experiment 6.2. Specific conditions and primers used are detailed in table 2.4.
As a positive control, expression was also analysed in murine cardiac muscle, which
is reported to express both a7Xl and a7X2 (Ziober et al, 1997). Murine heart was
collected into RNA-/afcr™ and RNA extracted as described for jejunum in 2.3.4.
6.8.2 Results
The X2 isoform ofal was expressed in both heart and mBMMCT+ samples (figure
6.10). However, expression of the XI isoform could be detected in neither sample,
even after thorough optimisation of the PCR protocol, suggesting a problem with the
primers.
(a) 100 BP X1 X2 (b) 100 BP X1 X2
Figure 6.10. Expression of extracellular splice variants of al, XI and X2.
Expression was analysed in (a) mBMMCT+ and (b) adult murine heart. Primers are
reported to amplify 200 BP and 220 BP products, corresponding to the XI and X2
domains ofal.
Only expression ofX2 was detected in mBMMCT+ and murine adult heart, which is
reported to express both XI and X2 isoforms. Arrows indicate bands representative
ofX2 expression in mBMMCT+ and heart.
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6.9 DISCUSSION
The previous chapter showed TGF-(31-regulated adhesion ofmBMMC to laminin-1,
and this chapter has revealed the mechanism as being upregulation of expression of
integrin al. Additionally, supplementation with TGF-Pi was associated with down-
regulation of a5 and P3, and this may contribute towards reduced adhesion of
mBMMCT+ to fibronectin and vitronectin.
a7pi has been described as being muscle-specific (Belkin & Stepp, 2000) and,
though several non-muscle locations have been described (Veiling et al, 1996;
Klaffky et al, 2001), expression has not previously been shown in leucocytes of any
subset. Importantly, TGF-Pi-regulated expression ofal has not been shown in any
cell type, and though developmental regulation ofal has been described in muscle
and proposed for intestinal epithelium (Basora et al, 1997), the molecular signals
controlling expression in these cells are unknown.
The a7B isoform expressed by mBMMCT+ is also expressed in skeletal myoblasts,
the a7A isoform being restricted exclusively to mature skeletal muscle (Collo et al,
1993; Ziober et al, 1997; Schober et al, 2000). However, as both isoforms promote
adhesion on laminin-1 and laminin-2/4 (Yao et al, 1996; Echtermeyer et al, 1996),
which may be rich in epithelial basement membranes (Simon-Assmann et al, 1994),
a7B expression in vivo could either promote intraepithelial migration or limit egress
ofMMC from the epithelium into the lamina propria via adhesion to BM laminin.
Additionally, restricted expression of a7B by epithelial cells of the crypt-villous
junction (Basora et al, 1997), the primary location of intraepithelial MMC in vivo
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(Friend et al, 1996), suggests al may be important for adhesion of both epithelial
cells and mast cells to the basement membrane at this site.
To investigate if a7 integrin could be expressed by intraepithelial MMC in vivo,
expression was analysed in jejunal epithelium from uninfected and N. brasiliensis
infected mice. If background expression was sufficiently low, increased levels of
expression caused by intraepithelial migration ofMMC might be detected on days 7
and 14 post-infection. However, expression of a7B mRNA was detected in jejunal
epithelium from both uninfected and infected mice (figure 6.9), and appeared to be at
similar levels, though semi-quantitative analysis was not performed. This is in
agreement with previous work showing expression of a7B transcripts in murine
small intestine (Collo et al, 1993). CMT-93 epithelial cells also expressed a7B
(figure 6.9), suggesting that jejunal epithelial cells, similarly, may be the main source
ofal. Ifal is expressed by intraepithelial MMC, it is not at sufficiently high levels
to substantially increase expression in jejunal epithelium.
• • T+
The extracellular splice variant ofal which is expressed by mBMMC was also
investigated, as differential adhesion to isoforms of laminin have been shown in cells
expressing either al XI or X2 (von der Mark et al, 2002). Both XI and X2 promote
adhesion to laminin-2, but XI shows high affinity binding to laminins-8 and -10/11,
whereas X2 binds to laminin-1 with much higher affinity than X2. Expression ofX2
by mBMMCT+ is therefore consistent with their adhesion to laminin-1; expression of
Ti
XI was detected in neither mBMMC nor murine heart, which was used as a
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positive control (figure 6.10), therefore it is unclear if this isoform is expressed by
mast cells.
Previous studies (Fehlner-Gardiner et al, 1996a; Vliagoftis & Metcalfe, 1997) have
implicated integrin a6 in promotion of murine mast cell adhesion to laminin-1 and
-2, however these studies used several mast cell lines and IL-3-dependent mBMMC,
which may be more representative of immature mast cells. mMCP-l+ mBMMCT+
closely resemble intraepithelial MMC (Scudamore et al, 1997; Miller et al, 1999),
and whilst these cells expressed a6 transcripts at levels similar to those of
mBMMC " (figures 6.1 and 6.2) flow cytometry showed low expression of a6 in
both cell types (figure 6.3). This made a6 an unlikely candidate for regulation of
y_i_mBMMC adhesion to laminin, and inclusion of the anti-a6 monoclonal GoH3 in
adhesion assays had no effect on adhesion ofmBMMCT+ to laminin-1 (figure 6.5).
Positive expression of a6 by flow cytometry in MC/9 cells, and GoH3-mediated
inhibition of adhesion to laminin-1 further supports our conclusion that a6 integrin
plays no role in adhesion ofmBMMCT+ to laminin-1.
Human skin mast cells also adhere to laminin, but do not significantly express a6
integrin, and adhesion is inhibited by antibodies to a3 integrin (Columbo et al,
1995). Antibodies to a3 integrin were not included in our studies, but in view of
conclusive evidence for the role of a7 integrin in adhesion ofmBMMCT+ (MMC
• • t+
homologues), and because the expression of a3 mRNA expression in mBMMC
was similar to that in mBMMC1" which do not adhere to laminin, a major role for a3
223
integrin in laminin binding seems unlikely in MMC. The importance of different
integrins in adhesion to laminin may vary between mast cell phenotypes, a6 possibly
playing a role only in adhesion of immature mast cells, whilst a3 and a7 may
mediate adhesion ofmature connective tissue mast cells and MMC, respectively to
laminin.
LBP has been implicated in adhesion of IL-3-dependent mBMMC to laminin-1
(Thompson et al, 1989a; Thompson et al, 1990), but expression of LBP mRNA was
similar in both mBMMC1" and mBMMCT+. Also, 37 and 25 kDa bands, which may
have represented LBP, were detected by Western blotting in both mBMMC1" and
T+
mBMMC (figure 6.4). The antibody used, which was raised against a 17-mer
synthetic peptide from the N-terminal region of LBP 32, has been reported to
recognise 32 and 45 kDa proteins (Clement et al, 1990), but detection of proteins
running slightly lower at 42 and 31 kDa has also been reported (Nomizu et al, 1995).
The bands detected may represent expression of LBP but, as expression of LBP is
post-transcriptionally regulated (Landowski et al, 1995) and both intracellular and
cell-surface forms exist, detection of protein expression does not necessarily reflect
surface expression of receptor.
Functional studies would be required to demonstrate a role for LBP in adhesion of
mBMMCT+ to laminin-1, as in IL-3-dependent mBMMC (Thompson et al, 1989a;
Thompson et al, 1990), but attempts were unsuccessful due to high background
inhibition of adhesion using control serum. Studies of T-lymphocytes (Canfield &
Khakoo, 1999) showed that a6-mediated adhesion to laminin is dependent on co-
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expression of LBP suggesting possible co-ordinate interactions between integrins and
LBP. Therefore, a role for LBP in adhesion ofmBMMCT+ to laminin-1 cannot be
excluded, as LBP may also act as a co-receptor for integrin ot7.
a5 integrin is expressed throughout differentiation of both IL-3-dependent mBMMC
and human CBMC (Tachimoto et al, 2001), and is also expressed by mature human
tissue mast cells in lung, skin and uterus (Sperr et al, 1992), but expression of this
Ti
integrin appears not to be a feature ofmBMMC . As shown by flow cytometry
(figure 6.3), functional expression of a5 in mBMMC may be post-transcriptionally
• T"
down-regulated since mRNA levels of this integrin were similar in both mBMMC
T+ • •
and mBMMC (figure 6.1). However, it is also possible that the semi-quantitative
RT-PCR method used was insufficiently sensitive to detect small changes in
transcription that may have occurred.
Reduced adhesion ofmBMMCT+ to fibronectin demonstrated in the previous chapter
may have been due to TGF-Pi-mediated down-regulation of a5 expression.
However, pretreatment with 5H10-27 only partially blocked adhesion ofmBMMC1"
to fibronectin, with median reductions in adhesion ranging from 19 - 52% in separate
experiments using cells from different cultures (figure 6.6; appendix 2, table A2.9).
This may have been due to expression of other fibronectin binding integrins, the
balance between which may vary between cultures. In support of this, partial
inhibition of IL-3-dependent mBMMC adhesion to fibronectin was attributed to co-
expression of integrin a4, which was down-regulated in older cultures (Fehlner-
Gardiner et al, 1996b). Further work would aim to investigate the role of a4 in
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TmBMMC " adhesion to fibronectin, however, these cells are phenotypically
undefined and their role in this study was primarily as a comparator for mBMMCT+,
as MMC homologues. Therefore exhaustive investigation of their adhesion
mechanisms was not the main focus of this work.
Transcriptional down-regulation of expression of the integrin subunit P3, which
dimerises with av to form a vitronectin-binding integrin, may represent the
mechanism ofTGF-Pi-mediated down-regulation ofmBMMC adhesion to
vitronectin. However, we showed only low expression of av on mBMMC1" by flow
cytometry (figure 6.3), and use of a monoclonal anti-av antibody did not
• T
significantly block mBMMC " adhesion to vitronectin (figure 6.7). Therefore,
although avP3 is the most likely candidate, the receptor mediating adhesion of
t
t
mBMMC " to vitronectin is unknown. These results are in contrast to those from
similar investigations using IL-3-dependent mBMMC (Bianchine et al, 1992) and
human skin mast cells (Columbo & Bochner, 2001), where adhesion to vitronectin
was inhibited by anti-avP3 polyclonal antibody and av expression was demonstrated
by flow cytometry. The reason for this may be technical problems with the antibody,
as no positive control was available, or it may be that av integrin does not play a role
in adhesion ofmBMMC1" to vitronectin.
As mentioned previously, the in vivo relevance of mBMMC " is unknown, but they
are likely to represent a more immature mast cell than mBMMCT+. If down-
regulation of expression of integrins mediating adhesion to ECM proteins fibronectin
and vitronectin occurs during differentiation from immature into mature MMC in
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vivo, it could promote disengagement from the ECM of the lamina propria, possibly
allowing intraepithelial migration. Thus, the combined TGF-0] -mediated down-
regulation of a5 and 03, and the selective upregulation of the laminin-binding
integrin a7 may synergistically regulate intraepithelial migration ofmast cells and
maintenance ofMMC intraepithelial^.
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CHAPTER 7
GENERAL DISCUSSION
Mast cells are an integral part of the immune response to gastrointestinal nematodes,
and the aim of this work was to investigate the mechanisms regulating migration of
MMC from the lamina propria into the jejunal epithelium following nematode
infection.
The problem was addressed by focussing on three main hypotheses. The first
hypothesis was that intestinal nematode infection would lead to upregulation of
expression of possible mast cell chemoattractants by intestinal epithelium. The
second hypothesis, therefore, was that MC would express receptors for chemokines
expressed by intestinal epithelium, and that this expression is regulated during mast
cell differentiation. The third hypothesis was that as TGF-pi regulates expression of
the epithelial cell-binding integrin aE (Miller et al, 1999), it could also regulate
expression of ECM-binding integrins, which could play a role in intraepithelial
migration ofMMC.
The first hypothesis was addressed in chapter 3, which showed that mRNA for
several potential mast cell chemoattractants was constitutively expressed by jejunal
epithelium, including RANTES, MlP-la, fractalkine, SCF and TGF-Pi; TECK,
which is chemotactic for IEL, was also expressed constitutively. Only MCP-1 was
upregulated on N. brasiliensis infection, and high expression of this chemokine by
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T+mBMMC was consistent with the hypothesis that upregulation ofMCP-1
expression in intestinal epithelium was derived from influx ofMMC.
The results of chapter 4 showed that mBMMCT+ expressed mRNA for receptors
corresponding to the chemokines expressed by intestinal epithelium; the receptors
expressed included MlP-la and RANTES receptors CCR1 and CCR5, the MCP-1 -
5 receptor CCR2, and the fractalkine receptor CX3CR1. IfmRNA is similarly
expressed by MMC in vivo, and is translated to functional receptor protein, this
would enable continuous migration ofmast cells towards epithelium, implying that
mast cell homing must be limited by other factors, as discussed in chapter 3.
However, before reaching this conclusion, further work would be required to show
expression of chemoattractant and receptor proteins by jejunal epithelium and MMC.
Commercially available ELISA kits could be used to investigate expression of
chemokine protein (Li et al, 1998; Realq et al, 1998). Dual immunofluorescent
staining for mMCP-1 and the receptor proteins would show receptor expression by
MMC, though studies would be limited by the availability of anti-murine chemokine
receptor antibodies and by fixation problems, as expression ofmMCP-1 is difficult to
show in frozen sections. Techniques such as tyramide amplification could be used to
increase sensitivity of detection of sparsely expressed receptor proteins (Toda et al,
1999). In .s'/fw-hybridisation would be an alternative method for demonstrating the
cells expressing receptor mRNA, although this would not prove protein expression.
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Expression of functional receptor proteins by mBMMCT+ could be shown by flow
cytometry and chemotaxis assays, and investigation ofmigration ofmBMMCT+ into
cultured intestinal epithelial monolayers could also be included. The majority of
available chemokine receptor antibodies are not functionally-blocking, but the effect
of specific small molecule antagonists such as met-RANTES, or of desensitising
concentrations of chemokines (Phillips & Ager, 2002) on intraepithelial migration of
mBMMCT+ could be investigated.
Our third hypothesis was that TGF-Pi could regulate adhesion ofmast cells to ECM
proteins. TGF-Pi did upregulate adhesion ofmBMMCT+ to the BM protein, laminin,
via expression of integrin al. This was unexpected as adhesion of IL3-dependent
murine mast cells (Fehlner-Gardiner et al, 1996a; Vliagoftis & Metcalfe, 1997) and
other leucocytes (Belkin & Stepp, 2000) to laminin is regulated by a6 integrin.
The major role ofal, as discussed in chapter 6, is thought to be adhesion of skeletal
myoblasts and mature skeletal myocytes to laminin, and the spectrum of adhesion is
different to that of a6: al isoforms adhere to laminins —1, -2/4 and -10/11 (von der
Mark et al, 2002), but not to laminin-5. Although expression ofal by epithelial
cells has been reported and is thought to participate in interactions with the BM
(Basora et al, 1997), some authors state that laminin-5 is the major laminin isoform
ofBM in vivo (Falk et al, 1999; Erickson & Couchman, 2000), and that interactions
of integrins a6pi and a6p4 with laminin-5 regulate epithelial cell attachment
(Belkin & Stepp, 2000).
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The relevance of a7 expression by mBMMCT+ to intraepithelial maintenance of
MMC is therefore debatable and, if it is expressed by MMC in vivo, a7 may regulate
aspects ofmast cell function other than migration into jejunal epithelium. However,
recent studies performed in our laboratory have co-localised expression of integrin
a7 and aE in intraepithelially located cells ofmurine jejunum collected on day 9 of
infection with N. brasiliensis, which are likely to be mast cells (figure 7.1). Fixation
problems currently limit co-localisation with mMCP-1, but further studies using anti-
IgE antibody would confirm the presumed identity of these cells, and strongly
suggest some function for a7 in intraepithelial MMC.
Use of a7 knock-out mice (Mayer et al, 1997) would be central to further
investigations of the role of oc7p 1 in intraepithelial migration or maintenance of
MMC. Comparison of intraepithelial MMC numbers in these mice, to those in wild-
type mice could determine the importance of a7 in these processes.
Expression of a7 by mBMMCT+ is regulated by TGF-Pi, and expression by MMC in
vivo may also be regulated by this cytokine. In vivo, secreted TGF-Pi must be
activated to form a functional molecule, and epithelially-expressed integrin avp6 has
been implicated in this process (Munger et al, 1999). Recent studies in our
laboratory have shown co-expression of TGF-Pi and integrin avp6 in murine jejunal
epithelium, and that p6 knock-out mice have significantly reduced numbers of
intraepithelial MMC following N. brasiliensis infection (Knight et al, 2002). This
result is consistent with a role for TGF-Pi in the intraepithelial MMC response to
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Figure 7.1. Integrin a7 and aE dual labelling of frozen sections ofmurine
jejunum infected 9 days previously with TV. brasiliensis .
Confocal images of (a), (b), (e) and (f) jejunal epithelium and crypts; and (c), (d)
jejunal smooth muscle.
a7 integrin was labelled with mouse anti-mouse-a7 IgGl (clone 3C12)((a) and (c))
or isotype control (e).
aE integrin was labelled with rat anti-mouse aE IgG2a (Becton Dickenson)((b) and
(d)) or isotype control (f).
(a) and (b) show co-localisation of expression of integrins a7 and aE in jejunal
epithelium, whereas, as expected, smooth muscle expresses a7 but not aE. Sections
(e) and (f), labelled with isotype controls, are negative.
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nematode parasites, and the mechanisms could include regulation of intraepithelial
migration and retention ofMMC via expression of a7pi.
Use ofmBMMCT+ as MMC homologues has formed a large part of this study,
therefore the suitability ofmBMMCT+ for study of the biology ofMMC is an
important consideration. These cells are, as described in 1.6.5 and 2.4.1, cultured in
the presence of four cytokines IL-3, IL-9, SCF and TGF-|3i, which result in
differentiation into cells resembling MMC in terms of both morphology and
expression ofmMCP-1. However, in vivo, mast cell differentiation is likely to occur
in the presence of a number of cytokines and other molecules, some ofwhich
including IL-4 (Hamaguchi et al, 1987), IL-6 (Yuan et al, 1998) and IL-10
(Thompson-Snipes et al, 1991; Yuan et al, 1998), regulate mast cell differentiation.
Ti
mBMMC are known to resemble MMC in some respects, but the extent of this
homology with respect to adhesion molecules remains to be confirmed.
As discussed in chapter 4, the culture system used is not suitable for examination of
MC precursors, which would confirm the trends in chemokine receptor expression
suggested in chapter 4, and enable investigation of the chemokines regulating
recruitment ofmast cell precursors into the jejunal mucosa. Further work would
include development of an assay to determine ifmast cell precursors from a
population of freshly isolated murine bone marrow cells migrated towards the
relevant chemokines; this would confirm expression of functional receptor proteins.
Enrichment for mast cell precursors in migrated cells could be shown by comparison
of% MMC in migrated versus non-migrated populations.
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If expression of the molecules described does regulate intraepithelial migration of
MMC in vivo, how then would these mechanisms compare with those of other cells?
The most obvious and relevant comparison would be that of IEL, which also reside
in the intestinal epithelium. IEL and mBMMCT+ share expression of some
chemokine receptors including CCR2 (Agace et al, 2000), CCR5 (Agace et al, 2000;
Shires et al, 2001), CX3CR1 (Muehlhoefer et al, 2000) and CXCR4 (Agace et al,
2000), suggesting common recruitment mechanisms. However, as discussed in
Ti
# t
chapter 4, mBMMC do not express CCR9, which is thought to be critical to small
intestinal recruitment of T lymphocytes (Kunkel et al, 2000), suggesting possibly
that mast cells and IEL share expression of receptors for chemokines expressed in
inflammation, but not those reputedly involved in trafficking.
T+
Both IEL and mBMMC express the integrin aEp7 in a TGF-Pi-dependent fashion,
which may maintain both cell-types intraepithelially, but investigations of adhesion
of IEL to ECM proteins suggests these two cells-types may differ in this respect. In
one study (Roberts et al, 1999), IEL adhered strongly to type IV collagen compared
to peripheral blood CD8+ T cells; antibodies to integrins al and pi blocked this
adhesion. Adhesion of IEL to type IV collagen was hypothesised to support
maintenance of these cells intraepithelially and, in support of this, there was a 50%
reduction of IEL in VLA1 (aipi) null mice (Meharra et al, 2000). mBMMCT+
adhered to type IV collagen in some experiments (appendix 2, table A2.3), but this
was inconsistent, and these cells adhered most avidly to laminin. In contrast, IEL
adhered poorly to laminin (Roberts et al, 1999), and showed low expression of
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integrin a6(31, the major laminin receptor for IL3-dependent mBMMC and T-
lymphocytes. To our knowledge, expression of the integrin al has not been shown
in IEL, though a recent study of gene expression in IEL using SAGE analysis
demonstrated strong expression of LBP, and integrins aE and P7 (Shires et al, 2001).
Therefore, if a role for al integrin is shown in intraepithelial location of MMC, it is
possible that IEL and MMC interact with the epithelial BM by different mechanisms.
Since MMC but not IEL are recruited following infection ofmice with N.
brasiliensis (Knight et al, 2002), some differences in the recruitment mechanisms of
these two cell types might be expected.
This study suggests that, as in other leucocytes and mast cell phenotypes, interplay
between integrins and chemokines is likely to regulate migration ofMMC and their
Ti
precursors. It has also shown that mBMMC adhere to laminin-1 through
expression ofal integrin, which has not previously been demonstrated in a
haemopoietic cell. The physiological significance of this finding is yet to be
determined, but this and other aspects of this work have opened up many avenues of
further investigation of the migratory mechanisms and biological functions ofMMC.
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APPENDIX 1
Preparation of solutions, buffers and substrates.
10 x PBS
85.0 g NaCl
27.0gNa2HPO4.12H2O
3.9 g NaH2P04.2H20
Dissolve in 1 litre of deionised water and dilute x 10 before use.
CARNOY'S FIXATIVE
60 ml 100% ethanol
30 ml chloroform
10 ml glacial acetic acid
20 X SALINE SODIUM CITRATE (SSC)
(3 M NaCl / 0.3 M sodium citrate)
175.3 g NaCl
88.2 g sodium citrate
Dissolve in 1 litre of deionised water and pH to 7.5 with HC1
Dilute as necessary to make SSC and SSC / SDS solutions used for washes during
Southern blotting.
MALEIC ACID BUFFER
(0.15 M NaCl / 0.1 M Maleic acid)
8.8 g NaCl
11.6 g Maleic acid
Dissolve in 1 litre of deionised water and adjust pH to 7.5 with solid NaCl then
concentrated NaCl.
CARBONATE BUFFER FOR ELISAS
A. 0.1 M NaHC03 - Dissolve 0.84 g NaHC03 in 100 ml deionised water
B. 0.1 M NaC03 - Dissolve 1.06 g NaCC>3 in 100 ml deionised water
Add solution B to solution A until the pH reaches 9.6.
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SCOTT'S TAP WATER
1 litre tap water
3.5 g NaHC03
20.0 g MgS04.7H20
Adjust pH to 8.0
SUBSTRATE BUFFER FOR p-HEXOSEAMINIDASE ASSAY
(7.5 mM p-nitrophenol-N-p-glucoseaminide)
A. 0.1 M citrate buffer, pH 5.0 - Dissolve 5.25 g citric acid monohydrate in 250 ml
of deionised water, pH to 5.5 with NaOH.
B. 0.5% triton -X 100 in deionised water
Dissolve 0.052g of 7.5 mM p-nitrophenol-N-P-glucoseaminide in 20 ml of buffer A,
heating gently and stirring. Add 20 ml of solution B, aliquot and store at -20°C.
SOLUBILISATION OF PROTEINS USED FOR COATING OF ELISA
PLATES IN ADHESION ASSAYS
Proteins were solubilised and stored as recommended by Sigma (table A1.1).
Protein Solubilisation method
Rat tail type I Solubilised at 1 mg/ml in sterile distilled H20 with 0.1%
collagen glacial acetic acid, agitating gently for 1 h, and stored
undiluted at 4°C before use.
Human placenta Solubilised at 1 mg/ml in sterile distilled H20, agitating
type IV collagen gently, and stored undiluted at 4°C before use.
Bovine fibronectin Solubilised at 1 mg/ml in sterile distilled H20 by leaving to
stand at 37°C for 30 min and stored undiluted at 4°C.
Murine Engelbreth- Laminin-1 was provided in a 1 mg/ml solution in Tris-
Holm-Swarm buffered saline. Before use, it was aliquoted and stored at
sarcoma laminin-1 -20°C.
Bovine plasma Solubilised at 50 pg/ml in sterile distilled H20 and stored
vitronectin undiluted at 4°C before use.
Table Al.l. Solubilisation ofECM proteins, all obtained from Sigma.
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SOLUBILISATION OF STIMULATING AGENTS USED FOR
ADHESION ASSAYS
PHORBOL MYRISTATE ACETATE (PMA)
PMA was dissolved at 1 mg/ml in DMSO and stored at -20°C in the dark. For
adhesion assays, PMA in DMSO was diluted 1:1000 in PBS and 5 ju.1 added to each
well to make a final concentration of 50 ng/ml.
CALCIUM IONOPHORE A23187
Calcium ionophore was dissolved at 1 mg/ml in DMSO and stored at room
temperature. For adhesion assays, calcium ionophore in DMSO was diluted 1:100 in
PBS and 5 pi added to each well to make a final concentration of 1 pM.
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APPENDIX
2
Results
of
repeat
experiments
in
chapters
5
and
6.
Expt
BSA
Coll
I
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IV
Fibronectin
Vitronectin
Laminin-1
1
h
2
h
1
h
2
h
1
h
2
h
1
h
2
h
1
h
2
h
1
h
2
h
1
0.3
0.0
0.4
0.0
1.0
0.0
5.3
0.0
0.5
0.0
42.2
26.6
(0.2
-
0.4)
(0.0
-
0.0)
(0.3-0.6)
(0.0-0.0)
(0.3-1.1)
(0.0-0.0)
(4.3-6.0)
(0.0-0.0)
(0.3
-
0.9)
O
O
1
O
o
(38.3-58.1)
(25.0-54.5)
2
0.0
ND
0.0
ND
0.0
ND
1.3
ND
0.0
ND
58.6
ND
(0.0-0.0)
(0.0-0.0)
0.0-0.0
(0.1-2.3)
(0.0-0.0)
(55.4-67.4)
3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
42.6
14.6
(0.0-0.0)
(0.0-0.0)
(0.0
-
0.0)
(0.0-0.0)
(0.0-0.0)
(0.0-0.0)
(0.0-0.0)
(0.0-0.0)
(0.0-0.0)
(0.0
-
0.0)
(31.8-43.8)
(14.5-17.6)
T+
Table
A2.1.
Experiment
5.2
-
investigation
of
adhesion
of
unstimulated
mBMMC
to
ECM
proteins.
mBMMCT+
were
incubated
for
1
or
2
h
in
wells
coated
with
20
pg/ml
of
ECM
proteins.
Results
are
expressed
as
median
(range)
n=3
wells
of
%
mBMMC
adherent.
Values
<
0
were
assigned
as
0.
ND
=
Not
done
in
this
experiment.
Laminin-1
Fibronectin
Vitronectin
Expt.
mBMMC1"
mBMMC1+
mBMMC7"
mBMMCT+
mBMMC7"
mBMMC
Control
PMA
Control
PMA
Control
PMA
Control
PMA
Control
PMA
Control
PMA
1
0.0
5.9
5.5
51.8
2.6
81.5
2.5
14.3
0.0
67.3
0.4
5.0
(0.0
-
0.0)
(3.4
-
8.9)
(4.4
-
5.6)
(42.3
-
59.5)
(4.2-5.6)
(80.8
-
86.7)
(1.6-9.0)
(13.8-18.9)
(0.0
-
0.0)
(51.3-76.6)
(0.3-0.5)
(3.0-5.1)
2
1.1
14.3
25.1
52.5
19.2
77.5
0.3
12.7
0.8
30.8
0.0
3.6
(0.0-
11.9)
(10.6-21.3)
(21.5-41.0)
(46.3
-
62.5)
(14.8-34.1)
(73.5
-
89.5)
0.0-1.1)
(11.1-24.9)
(0.6-1.2)
(24.1-41.8)
(0.0
-
4.7)
(2.7-4.8)
3
0.0
0
57.7
67.4
0.8
50.1
0.0
0
0.0
5.5
0.0
0.0
(0.0
-
0.0)
(0-0)
(48.6-61.5)
(62.1
-79.4)
(0
-
2.2)
(29.1
-56.5)
(0.0
-
0.0)
(0.0-0.9)
(0.0
-
0.0)
(3.2-18.9)
(0.0
-
0.0)
(0.0
-
0.0)
4
0.0
60.2
20.8
60.2
1.6
57.5
0.0
0.7
0.3
49.5
0.0
0.8
(0.0
-
0.0)
(46.6-76.9)
(7.3-35.8)
(46.6
-
76.9)
(0.4-4.4)
(51.7-65.6)
(0.0
-
0.0)
(0.0-3.5)
(0.2-0.5)
(31.0-60.7)
(0.0
-
0.0)
0.0-2.5)
Table
A2.2.
Experiment
5.4
-
adhesion
of
mBMMC1"
and
mBMMCT+
to
laminin-1,
fibronectin
and
vitronectin.
Data
are
from
4
separate
adhesion
experiments
(expt.),
each
performed
in
quadruplicate
using
cells
from
separate
cultures.
Results
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
Values
<
0
were
assigned
as
0.
Type
I
collagen
Type
IV
collagen
BSA
Expt.
mBMMC'"
mBMMC1
+
mBMMC1"
mBMMCT+
mBMMC1"
mBMMCT+
Control
PMA
Control
PMA
Control
PMA
Control
PMA
Control
PMA
Control
PMA
1
0.0
13.8
0.0
1.4
0.0
0.9
0.0
0.3
0.4
0.1
0.9
1.4
(0.0-0.3)
(11.9-18.3)
(0.0
-
0.7)
(0.8-1.5)
oT
o
d
(0.8-2.9)
(0.0
-
0.0)
(0.0
-
0.6)
(0.0-2.1)
On"
O
d
(0.5-2.0)
(0.4-2.7)
2
0.0
22.3
0.0
3.2
0.0
2.3
0.0
0.0
0.0
0.4
0.9
0.0
(0.0
-
4.3)
(15.5-31.2)
(0.0
-
0.0)
(0.0
-19.7)
(0.0
-
0.7)
(0.5-3.1)
(0.0
-
0.0)
VI
o
o,
(0.0-3.0)
(0.0-1.0)
(0.0
-
2.4)
(0.0
-
0.0)
3
0.0
0.0
0.0
0.0
0.0
24.5
0.0
0.0
0.0
0.0
0.0
0.0
(0.0-2.3)
o
d
(0.0-6.7)
(0.0-2.3)
(0.0-1.8)
(22.4-41.6)
(0.0
-
0.0)
(0.0-16.3)
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
2.5)
(0.0
-
0.0)
(0.0
-
9.2)
O)
o
d
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.0)
Table
A2.3.
Experiment
5.4
-
adhesion
of
mBMMC1"
and
mBMMCT+
to
type
I
collagen,
type
IV
collagen
and
BSA.
Data
are
from
4
separate
adhesion
experiments
(expt.)
each
performed
in
quadruplicate
using
cells
from
separate
cultures.
Results
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
Values
<
0
were
assigned
as
0.
Expt.
n
Control
Ag
IgE
Ag/IgE
A23187
PMA
1
3
0.0
ND
ND
22.5
ND
33.1
(0.0
-
0.0)
(17.6-25.3)
(27.2
-
45.0)
2
4
6.1
7.3
16.8
32.7
17.3
42.4
(2.5-8.2)
(6.7-14.7)
(14.9-
19.4)
(21.4-48.6)
(15.0-36.3)
(27.9
-
63.6)
3
4
19.4
25.4
17.4
12.5
26.8
47.7
(13.3-32.5)
(19.4-46.0)
(13.0-40.1)
(8.8-
18.3)
(18.3-51.4)
(21.2-90.2)
4
4
11.1
10.1
8.9
28.8
21.4
49.4
(5.1-21.1)
(8.0-12.4)
(0.0
-
27.5)
(18.5-36.7)
(18.8-21.7)
(35.0
-
60.3)
5
3
19.9
ND
ND
23.8
31.6
38.8
(19.1
-27.8)
(21.0-33.8)
(20.8-33.8)
(36.5
-42.1)
Table
A2.4.
Experiment
5.9
-
regulation
of
the
adhesion
of
mBMMCT+
to
laminin-1.
Data
are
from
5
experiments
investigating
mechanisms
stimulating
adhesion
of
mBMMCT+
to
laminin-1.
Results
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
ND
=
not
done
in
this
experiment.
Values
<0
were
assigned
as
0.
Expt.
n
Control
Ag
IgE
Ag/IgE
A23187
PMA
1
3
1.6
ND
ND
67.0
ND
77.3
(1.4-4.8)
(52.5
-
76.4)
(72.4
-
78.2)
2
4
31.6
19.5
7.0
44.7
45.8
93.8
(14.1
-41.4)
(9.2
-
36.6)
(4.3
-
27.0)
(25.7-61.3)
(29.6-57.8)
(67.4-
100.0)
3
4
0.0
0.0
0.0
33.8
0.0
74.4
(0.0
-
0.0)
(0.0
-
0.0)
(0.0
-
0.2)
(31.1-37.2)
(0.0
-
37.2)
(69.3
-
75.7)
Table
A2.5.
Experiment
5.9
-
regulation
of
the
adhesion
of
mBMMC1"
to
fibronectin.
Results
of
3
experiments
investigating
mechanisms
stimulating
adhesion
of
mBMMC1"
to
fibronectin.
Data
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
ND
=
not
done
in
this
experiment.
Values
<0
were
assigned
as
0.
Expt.
n
Control
Ag
IgE
Ag/IgE
A23187
PMA
1
3
0.0
ND
ND
38.9
ND
58.0
(0.0
-
0.0)
(27.5
-43.2)
(50.0-66.8)
2
4
0.0
ND
ND
10.3
3.3
43.7
(0.0
-
0.0)
(4.9-
14.0)
(1.5-4.4)
(38.8
-48.9)
Table
A2.6.
Experiment
5.9
-
regulation
of
the
adhesion
of
mBMMC7"
to
vitronectin.
Results
of
2
experiments
investigating
mechanisms
stimulating
adhesion
of
mBMMC7"
to
vitronectin.
Data
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
ND
=
not
done
in
this
experiment.
Values
<0
were
assigned
as
0.
Expt.
n
6A11
IgGl
No
antibody
%
reduction
1
3
0.0
(0.0-0.0)
52.7(48.4-60.5)
63.8
(57.2-79.6)
100
2
4
1.5
(1.2-2.5)*
65.4(59.3-69.0)
59.4
(54.7-72.3)
97.7
3
4
0.2
(0.0-0.4)*
80.9(80.4-85.5)
73.7
(69.3
-77.7)
99.8
Table
A2.7.
Antibody
blocking
experiment
6.5
-
6A11.
Results
of
3
experiments
investigating
the
effect
of
the
anti-a7
monoclonal
6A11
or
IgGl
control
(10
pg/ml)
adhesion
of
mBMMCT+
to
laminin-1.
Preincubation
with
6A11
results
in
a
significant
(p<0.05)(*)
reduction
in
adhesion
of
mBMMCT+to
laminin,
compared
to
cells
incubated
with
IgG2a
control,
or
no
antibody.
Data
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
Values
<0
were
assigned
as
0.
Expt.
n
GoH3
IgG2a
No
antibody
%reduction
MC/9
1
3
0.7
(0.7-0.8)
36.5
(34.3-47.0)
43.8
(40.8-48.5)
98.1
2
4
2.1
(2.0
-
2.8)*
30.1
(22.6-47.6)
39.4
(35.9-40.5)
94.4
3
4
1.7
(0.7-2.7)*
71.7(68.6-74.9)
76.5
(74.3
-
80.0)
97.6
mBMMCT+
1
3
68.5
(59.5-73.1)
70.8
(61.3
-70.8)
62.6
(59.4-67.5)
3.2
2
4
85.8
(76.9-
100.0)
84.5
(61.3
-88.7)
77.3
(73.3-79.0)
-1.5
3
4
60.1
(53.7-73.2)
59.2
(51.2-75.3)
45.7
(41.7-64.2)
-1.5
Table
A2.8.
Antibody
blocking
experiment
6.5
-
GoH3.
Results
of
3
experiments
investigating
the
effect
of
the
anti-a6
monoclonal
GoH3
or
IgG2a
control
(1
pg/ml)
on
adhesion
of
MC/9
cells
or
mBMMCT+
to
laminin-1.
Preincubation
of
MC/9
cells
with
GoH3
resulted
in
a
significant
(p<0.05)(*)
reduction
in
adhesion
to
laminin-1
compared
to
cells
incubated
with
IgG2a
control,
or
no
antibody.
In
contrast,
incubation
of
mBMMCT+
with
GoH3
under
the
same
conditions
did
not
inhibit
adhesion
to
laminin-1.
Results
are
expressed
as
median
(range)
of
%
mBMMC
adherent.
Values
>100
were
assigned
as
100.
Expt
Ab
conc.(pg/ml)
5H10-27
IgG2a
No
antibody
%
reduction
1
1
23.7
(15.9-26.3)*
49.4
(46.4-56.1)
56.5
(32.5-63.4)
52.0
1
5
22.4(17.3
-27.7)*
43.7
(39.5-48.0)
56.5
(32.5-63.4)
48.7
1
10
16.8(14.4-51.5)
48.2
(44.2-55.0)
56.5
(32.5-63.4)
65.1
2
10
46.7
(39.9-48.3)*
57.7
(54.6-62.2)
ND
19.0
3
10
43.5
(37.2-46.9)*
59.4
(57.2-60.6)
50.8
(44.6-56.2)
26.8
4
10
40.7
(16.7-58.4)
63.6
(44.3-69.1)
63.1
(50.6-72.2)
36.0
Table
A2.9.
Antibody
blocking
experiment
6.5
-
5H10-27.
Results
of
4
experiments
investigating
the
effect
of
the
anti-a5
monoclonal
5H10-27
or
IgG2a
control
on
adhesion
of
mBMMC1"
to
fibronectin.
*
indicates
a
significant
difference
(p<0.05)
between
adhesion
of
mBMMC1"
incubated
with
5H10-27
and
IgG2a.
Data
are
expressed
as
median
(range)
of
%
mBMMC
adherent,
n=4
wells.
ND
=
not
done
in
this
experiment.
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SUMMARY
Infection ofmice with the nematode parasite Nippostrongylus
brasiliensis results in a well characterized intestinal mastocy¬
tosis with intraepithelial migration of mucosal mast cells
(MMC). The molecules mediating this response are unknown.
We examined expression of several putative mast cell chem-
oattractants in intestinal epithelium following N, brasiliensis
infection. Expression of the chemokines monocyte chemoat-
tractant protein-1 (MCP-I), macrophage inflammatory
protein-la (MlP-la), RANTES (regulated on activation
normal T-cell expressed and secreted), fractalkine, and
thymocyte expressed chemokine (TECK); and the cytokines
stem cell factor (SCF) and transforming growth factor /},
(TGFl3j), was constitutive and no alteration was detected
following infection. MCP-I expression was also constitutive
hut at much lower levels and increased expression was delected
on days 7 and 14 postinfection. Expression of MCP-1 in whole
jejunum was at much higher levels than in epithelium. Consti¬
tutive expression of MCP-1. MIP-la and TGFfjj was also
detected in cultured bone marrow-derived homologues of
MMC. In an intestinal epithelial cell line (CMT-93), there
was constitutive expression of SCF, TGFaly fractalkine and
MCP-1. The results show that, in vivo, epithelium is a poten¬
tially important source of mast eelI chemoattractants.
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INTRODUCTION
As the first point of host contact, the epithelium is well
placed for an important role in the immune response to gut-
dwelling pathogens including nematode parasites. Expression
of chemoattractant molecules by epithelial or intraepithelial
cells may initiate the immune response by attraction of the
necessary spectrum of immune cells for parasite expulsion,
and recent attention has focused on chemokines as co¬
ordinators of the immune response by specific recruitment of
inflammatory cells. These molecules are a structurally related
group of 8-10 kDa inducible cytokines that are chemotactic
for a variety of immune cells, including dendritic cells (1), T-
cells, monocytes, neutrophils (2,3) and mast cells (4-7), and
are up-regulated in inflammatory diseases.
There is considerable evidence that modulation of chemo¬
kine expression plays an important role in the epithelial
response to intestinal infections. Interaction of invasive
bacteria stimulates up-regulation of monocyte chemoat¬
tractant protein-1 (MCP-1) and interleukin (IL)-8 in cultured
colon epithelial cells (8) and rotavirus infection of cultured
intestinal epithelium stimulates up-regulation of macro¬
phage inflammatory protein-la (MlP-la), MCP-1 and
RANTES (regulated on activation normal T-cell expressed
and secreted) (9). Also, stimulation of epithelium by pro¬
inflammatory cytokines such as IL-1 and tumour necrosis
factor a (TNFa) can up-regulate chemokine expression (10).
Less is known about the intestinal epithelial response to
gut-dwelling parasites, but studies using both cell culture
(11) and epithelial isolation methods (12) have shown
increases in IL-1 (3, IL-8 and epithelial-neutrophil activating
peptide-78 (ENA-78) in response to infection with the
nematode parasite, Trichinella spiralis. The epithelial cytokine
and chemokine response to Nippostronglylus brasiliensis
infection has not been studied but the cellular response to
this nematode is well characterized; infection of mice with
N. brasiliensis L3 larvae results in an intestinal mastocytosis
with intraepithelial migration (13). Since a number of
© 2002 Blackwell Science Ltd 67
A. Rosbottom et al. Parasite Immunology
chemokines are chemotactic for certain mast cell phenotypes
(4-7,14), it is possible that epithelially derived chemokines
could mediate this migration. In addition to this, the
cytokines stem cell factor (SCF) and transforming growth
factor Pj (TGFP,), which may also be expressed by epithe¬
lium (15,16), are both potential mast cell chemoattractants
(17,18). We therefore examined expression of the putative
mast cell chemoattractants MIP-lcc, MCP-1, RANTES,
fractalkine, SCF and TGFp,; along with the T-cell chemo-
attractant thymocyte expressed chemokine (TECK), in
intestinal epithelium following N. brasiliensis infection. The
expression of these cytokines and chemokines was com¬
pared with that of the mucosal mast cell-specific granule
chymase, mouse mast cell protease-1 (mMCP-1). This
chymase is uniquely expressed by intraepithelial mucosal
mast cells (MMCs) (19) and is released systemically and into
the gut lumen. We have also introduced a newly adapted
method of isolating intestinal epithelium, which allows
analysis of the epithelial immune response in vivo.
MATERIALS AND METHODS
Collection of whole jejunum and jejunal epithelial samples
The mouse-adapted strain of the nematode parasite N.
brasiliensis was maintained as described previously (20)
and 500 L3 stage larvae were used to infect anaesthetized
12-week-old male BALB/c mice (Bantam and Kingman
Universal, Hull, UK) by subcutaneous injection. Infection
of mice in this way has previously been shown to produce a
prolonged infection resulting in measurable faecal egg
counts from day 6, with worms being detectable in the intes¬
tines of mice 5 days after infection (19). Mice were killed in
groups of three and samples collected from uninfected mice,
and from mice 1, 2, 4, 7 or 14 days after infection. A solu¬
tion of 24 mM ethylenediaminetetraacetic acid (EDTA) in
Calcium-Magnesium-free Hank's Balanced Salt Solution
(CMF HBSS) (Gibco, Paisley, UK), pH 7-4 was prepared
immediately before experiments.
Anaesthetized mice were bled and serum retained for
analysis of mMCP-1 levels by ELISA as previously
described (19) before being killed by careful cervical disloca¬
tion. Epithelium was then stripped from a section of prox¬
imal jejunum using a modification of the method previously
described by Bjerknes et al. (21). The abdomen was opened
and a 10-cm length of proximal jejunum was flushed free of
intestinal contents using warm CMF HBSS. The thorax was
then opened and after sectioning the caudal vena cava at the
diaphragm, mice were perfused at a rate of approximately
10 ml/min via the left ventricle with 90 ml of 24 mM EDTA
in CMF HBSS at 37°C using a syringe driver (Harvard
Apparatus Ltd, Edenbridge, UK). Following perfusion, the
gut segment was removed and a 2-cm piece placed into
RNA later (Ambion, Austin, Texas USA) for at least 24 h
before homogenization, on ice, into TRI reagent (Sigma,
Poole, UK). The remainder was divided into two segments,
which were tied at one end onto a thin metal rod and then
everted. The epithelium was then released from the under¬
lying tissue by rapid manual rotation of the gut segment in ice
cold CMF HBSS. The epithelial fragments were allowed to
settle on ice before removing into cold TRI reagent. Some of
the exfoliated epithelium was placed in 4% paraformaldehyde/
PBS for examination by light microscopy and histological
examination in order to check the purity of the cell popula¬
tion collected (Figure 1, Table 1). After 24 h in parafor¬
maldehyde, samples were placed in 70% alcohol before
initial embedding in agar, followed by routine processing
into paraffin wax. Sections, 4 pm thick, were stained using
routine haematoxylin and eosin protocols.
Bone marrow mast cell culture
Bone marrow mast cells were cultured in the presence of
recombinant (r) IL3 or WEHI, rIL9, rSCF and rTGFp, as
described previously (22). 1 x 107 cells cultured for 14-21 days
were placed into TRI reagent for RNA extraction. These
cells were > 95% mast cells containing mMCP-1 and with a
morphology resembling mucosal mast cells (23) as described.
Culture of CMT-93 murine intestinal epithelial cells
The epithelial cell line CMT-93, derived from a mouse rectal
carcinoma, was a gift from Dr P.J. Kilshaw (Babraham
Institute, Cambridge, UK). Cells were seeded at 1-3 x 104/ml
in Dulbecco's minimum essential medium (Gibco) with 2 mM
L-glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin
(Sigma) and 10% foetal calf serum (Serotec, Kidlington, UK)
and grown to confluence before harvesting into TRI reagent.
Detection of transcripts by reverse transcription-
polymerase chain reaction (RT-PCR)
Expression of MCP-1, MlP-la, RANTES, TECK. fractalk¬
ine, TGFP, and SCF in jejunal epithelial samples, cultured
mast cells and cultured CMT-93 cells; and of MCP-1 in
whole jejunum and mMCP-1 in epithelium only, was meas¬
ured by RT-PCR. Total RNA was recovered from samples
in TRI reagent by chloroform extraction and precipitation
according to the manufacturer's instructions for TRI
reagent. RNA quality and quantity was then determined
by measurement of absorbance at 260/280 nm in a Beckman
DU 650 spectrophotometer. To eliminate contaminating
genomic DNA, 20 pi aliquots of each RNA sample were
DNAsed using a 'DNA-free' kit (Ambion) according to the
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manufacturers instructions; samples were then re-quantified
by spectrophotometry as before.
1 pg of each RNA sample was reverse-transcribed in a
20-pl volume using a Promega Reverse Transcription (RT)
kit (Promega, Southampton, UK). Incubation was for 1 h at
42°C followed by 5 min at 99°C. l/20th volume of cDNA
was used for PCR using gene-specific primers (Table 2)
which were intron-spanning where possible. cDNA was
amplified using 35 cycles of 94°C for 30 s, 50°C (fractalk-
ine), 55°C (TECK, RANTES, SCF), 60°C (MCP-1) or 63°C
(mMCP-1) for 30 s and 72°C for 1 min. For each sample,
primers for GAPDH were included as a positive control and
negative controls were also set up containing RNA only (no
cDNA). PCR products were separated on a 1-4% agarose
gel containing 0-5 pg/ml ethidium bromide and visualized
and recorded under ultraviolet light using a Kodak Image
Station 440cf imaging system. PCR product identities were
confirmed by Southern hybridization using gene-specific
oligonucleotide probes as described previously (24). Hybrid¬
ized digoxigenin (DIG)-labelled hybridized probes were
detected with an anti-DIG alkaline phosphatase antibody
using chemiluminescence with CDP-star (Hoffmann-La
Roche Co. Ltd. Basel, Switzerland), and images were visu¬
alized and recorded using the Kodak Image Station 440cf
imaging system.
Semi-quantitative analysis of MCP-1 expression
in jejunal epithelium
Since initial experiments suggested increased MCP-1
expression in jejunal epithelium on day 7 postinfection, this
was further investigated using semiquantitative PCR. Low
levels of MCP-1 expression in epithelial samples necessit¬
ated use of 10-fold more cDNA (1:2 volume of RT reac¬
tions) in each PCR reaction. The correct cycle number was
determined so that PCR reactions were not reaching satura¬
tion, and samples were amplified for 34 cycles as previously
described for MCP-1. To control for the amount of cDNA
in each sample, 1 : 20 of volume of cDNA was amplified for
20 cycles using primers for GAPDH. As before, the number
of cycles of amplification was chosen so that the reaction
was not approaching saturation. PCR products were separ¬
ated and visualized as before and the ratios of intensities of
signals for MCP-1 and GAPDH were taken to represent
relative MCP-1 expression.
RESULTS
Examination of stripped epithelium
Examination of stripped epithelium under low power using
a dissecting microscope showed that collected samples
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Figure I Jejunal epithelial samples from epithelial stripping
experiments demonstrating that intact crypt-villous units have been
isolated, (a) Haematoxylin and eosin-stained epithelial
preparations showing the relative absence of non-epithelial
elements (x 100). Arrows indicate contaminating non-epithelial
cells, (b) Isolated sheet of epithelium (x 25).
consisted of predominantly epithelium either in small
sheets, or as discrete crypt-villus units or separated crypts
and villi (Figure 1). Examination of haematoxylin and
eosin-stained histological sections confirmed this, levels of
contaminating nonepithelial cells were below 5% (Table 1).
Differential expression of MCP-1 in whole jejunal and
epithelial samples (see below) further supported evidence
that these represented two different cell populations.
mMCP-1 expression in epithelium
In order to confirm a mastocytosis (and therefore successful
infection and migration of N. brasiliensis to the gut), serum
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Table 1 Contamination of epithelial preparations with other cell
types. Five hundred epithelial cells were counted in each
haematoxylin and eosin-stained preparation examined, and the
number of associated nonepithelial cells estimated. Contaminating
cells consisted mainly of lymphocytes with occasional neutrophils
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Time postinfection (days) n Mean percentage
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Figure 2 Serum mMCP-1 concentrations in male BALB/c mice
following N. brasiliensis infection measured by ELISA. Values are
the mean ± SEM for three samples.
levels of mMCP-1 were measured. mMCP-1 was detected in
the serum of all mice, but at very low levels up to day 4
(mean serum concentration = 2-6 ng/ml day 4 postinfec¬
tion). Serum mMCP-1 concentrations (mean of three mice)
were increased above controls in mice from day 7 (0-5 pg/rnl)
and day 14 (20 pg/ml) postinfection (Figure 2). As previously
reported (19,24), the rise in mMCP-1 negatively correlates
with faecal egg counts in this case from a repeat experiment
using the same strains of mice and parasites (Figure 3). To
specifically confirm movement of mast cells into the epithe¬
lium, expression of mMCP-1 was measured in epithelial
samples by RT-PCR. Expression was detected in all samples
collected on days 7 and 14 postinfection (Figure 4); an
almost undetectable level of expression was seen in some
samples on days 0, 1 and 2 postinfection. This is consistent
with a previous study of whole jejunal mMCP-1 expression
using Northern blotting (25).
10000
6 7 8 9
Time postinfection (days)
10
Figure 3 Faecal egg counts after infection of male 12-week-old
BALB/c mice with 500 L3 stage larvae of the mouse-adapted strain
of N. brasiliensis. Results are the mean ± SEM of egg counts from
three mice.
Chemokine and cytokine expression in jejunal epithelium
After subcutaneous injection, N. brasiliensis migrates
through the lungs arriving in the intestine between 48 h and
72 h after infection. Numbers of MMCs begin to increase on
day 7 postinfection but, in order to examine both early and
late responses, expression of chemokines and cytokines was
examined (in triplicate) on days 1, 2, 4, 7 and 14 postinfec¬
tion. Using RT-PCR, expression of the chemokines M1P-
la, RANTES, TECK and fractalkine, and of the cytokines
SCF and TGFP,, was detected in both control (uninfected)
epithelial samples and in epithelial samples collected at all
time-points from infected mice (Figure 4). No consistent
changes in expression were detected using this method. All
PCR products were the expected size and hybridized, as
expected, to complementary oligonucleotide probes (Table 2).
Expression of the chemokine MCP-1 was initially un¬
detectable by RT-PCR in all except samples collected on day
7 postinfection and in one sample collected on day 14
postinfection (Figure 4). Southern blotting detected low
levels of expression in two control samples, two samples from
day 1 postinfection and in one day 2 sample, and confirmed
the increased levels of expression in all day 7 samples and
one day 14 sample. Use of 10-fold more cDNA for semi¬
quantitative PCR showed low levels of MCP-1 expression in
all samples, with increased expression in two samples
collected on day 7 and 2 samples from day 14 postinfection
(Figure 5).
MCP-1 expression in whole jejunum
As little MCP-1 was initially detected in epithelial samples,
expression of MCP-1 was examined in whole jejunal
samples collected alongside epithelial samples.
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Figure 4 Expression of cytokines and chemokines in mouse jejunal
epithelial samples following N. brasiliensis infection, (a) RT-PCR
expression of mMCP-1 on days 7 and 14 confirms movement of
mast cells into the epithelium as a result of N. brasiliensis infection.
All chemoattractants are constitutively expressed at levels
detectable by RT-PCR with the exception of MCP-1, which is
detected only on day 7 (shown by arrow) in this example. For
comparison, MCP-1 expression in whole jejunal samples is
shown, which is constitutive and appears to be at much higher levels
than epithelial expression. Results are representative of data from
three separate mice. Upper and lower bands of the SCF signal
represent secreted and transmembrane forms respectively,
(b) Southern blot of PCR products from amplification using
primers specific for MCP-1. Arrows indicate faint bands. Positive
controls are whole jejunal samples, showing much higher expression
of MCP-1.
In contrast to that seen in epithelium, expression was
detected by RT-PCR in control samples, and at all time
points postinfection (Figure 4) No increase in expression
was seen following N. brasiliensis infection. Expression of
Time postinfection
(days)
0 12 4 7
GAPDH
MCP-1
GAPDH
MCP-1
GAPDH
MCP-1
(b)
>
25
<D
tr
1.5
1.0
0.5
0.0
12 4 7
Time postinfection (days)
14
Figure 5 Semi-quantitative PCR analysis of MCP-1 expression in
jejunal epithelium following N. brasiliensis infection, (a) Ethidium
bromide-stained gels showing MCP-1 and respective GAPDH
signals, (b) Scatter graph of semi-quantitative MCP-1 expression in
jejunal epithelium. Values are the ratios of intensity of MCP-1
signal/intensity of GAPDH signal. Horizontal bars indicate
median values.
MCP-1 in whole jejunal samples was at higher levels than in
epithelium (Figure 4).
Chemokine expression in cultured mucosal mast cells and
CMT-93 cells
In order to investigate possible sources of the chemokines
and cytokines expressed from intestinal epithelial samples,
we examined (in triplicate) expression in a cultured mouse
rectal epithelial cell line (CMT 93) and in cultured MMC.
Both MCP-1 and TGFp, were strongly expressed in
MMC and epithelial cells (Figure 6). Expression of MlP-la
was detected in MMC but was not detectable in epithelial
cells; similarly, expression of fractalkine and SCF was
detected in epithelial cells, but not MMC. Expression of
RANTES was detected at very low levels in MMCs and
inconsistently in epithelial cells, TECK was detected incon¬
sistently and at low levels in mast cells and epithelial cells.
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Table 2 Primer and probe sequences used for PCR, with references where published sequences are used. Primers for GAPDH were purchased
from Stratagene (Amsterdam, The Netherlands). All are known to be intron-spanning with the exception of those marked with an asterisk*
Target gene Oligo sequence PCR product size (bp) Reference
GAPDH* Forward 5'-GAAGGGCTCATGACCACAGTCCATG
Reverse 5'-TGTTGCTGTAGCCGTATTCATTGTC
454
MCP-1 Forward 5'-GGAAAAATGGATCCACACCTTGC
Reverse 5'-TCTCTTCCTCCACCACCATGCAG
Probe- 5'-CCAGTGTGACAGTGAACTAGTGTG
582 (9)
SCF* Forward 5'-AACTTGGATTATCACTTGCAT
Reverse 5'-CAATGCCATGGCTGTCCATTG
Probe 5'-TGACCTCGTGTTATGC
562f/646f (49)
TGFfli Forward 5'-CGGGGCGACCTGGGCACCATCCATCAG
Reverse 5'-CTGCTGCACCTTGGGCTTGCGACCCAC
Probe 5'-CTGGAAAGGGCCCAGCACCT
406 (23)
RANTES Forward 5'-TCATCCTCACTGCAGCCGCCC
Reverse 5'-CTCTATCCTAGCTCATCTCCAAA
Probe 5MXTCTCCCTCGCGCTGCCTCGTG
254 (9)
MlP-la Forward 5'-GAAGAGTCCCTCGATGTGGCTA
Reverse 5'-CCCTTTTCTGTTCTGCTGACAAG
Probe 5'-CCCCGACTGCCTGCTGCTTCTCC
462 (9)
Fractalkine Forward 5'-TGGTCCAGAGCTGGCAATAA
Reverse 5'-TGGCTTCCTCACTCTCAGGA
Probe 5'-GTGTAGGGACTTGTGCATGTGTG
816 (50)
TECK* Forward 5'-TTTGAAGACTGCTGCCTGG
Reverse 5'-GTCTTCTTCCTAACAAGCC
Probe 5'-GAGCGCCTCAGACTCTCAGACTG
742 (34)
mMCP-1 Forward 5'-GGAAAACTGGAGAGAAAGAACCTAC
Reverse 5'-GACAGCTGGGGACAGAATGGGG.
460 (23)
n. Number of preparations examined. SCF, fsecreted form, ^transmembrane form.
DISCUSSION
Up-regulation of several chemokines and cytokines has
been shown in epithelium in response to viruses (9), bacteria
(8,26) and nematode parasites (11,12). In this study, we
show constitutive expression of a number of chemokines
and cytokines in murine intestinal epithelium, and increased
expression of MCP-1 following N. brasiliensis infection.
Serum niMCP-1 levels and mMCP-1 mRNA expression
in epithelial samples were measured as indicators of mast
cell numbers in the jejunum and epithelium. We have previ¬
ously characterized the mast cell response to N. brasiliensis
and shown the increase in mast cell numbers to be closely
paralleled by serum mMCP-1 levels (19,25), and by jejunal
mMCP-I mRNA expression (25).
The Bjerknes method of epithelial isolation is superior to
other chelating, enzymic or mechanical methods because
intact pieces of epithelium are recovered with little contam¬
ination with lamina propria cells and with high cell viability
(21). Our modification of this method was easier to perform and
resulted in a similar recovery of epithelium with comparable
viability (> 95%). Low contamination of samples with non-
epithelial cells was found at all time-points examined.
MCP-1 is well established as a monocyte chemoattractant
and has also been shown to be chemotactic for murine IL-
3-dependent bone marrow mast cells (7) and mouse skin
mast cells (14). Expression of MCP-1 has been correlated
with an increase in mast cell numbers in wound healing and
in chronic airway inflammation (27,28). In the intestinal
tract, MCP-1 expression has been detected by immuno-
histochemistry in normal colon epithelium (29), lamina
propria and endothelial cells (30), making it a potential
candidate for mast cell recruitment to the intestine in
nematode infection. The high levels of expression of MCP-1
seen in whole gut in this study suggest that it could be
involved in initial recruitment of mast cell precursors from
the circulation into the tissue, which normally occurs as
early as day 3 postinfection (31). Although the increased
expression of MCP-1 identified in the epithelium may be
important in intraepithelial migration of MMC, it seems
unlikely that a significant chemotactic gradient could be
established.
The source of expression of MCP-1 and the other mole¬
cules examined in the epithelial fraction is unknown, and
may include both epithelial cells and intraepithelial inflam¬
matory cells, such as lymphocytes and mast cells. We have
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Figure 6 Expression of MCP-1 and other chemoattractants in
cultured mucosal mast cell homologues (MMC) and the CMT-93
mouse intestinal epithelial cell line. Expression of SCF, TGFB,,
fractalkine and MCP-1 was detected in CMT-93 cells; whereas
expression of TGFB,, MlP-la and MCP-1 was detected in MMCs.
RANTES was also expressed at very low levels by MMCs and
inconsistently by CMT-93 cells. Expression of TECK was detected
inconsistently and at very low levels in both cell types.
shown strong expression of MCP-1, TGFp,, SCF, fractalk¬
ine and low levels of RANTES and TECK by cultured
mouse epithelial (CMT-93) cells, and expression of
RANTES (32), TECK (33) and fractalkine (34) has also
been demonstrated in various other intestinal epithelial cell
types. Expression of MCP-1 (35), MlP-la and RANTES
(36) has been reported in mast cells, and MMCs cultured in
our laboratory also expressed these three chemokines and
TGFp,. Expression of these molecules by newly recruited
intraepithelial mast cells could contribute to expression in
epithelial samples leading to the apparent increase in MCP-
1 against the low background expression of this chemokine
in epithelium. Intraepithelial lymphocytes (IEL) are able to
express MIP-loc, RANTES and TGFp, (37,38) and may
contribute to constitutive expression in epithelial samples.
Alterations in IEL numbers following infection were not
examined in this study; however, other authors have shown
a marked decrease in IEL numbers following infection with
the nematode parasite T. spiralis (39,40). If a similar
decrease was seen following N brasiliensis infection, this
would make IELs a less likely source of the chemoattract¬
ants examined.
The chemokines MIP-lot and RANTES, which are also
chemotactic for mast cells (4,7), are expressed constitutively
in intestinal epithelium, but up-regulation was not seen
following N. brasiliensis infection. This was surprising since
these molecules have been shown to be up-regulated in
other inflammatory diseases, including asthma (41) and
inflammatory bowel disease (30,42). Additionally, up-
regulation of RANTES expression in a rat model of colitis
was correlated with an increase in mast cell numbers, and
this increase was abrogated by use of Met-RANTES, a
specific antagonist of RANTES receptors CCR1 and CCR5
(43). Constitutive expression of TECK and fractalkine are
in agreement with previous studies, which have implicated
these molecules in lymphocyte trafficking (33,34), but frac¬
talkine was recently also shown to be chemotactic for mast
cells. Expression may therefore contribute towards nonin¬
flammatory recruitment of the small numbers of mast cells
that reside in the nonparasitized jejunum. Expression of the
cytokines SCF and TGFP, was also measured in epithelial
samples since these molecules are both mast cell growth
factors (23) and mast cell chemoattractants (17,18). Addi¬
tionally, SCF expression has been correlated with mast cell
accumulation in arthritis (44) and pollen allergies (45), and is
up-regulated in intestinal epithelial cell cultures following
Salmonella typhimurium infection (16). Both molecules were
expressed in epithelium, but no alteration in expression was
seen following nematode infection.
There was no evidence for a change in expression of the
majority of the chemoattractants examined following N.
brasiliensis infection. One reason for this may be that
invasion and damage of epithelial cells is necessary to evoke
alteration in inflammatory gene transcription and therefore
most studies of the epithelial response to nematodes have
focused on invasive parasites. This is also considered to be
the case for bacterial infection of the gut, with a lack of
inflammatory response to the high bacterial load of norma!
gut contents (46,47). Alteration of chemokine expression in
response to noninvasive parasites may, however, be possible
via other mechanisms; excretory-secretory products are key
allergens in the immune response to N. brasiliensis and those
from plerocoids of the parasite Spirometra erinaceieuropaei
can modulate chemokine expression in macrophages (48).
The limitations of RT-PCR in measurement of changes in
gene expression must also be considered, with small changes
in expression not being detected by the methods used.
The specific recruitment of MMCs following N. brasiliensis
infection is difficult to explain in the light of this evidence of
constitutive expression of several mast cell chemoattractants
from intestinal epithelium, especially since preliminary
unpublished data from our laboratory suggest that mucosal
mast cells express several of the corresponding receptors for
the chemoattractants expressed. However, mast cell recruit¬
ment may depend on other chemoattractants not investig¬
ated, or may be limited by other factors, such as seeding
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of mast cell precursors into tissues and expression of the
necessary integrins or proteases to allow cells to move
through the extracellular matrix.
In conclusion, we have shown both increased expression
of MCP-1 following N. brasiliensis infection, and constitu¬
tive expression of the chemokines MlP-la, RANTES,
TECK and fractalkine, and cytokines SCF and TGFP,, in
murine intestinal epithelium. Further investigation is
required to determine the role of these molecules both in cell
trafficking and in the inflammatory response to nematode
parasites in the gut.
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TGF-/31 Regulates Adhesion of Mucosal Mast Cell Homologues
to Laminin-1 Through Expression of Integrin a7l
Anne Rosbottom,* Cheryl L. Scudamore,2* Helga von der Mark,1 Elizabeth M. Thornton,+
Steven H. Wright,+ and Hugh R. P. Miller3+
Mucosal mast cells (MMC) or their precursors migrate through the intestinal lamina propria to reside intraepitheiially, where
expression of mouse mast cell protease-1 indicates the mature phenotype. Alterations in expression of integrins that govern cell
adhesion to the extracellular matrix may regulate this process. As the key cytokine mediating differentiation of mouse mast cell
protease-l-expressing MMC homologues in vitro, TGF-01 was considered a likely candidate for regulation of the integrins that
facilitate intraepithelial migration of MMC. Therefore, we examined adhesion of bone marrow-derived mast cells cultured with
and without TGF-/31 to iaminin-1, fibronectin, and vitronectin along with expression of intcgrins likely to regulate this adhesion.
Adhesion of PMA-stimulated cultured mast cells to laminin-1 increased from 5.3 ± 3.6% (mean ± SEM) in the absence of TGF-/31
to 58.7 ± 4.0% (p < 0.05) when cultured mast cells had differentiated into MMC homologues in the presence of TGF-/J1 Increased
adhesion of MMC homologues to laminin-1 was also stimulated by FceRI cross-linking and the calcium ionophore A23187.
Expression of the laminin-binding integrin a7 by MMC homologues grown in the presence of TGF-/J1 was demonstrated by
RT-PCR and flow cytometry, and preincubation of MMC homologues with the a7-neutralizing Ab 6A11 inhibited adhesion to
laminin-1 by 98% (p < 0.05), demonstrating a novel role for this molecule in adhesion of a hemopoietic cell to laminin-1. The
Journal of Immunology, 2002, 169: 5689-5695.
Cell trafficking into and through tissues depends uponcomplex interactions, including adhesion to extracellularmatrix (FCM)4 proteins (1); integrins are the major mol
ecules that mediate this process (?) Mast cells are involved in the
pathophysiology of immediate-type hypersensitivity reactions,
wound healing, and chronic inflammatory diseases (3, 4). The ability
to move through tissues is mandatory for their physiological function,
and integrins are likely to be involved in mast cell migration.
The roles of several integrins and other adhesion molecules in
mast cell adhesion to ECM proteins has been studied using murine
IL-3-dependent, bone marrow-derived cultured mast cell? (CMC).
These cells adhere to laminin-1 and -2 (5-8), fibronectin (9), and
vitronectin (10), and integrins ot0[it (5, 8), Oj/3, (11), and cvI33
(10), respectively, have been shown to play a role in this adhesion.
Additionally, Abs to the non-integrin 67-kDa laminin binding pro¬
tein (LBP) block adhesion of IL-3-dependent CMC to laminin-1
(6), indicating a role for this molecule
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In vivo, mast cells are phenotypically classified into two major
subsets, connective tissue and mucosal (12, 13), and mucosal mast
cells are important in tho immune response to gut dwelling ncm
atodes. Nematodo infection of the gut results in recruitment of the
precursors of mucosal mast cells (MMC) (14) and their migration
intraepithclially, where expression of the MMC specific chymasc,
mouse mast cell protease-1 (mMCP-1), indicates the mature mu¬
cosal phenotype (15). As IL-3-dependent CMC are thought to rep¬
resent an immature mast cell phenotype (16) and lack mMCP-1
expression (17), they may be a poor model for study of the mo¬
lecular interactions involved in this process, especially since it is
widely recognized that the cytokine stem cell factor (SCF) is a key
growth and differentiation factor for mast cells in vivo and in vitro
(18). We have recently developed an in vitro model of mast cell
differentiation in which addition of the cytokine TGF-/31 to bone
marrow cells supplemented with IL-3, IL-9, and SCF regulates
differentiation of bone marrow cells into a close homologuc of
the mucosal phenotype, as shown by abundant expression of
mMCP-1 (19).
Adhesion molecule expression in mast cells may be modulated
during differentiation. The integrin a4 is expressed by IL-3-depen¬
dent CMC, is down-regulated in older cultures (11, 20), and is not
present in mature tissue derived connective tissue mast cells (20),
but is required for the intestinal recruitment ofMMC (14). In our
in vitro model and in IL-3-dependent CMC (21), TGF-/31 up-reg-
ulates the expression of integrin aE (22), which may facilitate re¬
tention of MMC intraepithelially by binding E-cadherin (23).
Therefore, as the key cytokine mediating differentiation of the mu¬
cosal phenotype, TGF-/31 may also change the spectrum of inte¬
grins expressed to reduce adhesion to ECM proteins and increase
adhesion to the basement membrane (BM) protein laminin, thus
facilitating intraepithelial migration. In support of this, one study
showed that supplementing IL-3-dependent CMC with TGF-/3I
for 48 h increased adhesion to laminin-1 (7); the mechanism was
thought to be increased adhesion receptor expression.
Copyright © 2002 by The American Association of Immunologists, Inc. 0022-1767/02/S02.00
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To test the proposed hypothesis that the adhesion properties of
CMC are regulated by TGF-/31, we have compared adhesion of
mast cells cultured with and without TGF-/31 to the ECM proteins
fibronectin and vitronectin and the BM protein laminin-1. We have
also examined the expression of several integrins using RT-PCR
and flow cytometry. In addition to those integrins previously im¬
plicated in mast cell adhesion, we have investigated the role of the
laminin-binding integrin «7 in adhesion of TGF-J31-dependent
CMC. This integrin was originally thought to be skeletal muscle
specific (24), but expression of the a7B isoform has since been
found in other tissues, including intestinal epithelium, where it
correlates with intestinal cell differentiation (25). In this study we
show the expression of a7B integrin in cultured MMC homo-
logues, which is regulated by TGF-/31. We also demonstrate, by
use ot the blocking Ab 6A11, a novel role for a7 in promoting
adhesion of mucosal mast cell homologues to laminin-1.
Materials and Methods
Mast cell culture
Mouse bone marrow cells were isolated from the femurs ofmale 12-wk-o!d
BALB/c mice and suspended at 5 X 105/ml in DMEM (Life Technologies,
Paisley, U.K.)/10% FCS (Sigma, Poole, U.K.), 2 mmol of L-glutamine, 1
mmol of sodium pyruvate, 100 U/ml of penicillin, 100 pg/ml of strepto¬
mycin, and 2.5 pg/ml of fungizone (Life Technologies). Cells were then
supplemented with 5 ng/ml IL-9, 1 ng/ml 1L-3 (R&D Systems, Abingdon
U.K.), and 50 ng/ml SCF (PeproTech, London U.K.) with or without 1
ng/ml TGF-/31 (Sigma). Mast cells cultured with and without TGF-/31 are
termed CMCT+ and CMCT_, respectively. CMC were fed every 2-3 days
by centrifuging and resuspending in half-volume of original culture me¬
dium and half-volume of fresh medium. Cells used for studies were mature
cells, generally 14-30 days old, and consisted of >99% mast cells, as
shown by toluidine blue staining. Immunohistochemistry was used to iden¬
tify mMCP-1 -positive cells (15). Typically, <2% ofCMC' ~, but >98% of
CMCIT, were positive for mMCP-1 expression.
MC/9 culture
A mast cell line, MC/9, known to express the integrin a6/3, (5) was cul¬
tured for use as a positive control for flow cytometry and for blocking
studies using a neutralizing rat anti-a6 mAb (GoH3). MC/9 cells were
obtained from American Type Culture Collection (Manassas, VA) and cul¬
tured in DMEM (American Type Culture Collection) with 10% FCS
(Sigma) and 10% T-stim (BD Biosciences, Oxford, U.K.), as instructed by
American Type Culture Collection.
Antibodies
Mouse IgGl mAhs to n7pt integrins were obtained by immunization of
a7-deficient mice with wild-type primary myoblasts, as described previ¬
ously (26). Clone 6A11 was used for inhibition of CMCT+ adhesion to
laminin, since it has the strongest adhesion inhibition activity of all the
anti-a7 clones obtained. Clone 3C12 did not inhibit cell adhesion to lami¬
nin and was used for flow cytometry.
Murine IgG 1 and rat IgGl and IgG2a isotype controls, rat anti-mouse av
IgGl (clone RMV-7), rat anti-mouse a5 lgG2a (clone 5H10-27), rat anti-
mouse a6 IgG2a (clone GoH3), and rat anti-mouse FcyRIII/II (Fc block,
clone 2.4G2) were obtained from BD PharMingen (Oxford, U.K.). Bioti-
nylated-anti rat IgG?a or IgGl secondary Abs were also obtained from BD
PharMingen, and anti-mouse IgGl-Alexa Fluor 488 was obtained from
Molecular Probes (Leiden, The Netherlands).
Adhesion assays
Murine Engelbreth-Holm Swarm sarcoma BM laminin-1 and bovine fi¬
bronectin and vitronectin were obtained from Sigma, and optimum coating
concentrations for these proteins were determined from dose-response
studies (data not shown) Ninety-six-well ELISA plates were coated over¬
night with 100 pi of proteins at 20 pg/ml in PBS, with the exception of
vitronectin, which was used at 10 pg/ml; 3% BSA in PBS was used as a
control. Excess coating proteins were then removed, and nonspecific bind¬
ing was blocked by incubation for 2 h at 37°C with 3% BSA in PBS. CMC
(and MC/9 cells for blocking studies) were washed twice in PBS/0.1%
BSA before resuspending at 5 X 105 cells/ml in their respective culture
medium (without cytokines). CMC (100 pi) were then loaded in quadru¬
plicate into wells. PMA (50 ng/ml; Sigma) was added to some wells im¬
mediately after loading to investigate the effect of cell activation on adhe¬
sion. Cells were then incubated for 1 h at 37°C in 5% C02, after which
nonadherent cells were aspirated, and the wells washed three times with
PBS. The number of cells adherent to wells was estimated using the |3-hex-
ose aminidase assay (27).
Regulation ofCMCr+ adhesion to laminin-1
The effect of sensitization with IgE followed by addition of specific Ag and
the effect of calcium ionophore A23187 on adhesion of CMCT+ to lami-
nin-1 were investigated. For stimulation by FceRI cross-linking, CMCT+
were first sensitized by incubation overnight in complete culture medium
with 100 ng/ml of IgE anti-DNP (Sigma). They were then washed twice in
PBS/0.1% BSA and resuspended in culture medium (without cytokines)
before loading into wells and immediate addition of 10 ng/ml of DNP-
human serum albumin (Sigma). Controls included IgE-sensitized cells to
which no Ag was added and unsensitized cells to which Ag was added. For
stimulation with calcium ionophore, CMCT+ cells, washed and resus¬
pended in culture medium without cytokines, were loaded into wells, and
1 pM calcium ionophore A23187 (Sigma) was immediately added. PMA-
stimulated cells were also included as a positive control for stimulation of
adhesion, and as a negative control, wells were included where no acti¬
vating agent was added. The adhesion assay was then performed as de¬
scribed above.
Analysis of integrin expression by RT-PCR
Expression of integrins by cells from four separate cultures ofCMCT~ and
CMCt+ was investigated by RT-PCR. Total RNA was recovered from 5 X
106 cells/culture in Tri-Reagent (Sigma) by phenol-chloroform extraction.
RNA was then DNase treated using a DNA-free kit (Ambion, Houston,
TX) and 1 pg of RNA reverse-transcribed in a 20-pl volume using a
Promega RT kit (Promega, Southampton, U.K.). One microliter of each RT
reaction was used for semiquantitative PCR, employing gene-specific
primers (Table I); cycle numbers were optimized so that increases in ex¬
pression would result in corresponding increases in signal intensity. Neg¬
ative controls were set up for each sample containing RNA only (no
cDNA), and each PCR experiment included a negative control omitting
cDNA. PCR products were separated on a 1.4% agarose gel containing 0.5
pg/ml of ethidium bromide and were visualized and recorded under UV
light using a Kodak Image Station 440cf imaging system (Eastman Kodak,
Rochester, NY). PCR product identities were confirmed by Southern hy¬
bridization using gene specific oligonucleotide probes as described previ¬
ously (28).
Analysis of integrin expression by flow cytometry
Surface expression of integrins was analyzed by flow cytometry (FAC-
Scan; BD Biosciences). To detect the expression of a5, a6, and av, 1 X 106
cells were incubated for 5 min with 0.5 pg of murine Fc block, followed
by incubation for 60 min with 1 pg of rat mAb against a5 (5H10-27), a6
(GoH3), or av (RMV-7), respectively, or isotype control in PBS/10%
mouse serum. The cells were then washed twice in wash buffer (PBS/0.1%
BSA) and incubated for 30 min with 1 pg of biotin-anti rat igG2a or IgGl
in PBS/10% mouse serum before washing twice and incubating for 30 min
with 100 pg of streptavidin-PE (Vector, Peterborough, U.K.). To detect a7
expression, 2 X 10s cells were incubated with 0.1 pg of murine Fc block
before incubation for 60 min with 2 pg ofmouse anti-a7 (3C12) or mouse
IgGl isotype control in PBS/5% FCS. They were then washed twice in
wash buffer and incubated for 30 min with anti mouse IgGl Alexn Fluor
488 diluted 1/2000 in PBS/5% FCS. Following both labeling protocols,
cells were washed twice and fixed for 10 min in 2% paraformaldehyde
before analysis by flow cytometry; all procedures were performed on ice.
Blocking studies
The effects of integrin-specific mAbs on CMCT+ adhesion to laminin-1
were examined. Adhesion assays were as previously described, except
CMCt+ were preincubated with respective mAbs or isotype controls be¬
fore loading into wells. Preincubation conditions and optimum Ab con¬
centrations were determined in pilot studies (data not shown). To determine
the effects of a6 and a7 integrins on adhesion of CMCT+ to laminin-1,
CMCT+ were preincubated for 10 min at room temperature with the a6
mAb GoH3 (1 pg/ml) or for 30 min on ice with the a7 mAb 6A11 (10
pg/ml). MC/9 cells were included as a positive control in experiments
investigating the effect of GoH3 on adhesion to laminin-1(5).
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Table I. Primer sequences and conditions used for RT-PCR"
Gene Oligo Sequence
Product Size
(bp)
Anneal
Temperature
(°C) Mg2+ (mM) pH
Cycle
No.
Ref.
No.
a3 Forward: 5'-ATT GAC TCA GAG CTG GTG GAG GAG
Reverse: 5'-TAC TTG GGC ATA ATC CGG TAG TAG
Probe: 5'-GCT GGG TTG CTG CTG CTG GG
«3A 305
«3B 161
63 2.0 8.3 35 50
«5 Forward: S'-TTG CTG GAC TGT GGT GAA GAC
Reverse: 5'-CTG GTT GAT GAG CTG GTA GAC
Probe: 5'-CAG TCT CTG GGG TGG CCT TC
582 55 1.5 8.3 32 51
«6 Forward: 5'-GAG GAA TAT TCC AAA CTG AAC TAC
Reverse: 5'-GGA ATG CTG TCA TCG TAC CTA GAG
Probe: 5'-CGA TGC CAC CTA TCA CAA GG
«6A 399
«SB 269
55 2.5 8.3 35 50
av Forward: 5'-CCG CCG GTG CCA GCC CAT TGA G
Reverse: 5'-GCT ACC AGG ACC ACC GAG AAG T
Probe: 5'-CTG TGC TCC ATT GTA CCA CT
337 55 1.5 8.3 32 52
«7 Forward: 5'-CAC CGG ATG TCC ATC AGG AC
Reverse: 5'-GTT GCT CAG AGA TGC ATC C
Probe: 5'-CTG GTA CTG CTG CTG TGG AA
a7A 480
a1B 366
55 1.5 8.3 35 53
ft Forward: 5'-GGC AAC AAT GAA GCT ATC GT
Reverse: 5'-CCC TCA TAC TTC GGA TTG AC
Probe: 5'-TTG GGA TGA TGT CGG GAC
ftA 266
fto 348
55 1.0 8.3 30 50
ft Forward: 5'-CTG GTG TTT ACC ACT GAT GCC AAG
Reverse: 5'-TGT TGA GGC AGG TGG CAT TGA AGG
Probe: 5'-CCA CAG TGG GAG TCC TGT CT
393 60 2.5 8.9 38 52
LBP Forward: 5'-CTG AAG TTT GCT GCT GCC ACA
Reverse: 5'-GCT GGA TGG GCA CAG AGG GAA
Probe: 5'-ATG CCT GAT CTT TAC TTC TA
520 55 1.0 8.3 26
GAPDH Forward: 5 '-GAAGGGCTCATGACCACAGTCCATG
Reverse: 5'-TGTTGCTGTAGCCGTATTCATTGTC
454 55 1.5 8.3 20
" Cycle parameters were as follows: denaturation, 30 s at 94°C; annealing, 30 s at temperature indicated in the table; extension, 1 min at 72°C. References are included where
published primers are used, and all reactions were performed using a Techne Geneanip thermal cycler (Techne, Cambridge, U.K.).
Statistical analysis
PRISM (version 3.0 for Windows; GraphPad, San Diego, CA) statistical
software was used to compare data using the nonparametric Mann-Whitney
U test, with a statistical significance level ofp < 0.05.
Results
MMC homologues exposed to TGF-fil adhere to laminin-1
We investigated the effect on their adhesion properties of culturing
mast cells with and without TGF-jSl (1 ng/ml). Results are from
four separate experiments, each performed in quadruplicate, using
CMC from different cultures and are expressed as the mean ±
SEM of each experiment. The range ofmeans ± SEMs of separate
experiments is also shown. Experiments established that 27.7 ±
10.7% (range, 5.2 ± 0.3 to 56.4 ± 2.9%) of CMCT+ (mMCP-I +
MMC homologues) adhered spontaneously to laminin-1. CMCT+
adhesion to laminin-1 increased to 58.7 ± 4.0% (range, 51.4 ± 4.6
to 69.1 ± 2.9%) following PMA stimulation (Fig. la), and adhe¬
sion of both control (unstimulated) and PMA-stimulated popula¬
tions ofCMCt+ was significantly greater (p < 0.05) than that of
equivalently stimulated C'MCT~ (controls, 0.0 ± 0-1 to 3.5 ±
2.8%; PMA-stimulated, 0.0 ± 0.8 to 15.6 ± 2.6%) that were
grown in the absence of TGF-/31. In all experiments CMC adhe¬
sion to BSA was <5% (data not shown). Adherent CMCT+ flat¬
tened and took on a more polarized morphology on laminin-1 (data
not shown). PMA-stimulated CMCT+ adhered poorly to fibronec-
tin (7.9 ± 4.3%) and did not adhere to vitronectin (Fig. 16)
Stimulation with Ag/IgE and with the calcium ionophore A23187
up-regulates adhesion ofMMC homologues to laminin-1
Adhesion of IL-3-dependent CMC to ECM proteins can be stim¬
ulated by treatment with Ag/IgE or calcium ionophore A23187 (7),
and similar mechanisms may control adhesion in vivo. We there¬
fore investigated whether the TGF-/31-induced adhesion of
CMCT+ (mMCP-l+ MMC homologues) to laminin-1 was also
regulated by these mechanisms. Both Ag/IgE and ionophore treat¬
ments significantly increased (p < 0.05) adhesion by CMCT+ to
laminin-1 (Fig. 2). Ag/IgE treatment resulted in flattening and po¬
larization of cells, but after calcium ionophore treatment adherent
cells retained a rounded shape (data not shown). This experiment
was repeated twice using cells from different cultures, with similar
results.
MMC homologues exposed to TGF-j31 express the laminin-
binding integrin a7B at both mRNA and protein levels
To determine the mechanism of TGF-/31 -mediated binding of
CMC to laminin, we compared the expression of integrin tran¬
scripts by CMCT~ and CMCT+ populations. Previous studies (5,
8) have shown involvement of ctb in adhesion of CMC to laminin;
therefore, we examined the expression of this integrin and of the
laminin-binding integrins a3 and a7 in unstimulated CMC cultured
with and without TGF-/31, using semiquantitative RT-PCR. The
a7 primers could amplify both a7A and a7B mRNA, resulting in
PCR products of 480 and 366 bp, respectively, but only a single
band of 366 bp was detected, indicating the expression of a7B
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FIGURE 1. CMC adhesion to ECM and BM proteins. Adhesion of un¬
stimulated (control) and PMA-stimulated CMC1- and CMC'1" to lami¬
nin-1 (a), fibronectin (b), and vitronectin (c). CMCT+ grown in the pres¬
ence of TGF-/31 (MMC homologues) adhered to laminin-1, but not to
fibronectin or vitronectin, whereas CMCT~ grown in the absence of
TGF-/31 adhered poorly to laminin-1, but adhered to fibronectin and vi¬
tronectin following PMA stimulation The adhesion of both control and
PMA-stimulated CMCT+ to laminin was significantly greater (p < 0.05)
than the adhesion ofequivalently stimulated CMCTA Also, the adhesion of
CMCt~ to fibronectin and vitronectin was significantly greater (p < 0.05)
than the adhesion of PMA-stimulated CMCT+. Results are the mean ±
SEM of four separate experiments, each performed in quadruplicate and
using cells from four different cultures.
transcripts only. The expression of a7 integrin was low to unde¬
tectable after 35 cycles of PCR in CMC ' ~, whereas inclusion of
TGF-/31 in cultures resulted in a substantial up-regulation of a7B
mRNA expression by CMCT+ (Fig. 3). The expression of a7 in¬
tegrin was confirmed by flow cytometry using the mouse mAb
3C12. Surface expression of a7 was consistently detected in
TGF-/31-supplemented CMCT+ from three different cultures dur¬
ing separate experiments, whereas no expression was detected in
CMCt" (Fig. 4),
Transcripts for other laminin-binding integrin subunits, 3A and
6A, and of the very late Ag integrin j3-subunit /3, were expressed
at similar levels in both CMCT+ and CMCT_ (Fig. 3). However,
because others have reported the expression of a6 integrin in mu¬
rine CMC and the mast cell line MC/9 (5, 8, 10), we compared a6
expression in MC/9 cells and CMC with or without TGF-j31 by
flow cytometry. The expression of a6 was virtually absent in
CMCt+ and CMCT~, but, as expected, a6 expression was high in
control Ag IgE Ag/lgE A23187 PMA
FIGURE 2. Regulation of adhesion ofMMC homologues to laminin-1.
Adhesion was significantly increased (p < 0.05) by stimulation using
PMA, Ag/lgE, and the calcium ionophore A23187. Overnight sensitization
of MMC homologucc with IgE also significantly increased adhesion to
laminin, but addition of spocific A.g to sensitized cells significantly in
creased adhocion above that seen in colls sensitized only. Results are the
mean ± SEM (n = 4) of one experiment that was repeated twice more
using cells from different cultures, with similar results.
MC/9 cells (Fig. 4). LBP transcripts were also detected at similar
levels in both cell types (data not shown).
The ay-neutralizing mAb 6A11 blocks adhesion ofMMC
homologues to laminin-1
To demonstrate the role of integrins in adhesion of MMC homo¬
logues to laminin, CMCT+ were preincubated with neutralizing
Abs before use in adhesion assays. The a7-neutralizing mAb 6A11
at 10 /ag/ml resulted in a 98% reduction in adhesion of PMA-
stimulated CMCt+ (MMC homologues) to laminin-1 (Fig. 5a),
which was statistically significant (p < 0.05). This experiment
was repeated twico more in quadruplicate and triplicate, with re
ductions in adhesion of 98 and 100%., thus clearly indicating a role
for a7 in adhesion to laminin-1. 6A11 also blocked spontaneous
adhesion to laminin -1 (not shown) and adhesion following Ag/lgE
and A23187 stimulation (Fig. 5, b and c). The use of neutralizing
Abs has shown a role for a6 in adhesion of IL-3-dependent CMC
to laminin-1 (5, 8, 10), but the anti-a6 mAb GoH3 (1 /xg/ml) had
no effect on adhesion of CMCT+ to laminin-1 (Fig. 5d), whereas
adhesion of MC/9 cells, which arc reported to express the intcgrin
a6f3, (5) and were used as a positive control for this Ab, was
reduced by 98% in the presence of GoH3.
CMCT"
A
FIGURE 3. Analysis of adhesion molecule expression in CMC1" and
CMCt+ by semiquantitative RT-PCR. Expression of a7B integrin mRNA
was highly up-regulated in CMC cultured with TGF-J31, whereas TGF-/31
moderately down regulated the expression of intcgrin j8j. Transcripts for
other adhesion molecules were expressed at comparable levels by both
CMC1" and CMCT+.
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FIGURE 4. Analysis of integrin expression in CMC1 and CMCT+ bv
flow cytometry. MC/9 cells were included as positive controls for the ex¬
pression of a5 and a6 integrins. CMCT+ expressed a7 integrin, whereas
there was no expression in CMC7" cultured without TGF-/31. a6 expres¬
sion was virtually absent in both CMC7- and CMCT+; high expression
was detected in the positive control MC/9 cells. a5 integrin was expressed
by CMC7"", bur there was decreased expression in CMC7' and high ex¬
pression in MC/9 cells. The expression of integrin av was virtually absent
in both CMC7" and CMC7+. These experiments were repeated twice more
using cells from separate cultures, with similar results.
Mast cells cultured in the absence of TCF-fil adhere to
fibronectin and vitronectin, but not to laminin-1
Previous studies of the binding ofmurine CMC to matrix proteins
have predominantly used cells cultured in the presence of IL-3
alone (5, 7, 8, 10, 11). Adhesion of CMC grown in a combination
of IL-3, SCF, and IL-9, all of which are expressed in the gut (29,
30) and are known mast cell growth factors (31-33), has not pre¬
viously been studied. As shown above, CMC grown in the absence
of TGF-/31 did not adhere to laminin-1. Furthermore, these cells
did not adhere spontaneously to vitronectin, but had low (7.1 ±
4.9%; range, 0.5 ± 1.0 to 21.8 ± 4.3%) spontaneous adhesion to
fibronectin (Fig. lb). However, after PMA stimulation, CMC7"
adhered to vitronectin (38.4 ± 12.2%; range, 8.3 ± 3.6 to 65.6 ±
6.0%) and fibronectin (66.8 ± 8.6%; range, 47.9 ± 6.3 to 82.6 ±
1.4%) at levels which were significantly greater (p < 0.05) than
those observed for CMC77 (Fig 1, h and o). Adhesion ofCMC7"
to both ECM proteins was associated with cell flattening (data not
shown).
■ I
b Ag/lgE-stimulated CMC
6A11 lgG1 no antibody
d PMA-stimulated MC/9 cells and CMC7
FIGURE 5. Role of integrins in the adhesion of CMC77 (MMC homo-
logues) to laminin-l (20 /xg/ml). The a7 integrin-neutralizing Ab 6A11 (10
p-g/ml) reduced the adhesion of PMA-stimulated CMC77 to laminin-1 by
98% (p < 0.05; a) and similarly reduced the adhesion of CMC77 stimu¬
lated by Ag'IgE (b) and that of the calcium ionophore A23187 (c) to lomi
nin-1. In contrast, the a6-neutralizing Ab GoH3 (1 /xg/ml) had no effect on
the adhesion of CMC77 to laminin-1, but significantly (p < 0.05) reduced
the adhesion of MC/9 cells to laminin-1 by 98% (d). Results are the
mean ± SEM (n — 4) for single experiments. Experiments a and d wore
repeated twico moro using colls from different cultures, with similar results.
Mast cells cultured in the absence of TGF-fil do not express a7
intcgrin, but show increased expression offibroncctin- and
vitronectin-binding integrins
As previously described, analysis of intogrin expression by RT
PCR established that CMC7- do not express a7 integrin, but ex¬
press /31A, a3A and a6A at comparable levels to those seen in
CMC77 (Fig. 3). However, as CMC7- adhered to fibronectin and
vitronectin, we wondered whether this was also due to TGF-/3I-
modiatod alterations in intcgrin expression. We therefore investi
gated the expression of integrins a5 and av03 in CMC7" and
CMC77 by RT-PCR, as these integrins play a role in the adhesion
of IL-3-dependent CMC to fibronectin and vitronectin, respec¬
tively. The expression of as and av transcripts was similar in both
cell types, but the expression of the vitronectin-binding integrin /3 ,
was up-regulated in CMC7" (Fig. 3) compared with that in
CMC77. In the absence of differences at the mRNA level, flow
cytometry was used to investigate surface expression of a5 and av
(Fig. 4). Expression was measured on cells from three different
cultures ofCMC7" and CMC77 during separate experiments, and
the mast cell line MC/9, which has been shown previously to ex¬
press integrin a5 (11), was used as a positive control for the ex¬
pression of this integrin. Surface expression of cr5 was increased in
CMC7" compared with CMC77, but the expression in both CMC
was lower that seen in the positive control MC/9 cells. The ex¬
pression of av was low to absent in both CMC7" and CMC77.
Discussion
CMC have previously been shown to adhere to laminin (6, 7),
fibronectin (9), and vitronectin (10). Here we show TGF-/31 mod¬
ulation of adhesion of CMC to these proteins and a novel role for
a7 integrin in adhesion of MMC homologues to laminin-1. We
propose that TGF-j31-mediated up-regulation of a7 expression in
conjunction with differentiation of the mucosal mast cell pheno
type and expression ofmMCP-1 and aEj37 (22) may have a role to
play in the intraepithelial location of MMC in vivo.
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a7p] has been described as being essentially muscle specific
(34), and although several non-muscle locations have been dc
scribed (35, 36), expression has not previously been shown in leu¬
kocytes of any subset. Additionally, TGF-/31 -mediated regulation
of a7 expression has not been shown in any cell type, and although
developmental regulation of o7 has been described in muscle and
has been proposed for intestinal epithelium (25), the molecular
signals controlling expression in these cells are unknown.
The u7B isoform expressed by MMC homologues is also ex
pressed in skeletal myoblasts; the a7A isoform is restricted exclu¬
sively to mature skeletal muscle (26, 37, 38). However, as both
isoforms promote adhesion on laminin-1 and laminin-2/4 (39, 40),
which may be rich in epithelial BM (41), a7B expression in vivo
could either promote intraepithelial migration or limit egress of
MMC from the epithelium into lamina propria via adhesion to BM
laminin. Additionally, restricted expression of a7B by epithelial
cells of the crypt-villous junction (25), the primary location of
intraepithelial MMC in vivo (42), suggests that a7 may be impor¬
tant for the adhesion of both epithelial cells and mast cells to the
BM at this site.
The phorbol ester PMA stimulated maximal adhesion of MMC
homologues to laminin-1, presumably due to alterations in receptor
affinity or cytoskeletal rearrangements (43) and the anti-a7 mAb
6A11 blocked this adhesion. FceRI cross-linking and use of the
calcium ionophore A23187 also stimulated adhesion to laminin-1,
as previously shown in IL-3-dependent CMC (7, 8), and these may
represent in vivo mechanisms by which adhesion could be stimu¬
lated. Spontaneous adhesion ofCMCT+ to laminin-1 was observed
in some cultures, although this was inconsistent and may have
been due to low levels of endotoxin contamination, as LPS has
been shown to cause mast cell activation (44). Preincubation with
6A11, however, almost completely blocked adhesion via all the
above pathways, showing a universal role for integrin a7 in the
adhesion of MMC homologues to laminin-1.
Previous studies (5, 8) have implicated integrin a6 in the pro¬
motion ofmurine mast cell adhesion to laminin-1 and -2; however,
these studies used several mast cell lines and IL-3-dependent
CMC, which may be more representative of immature mast cells.
The mMCP-l+ CMCT+ closely resemble intraepithelial MMC
(15, 19), and while these cells expressed a6 transcripts at similar
levels to CMCT_, flow cytometry showed low a6 expression in
both cell types. This made a6 an unlikely candidate for regulation
of CMCT+ adhesion to laminin, and inclusion of the anti-a6 mAb
GoH3 in adhesion assays had no effect on adhesion of CMCT+ to
laminin-1. Comparison with positive a6 expression by flow cy¬
tometry and GoH3-mediated inhibition of adhesion to laminin-1 in
MC/9 cells further supports our findings that a6 integrin plays no
role in the adhesion of MMC homologues to laminin-1.
Human skin mast cells also adhere to laminin, but do not sig¬
nificantly express a6 integrin, and adhesion is inhibited by Abs to
a3 integrin (45). Abs to a3 integrin were not included in our stud¬
ies, but in view of conclusive evidence for the role of a7 integrin
in the adhesion of MMC homologues and because the expression
of a3 mRNA expression in CMCT+ was similar to that in CMCT_,
which do not adhere to laminin, a major role for a3 integrin in
laminin binding seems unlikely in MMC. The importance of dif¬
ferent integrins in adhesion to laminin may vary between mast cell
phenotypes, with a6 possibly playing a role only in he adhesion of
immature mast cells, while a3 and a7 may mediate the adhesion of
mature connective tissue mast cells and MMC, respectively, to
laminin.
LBP has been implicated in the adhesion of IL-3-dependent
CMC to laminin-1 (6, 7), but the expression of LBP mRNA was
similar in both CMCT_ and CMCT+ (data not shown). However,
it is reported that LBP expression is post transcriptionally regulated
(16); therefore, a cofactor role in the adhesion ofMMC homologuec
to laminin-1 is possible, as suggested in other cell types (47).
CMC cultured in the absence of TGF-jSl (CMCT~) do not have
a recognizable in vivo counterpart since they lack mMCP 1 and do
not show any morphological resomblance to tho very well charac
terized serosal mast cell population. Their role in this study was
simply as a comparator for MMC homologues cultured in TGF-/31,
and they bound preferentially to fibroncctin and vitronectin, but
not to laminin. Post-transcriptional down-regulation of the fi-
bronectin-binding integrin a5 and transcriptional down-regulation
of the vitronectin-binding integrin /33 in MMC homologucs com¬
pared with CMCt~ suggest that TGF-/31 may also regulate mast
cell adhesion to these ECM proteins by alteration in expression of
specific integrins.
In vivo, secreted TGF-/31 must be activated to form a functional
molecule, and epithelially expressed integrin av)36 has been im¬
plicated in this process (48). Our most recent studies have shown
coexpression of TGF-/31 and integrin aj36 in murine jejunal ep¬
ithelium, and that P6~'~ mice have significantly reduced numbers
of intraepithelial MMC following Nippostrongylus brasiliensis in¬
fection (49). This result is highly suggestive of a role for TGF-/31
in the intraepithelial MMC response to nematode parasites. It is
possible that mechanisms include regulation of the expression of
integrins, including a7l3, and aEjS7, that could be critical for in¬
traepithelial migration and retention of MMC.
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